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Neurons connect to their remote targets via axons, which usually survive for the lifetime of an 
organism. Spatiotemporal regulation of the axonal proteome by local protein synthesis (LPS) 
plays a critical role in neuronal wiring and axon survival, raising the intriguing possibility that 
some neurological disorders involve LPS dysfunction.   
To visualise LPS in situ, I optimised multiple imaging techniques to investigate Netrin-1-
induced translation in cultured retinal axons. Total axonal protein synthesis measured by 
metabolic and puromycin labelling indicates axons experience stage-dependent alterations in 
translation rate upon Netrin-1 stimulation. Remarkably, Netrin-1 triggers a burst of β-actin 
synthesis starting within 20 seconds of cue application at multiple non-repetitive sites visualised 
by single molecule translation imaging, an approach that allows direct visualisation of 
translation dynamics in response to external stimuli.  
Further studies have shown that local translation can occur on Rab7a-associated late endosomes, 
where mRNA recruitment and translation are coordinately regulated. Notably, mRNAs 
encoding mitochondria-related proteins are found translating on late endosomes docking in the 
vicinity of mitochondria, suggesting late endosomes act as ‘platforms’ for the localised 
synthesis of mitochondrial proteins necessary for maintaining mitochondrial integrity. Moreover, 
this process is affected in axons expressing the Charcot-Marie-Tooth disease type 2B 
(CMT2B)-related Rab7a mutants, leading to abnormal mitochondrial biogenesis and activity 
and compromised axon survival.  
Finally, attenuated de novo protein synthesis is observed in axons expressing amyotrophic 
lateral sclerosis (ALS)-associated fused in sarcoma (FUS) mutants and hypomethylated wild-
type FUS. Live imaging reveals mislocalised mutant or hypomethylated FUS granules are 
transported along axons and accumulate at growth cones, possibly irreversibly trapping RNA 
molecules, resulting in reduced distance travelled by RNA granules in axons. Furthermore, 
mutant FUS expression results in defective retinal projections in vivo, highlighting the 
importance of RNA metabolism and local translation in axonal homeostatic mechanisms. 
In conclusion, aberrant translational activity in axons leads to prominent axonopathy, which 
recapitulates features of early stages of neurological diseases, providing the basis for novel 
therapeutic strategies.  
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1 INTRODUCTION 
1.1 Local translation in axon 
1.1.1 Neuronal RNA localisation and local translation 
Neurons are highly compartmentalised cells comprising three morphologically and functionally 
distinct domains - somata, dendrites and axons. To facilitate their different cellular activities, 
each compartment has their unique set of membranes, organelles, enzymes, cytoskeletons, 
receptors and signalling molecules (Conde and Caceres, 2009; El-Husseini Ael et al., 2001; 
Lasiecka and Winckler, 2011). Therefore, it is anticipated that proteins are differentially 
localised to different subcellular regions to support local cellular activities. 
Once thought that mRNA translation in neurons occurs exclusively in perinuclear regions in the 
soma, research over three decades has demonstrated that protein synthesis can also take place in 
distal neurites, a process referred to as local translation. The earliest evidence of dendritic 
translation dates back to the early 1980s, when polyribosomes were first identified at the 
dendritic spines by electron microscopy (Steward and Levy, 1982). Later, metabolic labelling of 
nascent peptides provided direct evidence of de novo protein synthesis occurring in dendrites 
(Feig and Lipton, 1993; Torre and Steward, 1992). Interestingly, the close link between protein 
synthesis and long-term memory has been long established in vivo in multiple models (Davis 
and Squire, 1984). But not until these early evidence supporting dendritic protein synthesis and 
the discovery of the activity-dependent translation of a specific subset of mRNAs at 
postsynaptic sites, researchers were able to directly link synaptic plasticity with local translation 
in dendrites (Costa-Mattioli et al., 2009; Steward et al., 1998; Sutton and Schuman, 2006; 
Tanaka et al., 2008).  
Axonal translation, however, had been controversial for many years due to the absence of 
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polyribosomes in mature axons under the electron microscope, even though early experiments 
demonstrated protein synthesis could take place in giant squid axoplasm and axonal envelope 
by radioactive labelling (Giuditta et al., 1968) and polyribosomes were visible in growth cones 
(Bunge, 1973; Tennyson, 1970). It is now known that ribosomes can be localised close to the 
plasma membrane and associate with surface receptors, possibly translating in a monosomal 
manner (Heyer and Moore, 2016; Sotelo-Silveira et al., 2008; Tcherkezian et al., 2010), which 
may explain the difficulty in identifying polyribosomes in ultrastructural studies. Developing 
axons benefit greatly from local protein synthesis, through which they receive a high degree of 
autonomy. Remarkably, cultured axons severed from their somata were able to survive and 
respond to guidance cues (Campbell and Holt, 2001; Shaw and Bray, 1977) and somaless axons 
can still navigate properly in vivo (Harris et al., 1987). In mature axons, the regenerative ability 
of axons relies on local protein synthesis, particularly near injured sites (Gumy et al., 2010). 
Spatial regulation of protein translation involves subcellular mRNA localisation according to 
where the protein functions, which also offers finer temporal control of local protein synthesis 
in response to environmental stimuli without the delay during transport. Moreover, it is a more 
energy-efficient approach than transporting individual proteins to their destinations because few 
mRNAs are needed for many copies of translated proteins. In addition, ectopic expression of 
proteins in other subcellular compartments can be avoided by translating mRNAs only at sites 
where the proteins are needed (Holt and Bullock, 2009).   
The mechanism of mRNA localisation is evolutionally conserved in different cells and 
organisms. In neurons, nuclear-transcribed mRNAs associate with RNA-binding proteins (RBPs) 
through cis-acting regions referred to as zipcode sequences or localisation elements, commonly 
found in the 3’ untranslated region (UTR) of the transcript (Jambhekar and Derisi, 2007; 
Shahbabian and Chartrand, 2012; Xing and Bassell, 2013). In addition to mRNAs and RBPs, 
transport complexes also contain adapter proteins, molecular motors, accessory factors and 
ribosomal proteins, referred to as ribonucleoprotein particles (RNPs), which undergo active 
transport to remote subcellular locations along microtubules and microfilaments for on-site 
local translation (Eliscovich and Singer, 2017; Holt and Bullock, 2009; Mitchell and Parker, 
2014).  
Subsequently, translational control confers spatiotemporal precision to regulate protein 
abundance by inducing rapid changes in translation rates in response to signal inputs. 
Translational control can be exerted by multiple mechanisms involving changes in local 
amounts and activities of ribosomes, translation machinery components, tRNAs and 
microRNAs (Sonenberg and Hinnebusch, 2009). For example, during unfolded protein stress in 
the endoplasmic reticulum (ER), a transmembrane protein kinase of the pancreatic eIF-2α 
2
      
kinase (PEK) family, protein kinase RNA-like endoplasmic reticulum kinase (PERK), are 
oligomerised, autophosphorylated and phosphorylates eukaryotic translation initiation factor 2α 
(eIF-2α), decreasing global protein synthesis, which decreases protein load in the ER (Walter 
and Ron, 2011). Intriguingly, the translation of a small subset of mRNAs containing upstream 
open reading frames at their 5’UTR is upregulated by phosphorylated eIF-2α, including 
transcription factor ATF4 that activates proapoptotic gene transcription (Ameri and Harris, 2008; 
Costa-Mattioli et al., 2005). 
In sum, local translation in neuronal dendrites and axons is a fundamental mechanism to 
regulate local proteome under basal, stimulated and stress conditions. 
1.1.2 Local translation promotes axon survival 
In order to investigate the relationship between dysregulated axonal protein synthesis and 
neuropathies, it is important to first understand how local translation contributes to axon 
maintenance and survival. Early research proposed axon degeneration as a consequence of cell 
body death, due to insufficient material and energy support from the soma (Pease and Segal, 
2014). However, this view was first challenged by the identification of the Wallerian 
degeneration slow (WldS) protein that delays degeneration of somaless axons for weeks 
(Coleman et al., 1998). To date, accumulated evidence has demonstrated that axons rely on 
multiple soma-independent pathways that involve local translation for survival and degeneration 
(Cosker et al., 2013; Luo and O'Leary, 2005; Wang et al., 2012; Yan et al., 2010).  
The most well-establish mechanism to promote axon survival in developing axons depends on 
target-derived trophic factors secreted by post-synaptic target tissues, including nerve growth 
factor (NGF), brain derived growth factor (BDNF), neurotrophin 3 and 4 (NT3 and NT4), 
which bind to their receptors TrkA, TrkB and TrkC at growth cones located at axon terminals 
(Chao, 2003). Upon binding to neurotrophins, receptors are internalised, forming signalling 
endosomes, and subsequently retrogradely transported to cell bodies by dynein motors along 
microtubules (Yamashita and Kuruvilla, 2016), where they activate trophic signalling pathways 
including phosphoinositide 3 (PI-3) kinase and mitogen-activated protein (MAP) kinase 
cascades (Huang and Reichardt, 2003; Kuruvilla et al., 2000; Watson et al., 2001). This leads to 
upregulated transcription of transcription factors, such as cyclic AMP responsive element-
binding protein (CREB), the mRNAs of which are transported into axons for local translation to 
promote axon maintenance and survival (Cox et al., 2008; Riccio et al., 1997).  
In addition to the classic target-derived neuronal survival, a study by our group discovered an 
unexpected link between axonal translation of a nuclear lamina protein LaminB2, mitochondrial 
3
      
function and axon survival (Jung et al., 2012). Inhibition of LaminB2 local translation caused 
axon degeneration by disrupting mitochondrial functions and altering mitochondrial trafficking 
in axons. Because phosphorylation of LaminB2 triggers nuclear membrane fragmentation 
during cell division (Dauer and Worman, 2009), mechanistically, LaminB2 might control 
mitochondrial membrane cleavage during mitochondrial fission, which could explain the 
observed elongated mitochondrial morphology and decreased membrane potential in LaminB2 
knockdown axons. Suboptimal mitochondrial activities, which fail to provide sufficient energy, 
metabolites and calcium buffering, may result in comprised axon survival (Court and Coleman, 
2012). In fact, mitochondrial dysfunctions are known to associate with several 
neurodegenerative disorders with prominent axonal phenotypes (Delettre et al., 2000; Nunnari 
and Suomalainen, 2012), suggesting axons are particularly sensitive to disturbance to 
mitochondrial integrity. For instance, mutations of mitochondrial proteins and lamins may cause 
Charcot-Marie-Tooth type 2B (CMT2B) diseases, an inherited neuropathy characterised by 
sensory axon degeneration (Dauer and Worman, 2009; Lu et al., 2009a). 
Neurotrophin- and mitochondria-mediated mechanisms appear to be two independent pathways 
to promote axon viability. However, their close relationship was elucidated by the incredible 
work from Segal and colleagues (Cosker et al., 2016; Cosker et al., 2013). They showed, in 
response to neurotrophin signalling, RNA-binding protein splicing factor, proline-glutamine 
rich (SFPQ), as an axonal RNA regulon, promotes axonal localisation of multiple mRNAs, 
including creb and nuclear-encoded mitochondrial genes bclw and laminb2, by shuttling 
between cell bodies and distal axons. In addition, SFPQ might also control neurotrophin-
induced translation of its target mRNAs by releasing them in distal axon compartments for 
translation initiation, supporting the model that local translation of mitochondrial proteins 
sustains mitochondrial functions, important for axon maintenance and survival (Cosker et al., 
2016). 
1.1.3 Dysregulation of mRNA localisation and local translation in 
neuropathies  
Given the importance of local translation in axon maintenance and survival, it can be easily 
anticipated that aberrant translation activity can result in axonopathy. Indeed, dysregulated 
axonal mRNA trafficking and translation have been identified in an increasing number of 
neurodegenerative disorders (Jung et al., 2014; Millecamps and Julien, 2013; Wang et al., 
2016b). 
Assembly of mRNAs and other factors into RNPs is a critical step to ensure successful mRNA 
localisation and local translation. Both hyperassembly and hypoassembly of RNPs can result in 
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neurological diseases (Shukla and Parker, 2016). Therefore, as key components of RNPs, 
mutations in RBPs and associated mRNAs can cause mislocalization of mRNAs and 
compromised local translation. For example, spinal muscular atrophy (SMA)-associated RBP, 
survival of motor neuron (SMN), has been found to regulate axonal localisation and translation 
of β-actin and growth-associated protein 43 (GAP43) (Fallini et al., 2016; Rossoll et al., 2003). 
A missense mutation in the 3’UTR of Leucine-rich repeat kinase 2 (LRRK2) leads to a strong 
reduction of LRRK2 mRNA in a specific brain region, increasing the risk of Parkinson’s 
disease (Cardo et al., 2014). On the other hand, mutations in several RBPs, including RBPs 
Fused in Sarcoma (FUS) and TAR DNA-binding protein (TARBDP), are causative to 
amyotrophic lateral sclerosis (ALS) due to RNP hyperassembly (Kwiatkowski et al., 2009; 
Sreedharan et al., 2008). These RBPs contain intrinsically disordered domains that promote 
assembly of dispersed RNAs and proteins into higher structures like RNPs, which can be 
reversibly disassembled under physiological conditions (Kato et al., 2012). However, disease-
associated mutants likely stabilise these granules and irreversibly trap mRNA and components 
of translational machinery, impairing RNA trafficking and local translation in axons 
(Ramaswami et al., 2013; Yasuda and Mili, 2016).  
Neuropathies are also linked to defective translational regulation in neuronal compartments. 
Fragile X mental retardation protein (FMRP) is a translational repressor through its binding to 
the coding sequences of translating mRNAs and stalling ribosome translocation (Darnell et al., 
2011). Mutations in FMRP have been identified in fragile X mental retardation and autism 
(Darnell and Klann, 2013; Zukin et al., 2009), resulted from elevated local translation in 
dendrites and axons. Likewise, overactivation of mammalian target of rapamycin (mTOR) 
pathway, a major translational regulator in axons, is reported in autism spectrum disorders 
(ASDs) (Kelleher and Bear, 2008). 
It is thus evident that local protein synthesis and effective intervention approaches have 
emerged as a leading focus of neuropathy research. Elucidating molecular mechanisms of RNP 
assembly and translational regulation can offer valuable insights into pathophysiology of many 
diseases. Determining mRNA abundance and translation rates of individual proteins in dendrites 
and axons of disease-affected neurons by high-throughput genomewide approaches may lead to 
discovery of novel proteins related to individual neurological diseases, providing a genetic basis 
for the development of therapeutic approaches.  
  
5
      
1.2 Detecting RNA localisation and local translation in neurons 
1.2.1 Visualisation of mRNA localization in neurons  
In highly polarised cells, such as neurons, proper localisation of mRNAs to their destination for 
subsequent translation is a critical first step in regulating local translation at subcellular 
compartments. The capability to observe mRNA localization with high resolution in neurons 
yields critical information for understanding the cellular mechanisms for mRNA localisation. 
Among all the existing techniques, in situ hybridization (ISH) (Lawrence and Singer, 1985) and 
fluorescence in situ hybridization (FISH)  have been the most extensively used approaches in 
visualizing intracellular mRNA molecules in fixed tissues and cells. A digoxigenin (DIG)-
labelled antisense oligonucleotide probe is annealed to its target mRNA sequence, and 
subsequently recognised by an anti-DIG antibody, which can be visualised via pigments or 
fluorescent dyes  (Figure 1.1 A) (Levsky and Singer, 2003).  
As FISH had been extensively employed in numerous studies to visualise RNA intracellular 
RNA molecules, it was further developed to allow quantitative analysis of localised mRNA 
molecules at single molecule levels, a technique referred to as single-molecule FISH (smFISH). 
Multiple smFISH probes labelled with fluorophores bind to their complementary sequence in 
the target mRNA, allowing detection of single mRNA molecules in fixed samples (Figure 1.1 B) 
(Kwon, 2013). Variations of smFISH probes include five 50-nucleotide amino-modified 
oligodeoxynucleotides (ODNs) with 5 fluorophores each, yielding a high signal to noise ratio 
(Femino et al., 1998), or 48 singly labelled 20-nucleotide ODNs, which generate more uniform 
signals that can be computationally identified for accurate mRNA quantification and simplify 
probe preparation (Raj et al., 2008).  
Despite the quantitative analysis and high spatial resolution provided by smFISH, the number of 
mRNA molecules that can be visualised in one experiment is limited. To improve the 
throughput of smFISH, Xiaowei Zhuang’s group developed and successfully implemented 
multiplexed error-robust fluorescence in situ hybridization (MERFISH) to simultaneously 
image over hundreds of unique mRNAs in a tens of thousands of cells in a single run (Chen et 
al., 2015; Moffitt et al., 2016). In this approach, each mRNA is identified by a combinatorial 
barcode of colours, resembling the binary code used in computer calculations. Each round of 
hybridization and imaging, only a subset of mRNAs are labelled. The labelled mRNAs are 
assigned a “1”, while the non-labelled ones are noted as “0”. After N rounds of hybridization, 
each mRNA will obtain a binary code like “10010111…”, and the total number of unique 
barcodes will be 2N(Figure 1.1 C). For instance, a 16-round hybridization can generate over 
65000 barcodes, greatly expanding the RNA species can be identified in one assay. In 
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Figure 1.1 Methods for visualising mRNA localisation in neurons.
(A) Fluorescent in situ hybridization (FISH): a digoxigenin (DIG)-labelled antisense 
oligonucleotide probe binds to the target mRNA sequence, which is recognised by 
fluorophore-conjugated anti-DIG antibodies.
(B) Single-molecule fluorescent in situ hybridization (smFISH): multiple fluorescent probes 
complimentary to different regions of the mRNA amplify the signal of a single mRNA for quantitative 
analysis.
(C) Multiplexed error-robust fluorescence in situ hybridization (MERFISH): Unique barcodes for 
individual RNA species are identified through successive rounds of smFISH, each with a fluorescent 
probe complementary to the subsequent regions of the target RNA sequences. A time-lapse stack of 
smFISH images produces fluorescence spots with on/off patterns generating binary barcodes (“1” 
represents fluorescent signal on, and “0” represents fluorescent signal off) for RNA species localised 
to the corresponding spots.
(D) Fluorescent in situ sequencing (FISSEQ): the fixed mRNA is first reversed-transcribed into 
cDNA, which is circularised and amplified multiple times by rolling circle amplification. 
Subsequently, the replica DNA is sequenced in situ by sequencing by oligonucleotide ligation and 
detection (SOLiD) with a sequencing primer and fluorescent sequencing probes labelled with different 
fluorophores.
(E) SYTO dyes: fluorescence of SYTO dyes increases significantly upon binding to RNA 
molecules in live cells.
(F) Fluorescent synthetic mRNA: fluorescent mRNAs can be in vitro transcribed in presence of 
fluorophore-conjugated uridine triphosphates (UTPs) and introduced intracellularly.
(G) Molecular beacon: a single-stranded stem-loop shaped probe consists of two complimentary 
stem sequences located at either end of the probe that bring the quencher close to the fluorophore in 
an unbound state, and a loop sequence complementary to target mRNA sequence. Upon hybridisation 
of the loop sequence to the target mRNA, the separation of the quencher from the fluorophore restores 
its fluorescence. 
(H) MS2-MCP: tandem repeats of MS2 stem-loop sequences incorporated into the 3’UTR of the 
target mRNA can be recognised by GFP-labelled MS2 coat protein (MCP), revealing the localisation 
of the target mRNA with bright GFP puncta.
(I) Tagged-RNA-binding protein (RBP): mRNA localisation can be inferred by its associated 
RNP fused with a fluorescent protein. 
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combination with localization-based super-resolution microscopy, the spatial distribution of 
registered mRNAs can be precisely mapped (Moffitt and Zhuang, 2016).  
To further increase the number of different mRNAs detected in a single assay, a next-generation 
sequencing-based approach, fluorescent in situ sequencing (FISSEQ), was developed by Church 
and colleagues (Lee et al., 2014). mRNAs in fixed samples are first reverse-transcribed into 
cDNA with tagged random hexamers. The cDNA is then circularised and amplified on-site 
through rolling circle amplification, forming nanoballs of single-stranded DNA consisting of 
tandem repeats of the cDNA sequence. Subsequently, the amplified DNA is sequenced in situ 
through sequencing by oligonucleotide ligation and detection (SOLiD) (Goodwin et al., 2016; 
Valouev et al., 2008) to reveal the exact sequence of the replica DNA by sequential ligation of 
nucleotide-specific spectrally distinct fluorescent sequencing probes under a super-resolution 
microscope (Figure 1.1 D). The developed FISSEQ protocol has been tested in cultured cells, 
tissue sections, whole-mount Drosophila embryos and organoids (Lee et al., 2015), showing 
great promise as a reliable tool to interrogate mRNA localization in various biological systems, 
including small compartments such as axons.  
However, the temporal information obtained from in situ hybridization or FISSEQ relies on 
fixing samples at different timepoints after cellular state alteration. A finer temporal resolution 
of mRNA dynamics can be achieved by techniques capable of tracking mRNAs in live cells. 
SYTO dyes were the first cell-permeable fluorescent nucleic acid stain compatible with live 
imaging of RNA granules in neurons. It fluoresces at least 4 times brighter upon binding to 
RNA than to DNA, proteins, lipids or dye alone (Figure 1.1 E) (Knowles et al., 1996). TDP-43 
RNP granules were stained positively with SYTO14 dyes (Alami et al., 2014). Alternatively, 
intracellularly delivered fluorescently labelled uridine triphosphates (UTPs) (Figure 1.1 F) can 
be incorporated into RNA molecules during their synthesis and transported along neurites in 
ribonucleoparticles (RNPs) (Wong et al., 2017). The trafficking of endogenous RNAs can be 
monitored continuously in live samples without any washing step, which is required by SYTO 
dye imaging. 
Both SYTO14 dyes and fluorescent labelled-UTPs are non-specific RNA dyes. To visualised 
specific mRNAs, fluorescent mRNAs can be in vitro transcribed in the presences of fluorescent 
conjugated UTPs and introduced into live neurons through microinjection or electroporation 
(Gao et al., 2008; Tubing et al., 2010). Comparably, molecular beacon (MB) method also 
provides a reliable tool to detect native mRNA with sequence specificity in living cells. MBs 
are single-stranded stem-loop shaped probes with 20-25 nucleotides located at the loop 
complimentary to their targeted mRNA sequences (Figure 1.1 G). In an unbound beacon, the 3’ 
end quencher is located in close proximity to the 5’ end fluorescent reporter, quenching its 
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fluorescence emission. Upon hybridization to its target, the separation of the quencher and the 
fluorophore restores the fluorescence, allowing the visualization of endogenous transcripts. A 
well-designed MB needs to meet several criteria, including high sequence specificity to its 
target to minimize off-target binding, the accessibility of the targeted sequence on mRNA, and 
no disruption to the conformation or RBP-binding site of the mRNA that might interfere with its 
localisation (Mikl et al., 2010). An early study using MB approach was able to tracked oskar 
mRNA migration at various locations in developing Drosophila embryos (Bratu et al., 2003). 
Introducing a cocktail of multiple MBs targeting several regions of an mRNA can greatly 
enhance detection sensitivity and specificity (Mhlanga et al., 2009). However, the 
implementation of MB strategy in live neurons is scarce (Simon et al., 2010; Zepeda et al., 2013) 
due to the fast degradation of probes in transfection medium and inefficient delivery using 
conventional DNA transfection protocol (Nitin et al., 2004). Nevertheless, Cy3-conjugated MB 
introduced intracellularly by Lonza Nucleofector electroporation was successfully employed to 
visualise endogenous Neurofilament-L (Nefl) mRNA trafficking in axons of mouse cortical 
neurons and human motor neurons (Alami et al., 2014), demonstrating it as a promising strategy 
for future application in real-time visualisation of mRNA trafficking in neuronal compartments.  
An alternative strategy for monitoring both endogenous and exogenous mRNA localization in 
live cells at single-molecule level is the MS2-MCP system (Bertrand et al., 1998). In order to 
fluorescently label a specific mRNA with high signal-to-noise ratio, a tandem repeat of 8-132 
RNA stem-loops derived from the MS2 bacteriophage genome regulatory element is 
incorporated into the 3’ untranslated region (UTR) of the mRNA candidate (Bertrand et al., 
1998; Pichon et al., 2016; Wu et al., 2015). The stem-loops can be recognised specifically by an 
RNA-binding protein (RBP), the MS2 coat protein (MCP), which is linked to a fluorescent 
protein or fluorescent dyes (Figure 1.1 H). As a result, multiple fluorophores are tethered to the 
mRNA with MS2 stem-loops, amplifying the fluorescent intensity of the mRNA locally. In 
order to reduce the cytoplasmic background signals caused by free fluorescent MCP, nuclear 
localization signals can be included into the MCP sequence (Wells et al., 2007). Resembling the 
MS2-MCP system, PP7-PCP from Pseudomonas aeruginosa PP7 bacteriophage (Chao et al., 
2008) and λNbox derived from λ bacteriophage boxB RNA sequence and antiterminator protein 
N (Daigle and Ellenberg, 2007) have been characterised to enable dual-colour or multicolour 
imaging of different mRNA species (Fu et al., 2016; Ma et al., 2016). 
When mRNAs travel in neuronal processes, they often associate with RBPs to form messenger 
ribonucleoprotein particles (mRNPs) that travel along cytoskeleton tracks towards their 
destinations (Buchan, 2014; Kiebler and Bassell, 2006). Most RBPs preferentially complexed 
with specific mRNAs via cis-acting localization elements, for example, zipcode-binding protein 
(ZBP1) binding to β-actin “zipcode” sequence located in its 3’UTR (Bassell et al., 1998; 
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Condeelis and Singer, 2005) and Staufen interacting with stem-loops within bicoid 3’UTR 
(Ferrandon et al., 1994). Therefore, mRNA localisation in cells can be inferred by investigating 
the dynamics of their associated RBPs fused with fluorescent proteins (Figure 1.1 I) (Kohrmann 
et al., 1999; Wang and Hazelrigg, 1994). However, the information obtained using this method 
should be interpreted with caution, as an RBP likely binds to multiple mRNA targets in addition 
to the mRNA of interest. Besides expressing fluorescently tagged RBPs, nanobodies (Rothbauer 
et al., 2006) and aptamers (Paige et al., 2011) have also been introduced intracellularly to 
visualise the endogenous RBPs. 
1.2.2 Detecting de novo protein synthesis in living cells  
Even though mRNA localisation is the prerequisite for local protein synthesis, increasing 
evidence indicates that the abundance of mRNAs measured by microarrays or RNA sequencing 
(RNA-seq) does not usually predict the protein level determined by mass spectrometry (MS) in 
most cellular systems, with a R2 correlation coefficient of approximately 0.4 (Lundberg et al., 
2010; Schwanhausser et al., 2011; Tian et al., 2004; Vogel et al., 2010; Vogel and Marcotte, 
2012). This is because mRNAs do not have equal translation efficiency. For example, 
housekeeping genes tend to have stable mRNAs and proteins. On the contrary, mRNAs and 
proteins of transcription factors and signalling genes usually have shorter half-lives and higher 
turnover rates and are thus expected to show poor correlation (Schwanhausser et al., 2011). 
Furthermore, over 1000 microRNAs encoded by human genome function as intracellular 
translational repressors of a large proportion of mRNAs (Bartel, 2009; Moore, 2013). In 
particular, in many disease models, a larger percentage of mRNAs associate with P-bodies and 
stress granules, entering the translationally repressed state (Buchan, 2014; Wolozin, 2012). For 
these reasons, mRNA translation efficiency rather than abundance at different cellular states 
would be the more useful parameter to evaluate disease progress. Several MS- and RNA-seq-
based methods for detecting newly synthesised proteins have been developed.   
Early studies of protein synthesis heavily relied on labelling nascent peptides with radioactive 
(3H, 14C, 35S, 32P or 33P) amino acid isotopes, which can be precipitated in trichloroacetic acid 
(TCA) and measured by scintillation counting (Campbell and Holt, 2001; Schubert et al., 2000). 
However, the implementation of this method in living cells is confounded by a number of 
limitations, including safety concerns (Meisenhelder and Hunter, 1988), potential perturbation 
to biological systems (Hu and Heikka, 2000), uneven and uncontrolled distribution of the 
radioactive label in nascent peptides and incompatibility with MS analysis.  
To solve these problems, stable isotope labelling by amino acids (SILAC) was introduced to 
replace radioactive isotope incorporation into synthesising polypeptides in living cells (Ong et 
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al., 2002). The principle of SILAC lies in metabolic incorporation of amino acids labelled by 
stable isotopes (2H, 13C or 15N-labelled methionine, arginine or lysine) into the proteome during 
de novo protein synthesis. Incubating the cell cultures sequentially with “light” (natural isotope) 
and “heavy” (stable isotope) forms of amino acid or a combination of different amino acids with 
distinct isotopes can be used to compare multiple proteomes at different cellular states in a 
single assay (Andersen et al., 2005; Olsen et al., 2006). The temporal dynamics of protein 
expression in response to extracellular stimulation can be determined by pulsed SILAC 
(pSILAC) by incubating cells with light, middle or heavy isotope-labelled amino acids for a 
short period of time. The abundance ratio between differentially labelled populations correlates 
with the difference in translation rate (Milner et al., 2006; Schwanhausser et al., 2009). In 
addition, performing SILAC concurrently with subcellular purification techniques provides 
spatial information of proteomes or translatomes associated with multiple organelles and 
subcellular compartments, including mitochondria (Chen et al., 2010), nucleolus (Emmott et al., 
2010) and lipid rafts (Foster et al., 2003). Taken together, SILAC is a simple and robust MS-
based approach with high accuracy and reproducibility for quantitative proteomic studies 
universally applicable in cell culture systems. 
Another MS-based approach, bioorthogonal noncanonical amino acid tagging (BONCAT), 
enables the identification of newly synthesized proteins by replacing the amino acid methionine 
with an azide-bearing analogue azidohomoalanine (AHA) or alkyne-bearing analogue 
homopropargylglycine (HPG) (Dieterich et al., 2007; Dieterich et al., 2006). AHA and HPG are 
membrane permeable and can be charged onto intracellular methionine tRNAs. The nascent 
proteins synthesised during AHA or HPG incubation thus carry methionine surrogates, 
distinguishing them from the pre-existing proteins. AHA and HPG can be recognised by alkyne- 
or azide-conjugated affinity tags (Lichty et al., 2005) through a click chemistry reaction, 
Copper(I)-Catalysed Azide-Alkyne Cycloaddtion. Affinity tag-incorporated proteins can be 
analysed using 1D or 2D Western Blot or separated from the preexisting proteome by affinity 
purification and identified by high-throughput mass spectrometry (Yoon et al., 2012). BONCAT 
can also be used in conjunction to SILAC, combining their strengths in quantitative proteomic 
analysis to yield high accuracy and sensitivity (Bagert et al., 2014; Howden et al., 2013). 
In addition to the MS-based techniques, RNA-seq-based approaches for translation studies have 
also advanced rapidly during the past decade. To reveal the identities of endogenous transcripts 
undergoing differential translation at a whole-genome scale, polysome profiling (Arava et al., 
2003), ribosome profiling (Ingolia, 2014; Ingolia et al., 2009), translating ribosome affinity 
purification (TRAP) (Heiman et al., 2008) and Ribotag (Sanz et al., 2009) methods have been 
developed. Ribosome profiling, also known as ribosome footprinting, generates a quantitative 
profile of translation through deep sequencing of ribosome-protected mRNA fragments and is 
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capable to determine translation rate, identify translated regions in transcripts and provide 
insights into translational regulation (Heyer and Moore, 2016; Ingolia, 2016). Since its first 
application, the spatial resolution of ribosome profiling has been further improved, allowing 
translation detection at specific subcellular compartments, such as mitochondria and 
endoplasmic reticulum (ER) (Jan et al., 2014; Williams et al., 2014). Alternative, TRAP and 
Ribotag strategies offer a simpler solution to translatome analysis in specific tissues or 
subcellular compartments. Both methods rely on pulling down ribosomes and their associated 
mRNAs through GFP- or HA-tagged ribosomal proteins, revealing the identity of ribosome-
bound mRNA by RNA-seq. By placing tagged ribosomal proteins under the control of a tissue-
specific promoter, such as Synapsin1 for neurons (Nathanson et al., 2009) or Pax6 for retinal 
ganglion cell (Shigeoka et al., 2016), TRAP and Ribotag have their unique advantage for tissue-
specific translational profiling.  
1.2.3 Visualising protein synthesis in neurons at single cell level 
While all the MS- and RNA-seq-based translation detection have led to insightful discoveries 
on translation regulation, they only allow ensemble measurements of average protein synthesis 
rates from cell lysates, masking the differences between different mRNA molecules in the same 
or different cells. Moreover, most of these methods do not yield sufficient temporal resolution 
to follow the dynamics of translation activity of individual mRNAs in real time. Nor do they 
preserve the precise spatial information of translation sites due to the pooling of mRNAs from 
thousands of cells in each measurement. Many unsolved questions regarding the heterogeneity 
in translation speed and translation site localisation among individual mRNAs encoded from the 
same or different genes call for in vivo imaging strategies at the single-cell or even single-
molecule level.  
Derived from BONCAT, fluorescent noncanonical amino acid tagging (FUNCAT) visualises 
newly synthesised proteins in situ by tagging AHA and HPG incorporated into nascent peptides 
with alkyne- or azide-bearing fluorescent tags instead of affinity tags (Figure 3.1 A-C) 
(Dieterich et al., 2010). FUNCAT has been successfully applied to visualise endogenous protein 
production at subcellular scale in cell cultures (Tom Dieck et al., 2012) and in live animals 
(Dieterich et al., 2010; Erdmann et al., 2015). However, a caveat of FUNCAT method is when 
used in cell cultures, the protocol often includes an initial methionine deprivation step by 
incubating cells in methionine-free medium to improve the signal-to-noise ratio of methionine 
analogue detection. This stress could potentially alter the localisation and synthesis rate of 
nascent proteins. To address this issue, a complimentary imaging method was developed 
making use of puromycin, commonly known as an aminonucleoside antibiotic produced 
by Streptomyces alboniger (Goodman et al., 2012; Schmidt et al., 2009). As a structural 
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analogue of tRNAs, puromycin can enter the ribosome and be incorporated into elongating 
polypeptides, terminating their translation (Figure 3.4 A). When used at low concentration, 
puromycin labels the C-termini of endogenous proteins during their synthesis, which can be 
subsequently visualised with a fluorophore-conjugated anti-puromycin antibody.  
Despite being easy and robust techniques for visualisation of endogenous protein expression, 
FUNCAT and puromycin labelling are not capable to detect translation of a specific protein in 
situ. To overcome this hurdle, the combination of FUNCAT or puromycylation with proximity 
ligation assay (PLA), referred to as FUNCAT-PLA and Puro-PLA respectively, provides a 
convenient approach to label specific newly synthesised proteins in cell cultures (tom Dieck et 
al., 2015). In FUNCAT-PLA, a biotin tag covalently binds to the methionine analogue via 
Azide-Alkyne Cycloaddtion, and nascent peptides can be detected with an anti-biotin antibody. 
Meanwhile, the protein of interest is recognised by a primary antibody raised in different 
species as the anti-biotin antibody. Next, a proximity ligation assay is performed to assess the 
distance between the two primary antibodies. The appearance of each PLA fluorescent punctum 
indicates both antibodies recognise epitopes within the same protein, marking the presence of a 
specific newly synthesised protein (Figure 3.6 A). Similarly, Puro-PLA utilises puromycin and 
its antibody to identify nascent peptides. In Puro-PLA, it is preferable to use a primary antibody 
for the candidate protein targeting the N-terminal epitope, because a significant proportion of 
the nascent polypeptides are C-terminally truncated due to the puromycin-induced premature 
termination.   
However, the aforementioned approaches require fixation steps for click reaction or antibody 
incubation. Therefore, limited temporal resolution can only be obtained by performing time-
series studies, which substantially increases workload and lengthens experiments. On the other 
hand, studies of translation kinetics can benefit drastically from live imaging strategies.  
The most extensively used approach to investigate translation rate of a candidate protein is by 
expressing a reporter construct containing a fluorescent protein fused with the coding sequence 
of the protein of interest and/or flanked by its UTRs to regulate the fluorescent reporter 
translation (Figure 1.2 A). For instance, green fluorescent protein (GFP) flanked by the UTRs of 
the Ca2+/calmodulin-dependent kinase II-α (CAMKII-α) that convey the essential and sufficient 
information for the dendritic mRNA localisation and translation control showed increased 
translation in dendritic foci upon growth factor stimulation (Aakalu et al., 2001). In particular, 
when combining with fluorescence recovery after photobleaching (FRAP), fluorescent protein 
reporters can be used to monitor translation activity in living cells (Kourtis and Tavernarakis, 
2009).  The introduction of photoconvertible fluorescent proteins (pcFP), such as Kaede, 
Dendra2, mEos2 and mMaple, has greatly expanded the capacity for fluorescent reporters to 
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Figure 1.2 Methods for visualising translation at single cell level.
(A) Fluorescent protein reporter: coding sequence (CDS) of the protein of interest is fused to a 
fluorescent protein sequence and/or flanked by its UTRs to regulate the fluorescent reporter 
translation.
(B) Self-labelling tags: a modified enzyme tag, such as HaloTag, SNAP-Tag or CLIP-tag, is fused 
to the protein of interest, which can be recognised specifically by their fluorophore-conjugated 
ligands.
(C) Biarsenical dyes: a tetracysteine motif added to the N-terminus of the protein of interest binds 
with high affinity and increases the photon emission of a fluorescent dye bearing two arsenic moieties.
(D) Gaussia luciferase reporter: the newly synthesised protein of interest fused to Gaussia 
luciferase catalyses its substrate coelenteraizine (CTZ) to trigger bioluminescence. Majority of the 
signals decays within 10 seconds to distinguish the nascent peptides from the pre-existing signals.
(E) Translating RNA imaging by coat protein knock-off (TRICK): on an untranslated mRNA, 
PCP-GFP and MCP-RFP bind to PP7 stem-loops in the translating region and MS2 stem-loops in the 
3’UTR, respectively, labelling untranslated mRNAs with yellow fluorescence. After first round of 
translation, a ribosome moving across the coding region removes PCP-GFP molecules from PP7 
stem-loops, changing the colour of the target mRNA from yellow to red.
(F) SunTag: protein of interest is fused to multiple tandem repeats of SunTag sequences at its 
N-terminus. GFP-conjugated single-chain variable fragment (scFv-GFP) proteins bind to SunTag 
epitopes, labelling the synthesising fusion proteins with tens of pre-formed fluorescent molecules. 
16
      
visualise de novo translation at subcellular locations (Leung et al., 2006; McEvoy et al., 2012; 
Mohapatra et al., 2017; Wang et al., 2009). The emission spectrum of nascent pcFPs is similar 
to GFP (λexcitation≈488nm, λexcitation≈509nm). Upon irradiation with ultraviolet light 
(λexcitation≈405nm) or intense blue light (λexcitation≈488nm) in case of Dendra2, they are 
irreversibly photoconverted to red fluorescent protein (RFP) spectrum (λexcitation≈566nm, 
λexcitation≈582nm) (Lukyanov et al., 2005; Shaner et al., 2007). Therefore, after UV 
photoconversion, green newly synthesised proteins can be spectrally distinguished from the pre-
existing pool in red (Leung et al., 2006; Shcherbakova et al., 2014). However, the drawback of 
using photoconvertable proteins for this purpose is the long maturation time, which can take up 
to 90 minutes at 37°C (Ahmad et al., 2008; Zhang et al., 2007).  
To circumvent this problem, a “self-labelling” tag sequence, such as HaloTag (Los and Wood, 
2007), SNAP-Tag (Keppler et al., 2003) or CLIP-tag (Gautier et al., 2008), that can be 
recognised by fluorescently labelled ligands is added to the N-terminus of the protein of interest 
(Grimm et al., 2015). The fluorescent conjugated ligands are membrane permeable, capable to 
recognise and form irreversible covalent bonds with their targeted tags, which are modified 
enzymes, rapidly and with high specificity in live or fixed cells (Figure 1.2 B). Most 
importantly, self-labelling tags allow instantaneous imaging of nascent peptides as the 
conjugated fluorophores are preformed. Proteins encoded from the same gene synthesised at 
different times can be temporally distinguished by incubating the sample with ligands 
conjugated to different fluorophores. To improve the signal-to-noise ratio, unbound ligands can 
be removed with washing steps (Los et al., 2008), or tandem repeats of recognition sequences 
are fused to the protein to enrich the fluorophore-tagged ligands (Wu et al., 2016).  
The first success in continuous visualisation of single translation sites in living cells used 
biarsenical dyes (Ju et al., 2004; Rodriguez et al., 2006), developed by Tsien and colleagues 
(Gaietta et al., 2002; Griffin et al., 1998). A fluorescent dye carrying two arsenic moieties binds 
with high affinity to a short peptide stretch fused to the N-terminus of the protein of interest 
encoding a motif with four cyteines (-C-C-X-X-C-C-, X=any non-cysteine amino acid). Two 
commonly used cell permeable biarsenical dyes are fluorescein-based FlAsH and resorufin-
based ReAsH (Figure 1.2 C), which increase in fluorescence upon biding to the tetracysteine 
motif. Using the two spectrally distinct dyes in a pulse-chase assay enabled detection of locally 
synthesised AMPA receptor subunits, GluR1 and GluR2 in dendrites in an activity-dependent 
manner (Ju et al., 2004). However, the washing step to remove dye molecules for single peptide 
detection (Gaietta et al., 2011) makes continuous imaging in real time challenging. Additionally, 
the potential toxicity of the dye solution can be harmful to sensitive cell types, such as primary 
neuron cultures, during long-term imaging. 
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Another pitfall of visualising nascent peptides with biarsenical dye is that it cannot be used to 
differentiate synthesising or newly synthesised proteins from the dye-labelled completed 
proteins until their degradation. Therefore, it has limited capacity to monitor translation activity 
of abundant proteins over time. A recent bioluminescence-based translation imaging approach 
(Na et al., 2016) took advantage of the fast bioluminescence emission and fast signal decay 
property of Gaussia luciferase (Gluc) upon interacting with its substrate coelenteraizine (CTZ) 
(Figure 1.2 D) (Tannous et al., 2005). In this assay, the protein of interest expressed 
intracellularly is fused with Gaussia luciferase. Upon CTZ administration, a sudden increase of 
bioluminescent signals was observed within all subcellular compartments in neurons, 
representing the pre-existing pool of Gluc-fused proteins. 90% of Gluc bioluminescence decays 
in approximately 10 seconds. Thereafter, de novo proteins can be visualised as individual 
puncta. Increased bioluminescence of Gluc-Arc (activity-regulated cytoskeletal associated 
protein) in dendrites within 15 seconds of glutamate stimulation supported the high temporal 
resolution of the technique relying on the rapid reaction between Gluc and CTZ.  
With the advancement of super-resolution fluorescence microscopy to improve optical 
resolution to tens of nanometers by breaking the diffraction limit, the precise localization and 
kinetics of individual mRNA and protein molecules in subcellular compartments during 
translation have raised great interest among neuroscientists. Detection of the translation sites 
can be achieved through biarsenical dye-based method, but it does not allow quantification of 
translation rates. Despite the high temporal resolution provided by the bioluminescence-based 
system, it does not possess the resolution of single molecules due to its incompatibility with 
super-resolution microscopy. The first success in real-time visualisation of single protein 
expression used a fast-folding, fast-photobleaching bright yellow fluorescent protein derivative, 
Venus, as a translation reporter in bacteria (Yu et al., 2006). Since then, two successful 
implementations of the method in dendrites of live neuron cultures have been reported (Ifrim et 
al., 2015; Tatavarty et al., 2012). During continuous imaging under laser illumination sufficient 
to photobleach Venus molecules, as soon as the Venus-tagged protein is translated and matures 
(<2min in neurons), it emits a brief burst of photons before photobleached shortly after (<1s), 
significantly quicker than Gluc bioluminescence. The intensity, starting time, duration and 
precise location of all the fluorescent flashes within the field of view can be captured by a high-
speed camera and used to generate localisation maps and further analyse the instantaneous 
translation rates (Figure 3.8 B).  
However, in all fluorescent protein-based imaging systems, a major concern is the fluorophore 
maturation time. The maturation half-time of Venus is approximately 7 minutes in bacteria (Xie 
et al., 2008) and less than 2 minutes in neurons (Tatavarty et al., 2012), possibly with the 
assistance from eukaryotic chaperones. To bypass the potential delay for fluorophore maturation, 
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Halstead et al. developed a biosensor, translating RNA imaging by coat protein knock-off 
(TRICK), which can distinguish untranslated mRNAs from those that have undergone at least 
one round of translation (Halstead et al., 2015). In this study, mRNAs are labelled with two 
spectrally distinct fluorophores using the PP7 and MS2 system. On untranslated mRNAs, PCP-
GFP binding to PP7 stemloops colocalise with MCP-RFP binding to the MS2 sequence, 
indicated by a yellow fluorescent signal (Figure 1.2 E). During the first round of translation, 
PCP-GFP is removed from the mRNA as a ribosome traverses the coding region containing the 
PP7 stemloops. Therefore, translated mRNAs are labelled only with MCP-RFP, changing from 
yellow to red colour. 
Although TRICK offers an immediate readout of the change in mRNA translating status, it 
cannot follow the mRNA translation after the first round. The newly developed SunTag/Flag-
tag-based single molecule translation imaging technique provides a solution to it. The SunTag 
system was first developed by the Vale’s group (Tanenbaum et al., 2014), inspired by the MS2 
system, applying the same principle of signal amplification via protein multimerization. 
Essentially, the SunTag system uses a recombinant single-chain variable fragment (scFv) 
antibody that recognizes a yeast leucine zipper motif, the Gcn4 dimerization domain (Worn et 
al., 2000). The protein of interest carries 24 tandem repeats of this peptide epitope at its N-
terminus, whereas the scFv is fused to GFP (Figure 1.2 F). By expressing these two fusion 
proteins intracellularly, each newly synthesized peptide binds to 24 molecules of pre-formed 
scFv-GFP fluorophores, avoiding the delay of signal detection resulted from fluorescent protein 
maturation and generating sufficient signal-to-noise ratios to visualize single molecule 
translation events at the translation sites. Concurrently, an alternative multi-epitope tag and 
antibody-based imaging system, nascent chain tracking (NCT), was developed by the Stasevich 
group (Morisaki et al., 2016). In this method, the newly synthesized proteins are visualized by 
fusing flag-tag and HA-tag repeats that can be recognized by their corresponding fluorescently 
labelled fragments of antibodies, resembling the SunTag epitopes bound by scFv. NCT has the 
capability for two-colour imaging, visualising the translation of two separate groups of mRNAs 
simultaneously.  
In addition to the essential components for visualising nascent peptides, mRNAs of the protein 
of interest are also labelled by the MS2 or PP7 systems to be able to distinguish the synthesising 
peptides from the pre-existing proteins. When the scFv-GFP signal colocalises with mRNA 
fluorescence, the peptides are being synthesised from active mRNAs. When the two signals 
dissociate from each other, the protein translation is complete and the nascent peptide is 
released from the ribosomes. To further ensure the easy identification of translation sites, an 
auxin-induced degron (AID) (Wu et al., 2016) or a short-lived protein such as omithine 
decarboxylase (ODC) (Wang et al., 2016a) can be added to the C-terminus of the reporter 
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construct to remove completed proteins. 
These up-to-date fluorescent antibody techniques solve many of the problems associated with 
the previous imaging methods. The pre-formed fluorophores and rapid binding of epitopes by 
the antibody fragments avoid delayed readout of translation activities due to the fluorescent 
protein maturation time. Meanwhile, the lack of a photobleaching step in the imaging protocol 
significantly reduces phototoxicity and thus make a long-term imaging session (>1h) possible. 
1.2.4 Strengths and limitations of single-molecule translation imaging   
The visualisation of intracellular protein synthesis has been revolutionized by various single-
molecule translation imaging approaches summarised in the previous section, which have been 
demonstrated to be powerful tools for studying translation kinetics and regulation of individual 
mRNAs in single cells.  
Detailed analysis of translation kinetics from time-lapse images provides a real-time readout of 
translation activity with high temporal resolution for detecting transient changes in translation 
activity in response to internal regulation or environmental fluctuations. For instance, both 
Venus-based and SunTag-based imaging revealed that a majority of mRNA translation in 
dendrite and cell bodies occurs in bursts rather than sporadically or continuously, with repeated 
cycles of translating and non-translating states during the mRNA lifetime, although the 
frequency and duration of each state varied among individual mRNA molecules (Na et al., 2016; 
Tatavarty et al., 2012; Wu et al., 2016; Yan et al., 2016). Occasionally, ribosomes were found 
stalled or slowed down on mRNAs during translation, due to naturally occurring or chemically 
induced mRNA damage (Yan et al., 2016). Moreover, when cells were under drug-induced 
unfolded protein and oxidative stresses, a brief increase followed by immediate downregulation 
of translation rates of mRNAs carrying ATF4 uORFs was detected for the first time using 
single-molecule imaging (Wang et al., 2016a).  
Meanwhile, these imaging approaches are capable to preserve the accurate spatial information 
of translation sites, allowing the differentiation of distinctive translation behaviour at subcellular 
compartments. Observed by SunTag imaging, polysomes in the perinuclear region display 
significantly slower movement compared to those in the rest of the cytoplasm, suggesting the 
perinuclear polysomes may be anchored to other cellular structures, such as endoplasmic 
reticulum and nuclear envelops (Wang et al., 2016a). Unexpectedly, most of the Dynein 1 heavy 
chain (DYNC1H1) mRNA translation takes place in cytoplasmic foci, where DYNC1H1 
mRNAs accumulate, rather than dispersedly throughout the cytoplasm, confirming these foci 
are not silent mRNA storage granules like P-granules or stress granules, but active translation 
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sites accessible to translation machinery (Pichon et al., 2016). 
The most unique advantage of single-molecule translation imaging is its power to distinguish 
individual transcripts, even for the ones derived from the same genes. This led to the discovery 
of a substantial heterogeneity in the number of ribosomes bound to each mRNA, the time for 
completing translation, and the duration and frequency switching between translationally active 
and inactive states (Morisaki et al., 2016; Tanenbaum et al., 2014).  
However, each imaging technique has its own limitations, which should be taken to 
consideration when choosing the appropriate strategy to fulfil the experimental goals. Most of 
the imaging methods are relatively low throughput, allowing the study of one or two mRNA 
candidates at a time. In comparison, biochemical techniques such as ribosome profiling or 
RiboTag have much higher throughput at the genome-wide scale. For fluorescent protein fusion 
methods, the time for fluorophore maturation, which can sometimes take up to minutes, may 
prevent the instant visualisation of the newly synthesised polypeptides at their translation sites. 
In addition, they often cannot accommodate a long time continuous imaging session due to 
phototoxicity. For the fluorescent antibody-tagging systems, the introduction of the tandem 
repeats lengthens the mRNAs and potentially alters their secondary structure, which could result 
in possible perturbation of mRNA association with RBPs and thus interfere with mRNA 
localization. Nevertheless, if the pros and cons of each method are carefully evaluated and 
proper control conditions are used in the experiment, single-molecule translation imaging holds 
great promise to interrogate the translation mechanisms of individual mRNAs in living neurons 
and other cell types.    
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1.3 Axonal endosomal system and CMT2B disease 
1.3.1 Endosomes and endocytic pathways in neurons 
Cells internalised external materials, ligands and membrane lipids and proteins by endocytosis 
(Doherty and McMahon, 2009; Grant and Donaldson, 2009; Kelly and Owen, 2011; Mukherjee 
et al., 1997). The membrane pinched off from the cell surface is compensated by endosomal 
recycling pathways, which return lipids and proteins back to plasma membrane. Strikingly, 
fibroblasts internalised half of their surface area and 5-10% of their cell volume per hour, yet 
the overall cellular dimensions remain constant (Steinman et al., 1976), which is not possible 
without rapid membrane recycling. Such dynamic process controls the distribution and 
composition of lipids and proteins on cell membranes. Diverse cellular processes are related to 
endocytic pathways, such as nutrient uptake, cell junction formation, cell migration and signal 
transduction. 
Endocytosis undergoes clathrin-dependent or clathrin-independent pathway. The main feature 
of clathrin-dependent endocytosis is the formation of a clathrin-coated pit that consists of 
clathrin, adaptor protein-2 (AP-2) and other accessory proteins. Clathrin-dependent endocytosis 
controls constitutive and stimulated internalisation of receptors to regulate cellular homeostasis. 
Specifically, cytoplasmic domains of receptors are specifically recognised by AP-2 or other 
adaptor proteins, packaged into clathrin-coated pits, then internalised into the cell, where the 
vesicles are fused with early endosomes or recycled back to plasma membrane (McMahon and 
Boucrot, 2011; Mousavi et al., 2004). A typical example of clathrin-coated vesicles is synaptic 
vesicles at axon terminals, which facilitate the recycling of synaptic vesicle membrane and 
proteins after release of neurotransmitters in response to action potentials (Maycox et al., 1992). 
On the other hand, clathrin-independent pathways comprise multiple receptor-mediated 
pathways (Mayor and Pagano, 2007; Mayor et al., 2014). Clathrin-dependent and independent 
pathways are not mutually exclusive and instead, multiple endocytosis pathways can operate 
concurrently. In the case of epidermal growth factor (EGF) receptor (EGFR), low does of EGF 
activates clathrin-dependent receptor endocytosis, while EGFRs exposed to high doses of EGF 
tend to use a clathrin-independent pathway, involving cholesterol and detergent-insoluble 
membrane structure “lipid raft” association (Pike and Casey, 2002; Sigismund et al., 2013; 
Sigismund et al., 2005). 
Following endocytosis, internalised liquid and cargos within endocytic vesicles generated by 
clathrin-dependent or independent pathway are first delivered to early endosomes, a major 
sorting station in the endocytic pathway (Scott et al., 2014). Membranes, house keeping 
receptors and liquid of incoming vesicles are retained by early endosomes for 10 minutes, 
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before they are recycled back to the cell surface via recycling endosomes (Maxfield and 
McGraw, 2004). Other cargos are delivered to late endosomes for further sorting to trans-Golgi 
network or to lysosomes for degradation. The functional attributes of an endosome are defined 
by its association with a set of cytosolic proteins to the outer membrane surface. In particular, 
small GTPase Rab5 together with its effectors mark the early endosome and regulate its 
function throughout different stages of early endosomes maturation and plays an important role 
in its conversion to late endosomes, which is accompanied by major lipid and protein 
remodelling (Behnia and Munro, 2005; Scott and Gruenberg, 2011; Zerial and McBride, 2001). 
Essentially, late endosomes formation is initiated by Rab5 recruitment of another small GTPase 
Rab7 to the early endosome, resulting to the transient formation of a hybrid Rab5/Rab7 
endosome. Subsequently, a fission event separates the Rab7 domain from the rest of the hybrid 
endosome containing Rab5 and other early endosome-associated proteins, revealed by live 
microscopy following endocytosed viruses and ligands (Driskell et al., 2007; Vonderheit and 
Helenius, 2005). Notably, this early to late endosome conversion and especially the fission step 
can be blocked by expression a constitutively active mutant Rab5Q79L, resulting in the retention 
of hybrid Rab5/Rab7 endosomes and defective sorting of cargos destined for recycling and 
degradation (Rink et al., 2005; Rosenfeld et al., 2001). 
After the switch from Rab5 to Rab7, the newly formed Rab7-positive late endosome 
immediately undergoes a series of compositional, morphological and functional transformation, 
referred to as late endosome maturation (Huotari and Helenius, 2011). This process involves 
exchange of membrane lipids and proteins, luminal acidification from pH 6.1-6.8 to 4.8-6.0, 
morphological change from tubular to round or oval shape, increase in size, acquisition of 
lysosomal hydrolases and other membrane proteins, switch of fusion partner from early 
endosomes to late endosomes, lysosomes and autophagosomes (Huotari and Helenius, 2011; 
Luzio et al., 2007; Maxfield and Yamashiro, 1987).  
Upon maturation, the majority of late endosomes components are then degraded within 
lysosomes, while others, including soluble N-ethylmaleimide-sensitive factor activating protein 
receptors (SNAREs), are incorporated to lysosomes, contributing to lysosome biogenesis and 
maintenance (Luzio et al., 2007). It has been proposed that late endosomes and lysosomes can 
undergo transient “kiss-and-run” fusion and fission events, allowing a rapid exchange of 
membrane components, cargos and enzymes (Deng and Storrie, 1988; Luzio et al., 2007). Or 
they may permanently fuse to form hybrid organelles endolysosomes (Huotari and Helenius, 
2011; Luzio et al., 2000). In fact, time-lapse imaging showed that both mechanisms 
concurrently take place in living cells, leading to the mixing of membrane and internal contents 
of the two organelles (Bright et al., 2016; Bright et al., 2005). As a result, the molecular 
distinction between late endosomes and lysosomes is obscure, due to their almost identical 
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protein composition, with lysosomal-associated membrane protein 1 and 2 (LAMP1 and 
LAMP2) being the main membrane components (Eskelinen, 2006). Nevertheless, late 
endosomes and lysosomes can be distinguished by their ultrastructure. Compared to late 
endosomes, lysosomes often contain spherical electron-dense structures, reflecting high protein 
concentrations (de Duve, 2005; Klumperman and Raposo, 2014). 
To summarise, early endosomes, recycling endosomes, late endosomes, endolysosomes and 
lysosomes provide a robust continuum for intracellular signalling, cargo sorting and degradation, 
critical for numerous aspects of cellular biology (Figure 1.3). In highly polarized cells, such as 
neurons, the endocytic pathway collaborates with unique molecular players in subcellular 
compartments, allowing them to participate in an even wider range of physiological processes, 
including axon pathfinding, retrograde neurotrophic signalling, synaptic vesicle recycling, 
synaptic plasticity and local protein degradation (Dittman and Ryan, 2009; Itofusa and 
Kamiguchi, 2011; Kennedy and Ehlers, 2006; Winckler and Mellman, 2010). It is therefore not 
surprising that impaired neuronal endosomal function leads to severe defects in trophic 
signalling, cargo degradation and membrane trafficking, directly or indirectly causing a large 
number of neurological diseases, such as atherosclerosis, Alzheimer’s disease and lysosomal 
storage diseases (Aridor and Hannan, 2000, 2002; Maxfield, 2014). 
In neurons, endosomal trafficking is crucial for both long-range protein transport and local 
protein recycling and degradation, especially in distal compartments, such as growth cones and 
synapses (Lasiecka and Winckler, 2011). Moreover, local endocytic pathways also dynamically 
regulate the amount of cell surface receptors and adhesion molecules (Itofusa and Kamiguchi, 
2011). Interestingly, an early study in fungus suggested functional differences between axonal 
and dendritic endocytic systems (Mundigl et al., 1993). One example is the early endosomal 
regulator early endosomal antigen 1 (EEA1), which facilitates endosome fusion, is localised 
exclusively on somatodendritic early endosomes (Lasiecka et al., 2014; Wilson et al., 2000). At 
post-synaptic sites, local recycling of glutamate receptors by the local endosomal system 
contributes to the early phases of long-term potentiation (Kennedy and Ehlers, 2006).  
In contrast to the bi-directional trafficking of dendritic endosomes, axonal endosomes 
containing endocytosed cargos are transported along microtubules mainly in retrograde 
direction. In addition to carrying cargos to the proximal axon or cell body for degradation, 
retrograde transport of axonal endosomes also plays a role in neurotrophic signalling and target-
derived neuron survival (Cosker and Segal, 2014; Howe and Mobley, 2004; Ibanez, 2007). For 
example, upon binding of nerve growth factor (NGF) to its receptor tropomyosin receptor 
kinase A (TrkA), NGF/TrkA complex is internalised, resulting in the formation of “signalling 
endosomes” that are retrogradely transported to the nucleus to activate transcription factors, 
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Figure 1.3 The endosome/lysosome system.
The primary endocytic vesicles deliver their contents and their membrane to early endosomes (EEs) 
in the peripheral cytoplasm. After a period of about 8–15 min during which the EEs accumulate cargo 
and support recycling to the plasma membrane (directly or via recycling endosomes in the perinuclear 
region), conversion of the EEs to late endosomes (LEs) takes place. The nascent LEs carry a selected 
subset of endocytosed cargo from the EE, which they combine en route with newly synthesized 
lysosomal hydrolases and membrane components. Their role is to deliver endocytosed cargos to 
lysosomes. To be able to do it, they continue to undergo a maturation process that prepares them for 
the encounter with lysosomes. The fusion of an endosome with a lysosome generates a transient 
hybrid organelle, the endolysosome, in which active degradation takes place. What follows is another 
maturation process; the endolysosome is converted to a classical dense lysosome, which constitutes a 
storage organelle for lysosomal hydrolases and membrane components. Adapted from (Huotari and 
Helenius, 2011). 
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such as cAMP response element binding (CREB) protein, and induce transcriptional changes 
critical for neuronal survival (Harrington et al., 2011; Riccio et al., 1997; Watson et al., 1999). 
A more recent study from Segal and colleagues showed that target-derived neurotrophins induce 
transcription of an antiapoptotic gene bclw and the subsequent transport of bclw mRNA into the 
axon for local synthesis of Bclw protein, protecting axons from degeneration (Cosker et al., 
2013), underscoring the importance of neuronal endocytic pathways in axon maintenance and 
survival. 
1.3.2 Endosome-coupled mRNA transport and translation  
In addition to the abovementioned physiological roles of the endosomes, recent studies using 
fungal models proposed a novel function of endocytic pathways in polarised cells, which is 
endosome-coupled mRNA trafficking (Haag et al., 2015; Jansen et al., 2014).   
Extensive studies have already showed that in neurons, nuclear transcribed mRNAs associate 
with RNA-binding proteins (RBPs), ribosomal proteins and other factors to form 
ribonucleoprotein particles (RNPs), which can be active transported to dendritic or axonal 
compartments by motor proteins along microtubules and microfilaments for local protein 
synthesis (Eliscovich and Singer, 2017; Holt and Bullock, 2009; Mitchell and Parker, 2014).  
Endosomes, on the other hand, appear to be an independent group of molecular cargo 
transported along cytoskeletons in neurites, mainly responsible for lipid and protein trafficking. 
Surprisingly, increasing evidence has implicated a direct link between mRNA and endosome 
trafficking in several biological systems. In myelinated axons of zebrafish oligodendrocytes, 
kinesin motor protein Kif1b, which often function in mitochondria and vesicle trafficking 
through its membrane-binding domains (Nangaku et al., 1994; Zhao et al., 2001), is involved in 
axonal mRNA transport, suggesting a potential mechanism to support co-transport of mRNA 
and axonal vesicles (Lyons et al., 2009). One of the earliest direct observations of the co-
transport of mRNAs and endosomes was that the polyadenylate-binding protein-1 (Pab1) 
recognising mRNA poly(A) tails colocalised with shuttling endosomes in fungal hyphae 
(Baumann et al., 2012; Konig et al., 2009). In high eukaryotic systems, Drosophila oocytes 
expressing loss-of-function mutants of Rab11, a recycling endosome-associated small GTPase, 
showed oskar mRNA mislocalisation (Dollar et al., 2002; Jankovics et al., 2001). Moreover, 
endosomal sorting complexes required for transport (ESCRT)-II was shown to colocalise and 
co-transport with β-actin mRNAs in Xenopus RGC axons, suggesting the potential role of 
endosomes in mRNA trafficking (Konopacki et al., 2016).  
However, if mRNAs and mRNPs can be transported on microtubules in an endosome-
26
      
independent manner, what is the functional significance of endosome-coupled mRNA 
trafficking? To answer this question, an interesting observation that endosomes can also 
mediate ribosome distribution in fungal hyphae (Higuchi et al., 2014) led to the hypothesis that 
endosomes may function as a versatile multipurpose platform for recruitments of mRNA, 
ribosomes and possibly other translational machinery components to facilitate on-site protein 
synthesis. Indeed, in Ustilago maydis, the polarised growth of fungal hyphae requires 
endosomal-dependent transport of the RBP Rrm4 and its associated septin mRNA. Moreover, 
septin protein is accumulated exclusively on endosomes associated with septin mRNA and 
ribosomes, strongly suggesting local translation activity on endosomes (Baumann et al., 2014). 
To date, there is no direct evidence indicating endosome-sited translation takes place in higher 
eukaryotes yet, but a previous study from our lab showed loss of Rab4 or Rab5 activity 
inhibited axonal growth (Falk et al., 2014). More recently, we also found that depletion of 
ESCRT-II components impaired local protein synthesis in Xenopus RGC axons and decreased 
the speed of axon outgrowth (Konopacki et al., 2016), implying that endosome-coupling 
translation might be conserved in vertebrates and other higher eukaryotes. 
Given the growing evidence supporting endosome-coupled translation, the next question to ask 
is what may be the advantages of using endosomal platforms for protein synthesis, if translation 
can occur without anchoring to vesicular structures. A DIGE experiment comparing the 
proteomes of a wild-type Ustilago maydis strain and an Rrm4-deletion mutant, resulting in 
failure of mRNAs recruitment to endosomes, revealed only a small percentage of the 600 
detectable proteins were differentially expressed more than 2.5 fold, including ribosomal 
protein RPS19, mitochondrial proteins Afg3, Atp4 and Nuo2, and secretory protein 
endochitinase Cts1 (Koepke et al., 2011). Despite the likely minimal contribution of endosome-
mediated translation to the total proteome in fungal hyphae, endosome-coupled translation may 
be closely linked to specific cellular functions, such as mitochondrial biogenesis and protein 
secretion.  
1.3.3 CMT2B disease 
Charcot-Marie-Tooth (CMT) diseases are a group of genetically and clinically heterogeneous 
inherited diseases with a prevalence of 1 in 2500 (Skre, 1974). Five different subtypes (CMT1-4 
and CMTX) have been categorised so far, predominantly affecting sensory and/or motor 
neurons resulting in distal sensory loss, foot deformities, progressive weakness and atrophy of 
distal muscles and decreased of tendon reflexes (Bird, 1993a; Harding and Thomas, 1980; Lus 
et al., 2003). CMT1 is the demyelinating and the most common subtype, accounting for two-
thirds of all CMT cases (Bird, 1993b). CMT2 is characterised by prominent axonal dysfunction 
and degeneration (Bird, 1993c). CMT3, also known as Dejerine Sottas Syndrome (DSS), causes 
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severe early onset demyelination (Plante-Bordeneuve and Said, 2002). CMT4 refers to the 
subtype exhibiting autosomal recessive inheritance (Bird, 1993d). CMTX is linked to mutations 
on the X chromosome and tends to show milder phenotypes in women compared to men (Bird, 
1993e). Disease-causing mutations in over 30 loci and 20 genes have been identified (Barisic et 
al., 2008), but no cure is currently available for CMT diseases. 
Among all subtypes, type 2B, one of the 6 identified subtypes of CMT2 based on genetic causes, 
is of particular interest in this study because 5 missense mutations in late endosome-associated 
Rab7 (L129F, K157N, N161T/I, V162M) that are conserved among vertebrates have been 
reported in CMT2B cases (Auer-Grumbach et al., 2000; Houlden et al., 2004; Meggouh et al., 
2006; Verhoeven et al., 2003; Wang et al., 2013). CMT2B is an autosomal dominant hereditary 
disease with the major clinical manifestation being axonopathy and axon degeneration of 
peripheral sensory neurons, resulting in distal muscle weakness, repetitive foot infections, high 
frequency of ulcers and eventually toe amputations (Auer-Grumbach et al., 2003). The average 
onset of the disease is in early adulthood, with some cases occurring even later (Pareyson et al., 
2006).  
Rab7 and other GTPases serve as molecular switches by cycling between active, GTP-bound 
states and inactive, GDP-bound states (Figure 1.4 A). Rab proteins in active states tend to 
associate with vesicular membranes, while inactive Rab proteins dissociate from target 
membranes and become cytosolic. Active Rabs can recruit effector proteins involved in specific 
vesicular functions, such as vesicle transport and fusion. Hydrolysis of the phosphate of GTP by 
GTPase activating protein (GAPs) terminates Rab activity. When inactive Rabs dissociate from 
membranes, they are sequestered in the cytoplasm by Rab GDP-dissociation inhibitor (GDI) 
(Rak et al., 2003; Ullrich et al., 1993). To active Rabs again, GTPase disassociated from GDI 
are recognised by guanine nucleotide exchange factors (GEFs), which induce conformational 
alteration when binding the GDP-bound Rabs and facilitate GDP release and GTP binding (Sato 
et al., 2007). 
Conformational changes to nucleotide binding pockets can switch Rab7 to GTP-bound 
constitutively active form Rab7Q67L or GDP-bound dominant negative form Rab7T22N (Dumas et 
al., 1999). To understand whether CMT2B-associated Rab7 mutants mimic the active or 
inactive form of Rab7 mutants, an early biochemical study found that disease mutants 
demonstrated higher nucleotide exchange rates and reduced GTP hydrolysis. Additionally, the 
majority of CMT2B-related Rab7 mutants were in GTP-bound form, resembling the 
constitutively active form of Rab7 (Spinosa et al., 2008). More recently, a structural study by 
Taylor lab validated and challenged some of the abovementioned observations and provided 
further insights into the question (McCray et al., 2010). In contrast to previous findings, 
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Figure 1.4 Model of how CMT2B-associated Rab7 mutants cause dysregulated activation cycle.
(A) Activation of membrane-associated Rab7 normally requires GEF activity due to very slow 
dissociation of GDP. Following GTP binding, GAP-catalysed hydrolysis inactivates Rab7 and allows 
extraction from the membrane by GDI. 
(B) In Rab7 disease mutants, the regulation of the activity cycle is disrupted. Decreased affinity 
for GDP allows GTP exchange to occur independent of GEF activity, and GTP dissociation allows 
hydrolysis-independent inactivation of Rab7. Following GTP dissociation, Rab7 mutants can either 
become reactivated by binding GTP or can bind GDP and become extracted by GDI. As the relative 
affinity for GTP is greater than for GDP, Rab7 mutants are more likely to rebind GTP and undergo 
multiple activation cycles on target membranes before they are extracted. Thus, disease mutants cause 
misregulation of activation and inactivation of Rab7 resulting in alteration of the GTP–GDP ratio and 
an increase in residence on target membranes. Adapted from (McCray et al., 2010).  
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although one of the mutants Rab7L129F exhibited upregulated nucleotide exchange, the overall 
GTPase activity was not altered. Due to such rapid GTP dissociation and reassociation, cells 
expressing Rab7L129F have a larger number of active Rab7 and associated effector proteins, 
including Rab-interacting lysosomal protein (RILP), vacuolar protein sorting-associated protein 
13 (Vps13C), retromer core complex and cholesterol sensor oxysterol-binding protein-related 
protein 1L (ORP1L) (Cantalupo et al., 2001; McCray et al., 2010; Nakada-Tsukui et al., 2005). 
However, this excessive activation is counteracted by high levels of aberrant GTP hydrolysis-
independent inactivation. Therefore, this study illustrated that CMT2B-associated mutations 
cause misregulation of multiple steps of Rab7 activity cycles (Figure 1.4 B), distinctive from the 
molecular mechanism of constitutively active or dominant negative form of Rab7. 
Ever since the discovery of Rab7 mutations in CMT2B patients, the main challenge is to explain 
why despite the fact that Rab7 is a ubiquitously expressed protein and a master regulator of 
vesicular trafficking and cargo sorting, CMT2B-associated mutants have an impact only on 
peripheral axons. It has been proposed Rab7 mutations alter the binding affinity to effector 
proteins functioning specifically in peripheral axons. For instance, Rab7 effector RILP, which 
showed stronger interaction with Rab7 disease mutants (Spinosa et al., 2008), is responsible for 
recruiting dynein to late endosome through dynactin and facilitate EGF degradation (Cantalupo 
et al., 2001; Jordens et al., 2001), potentially affecting the axonal EGF signalling pathway. 
Furthermore, peripherin, an intermediate filament cytoskeleton component mainly expressed in 
peripheral nervous system interacting with Rab7, binds to disease mutants with higher affinity, 
disrupting peripherin filament assembly and affecting axonal transport (Cogli et al., 2013). In 
fact, CMT2B mutant-containing endosomes moved slower compared to wild-type late 
endosomes in zebrafish sensory neurons (Ponomareva et al., 2016). Retrograde signalling of 
nerve growth factor (NGF) and TrkA receptors were also disrupted by mutant-induced 
dysregulated axonal transport (Zhang et al., 2013). All these discoveries favour a hypothesis 
that aberrant neurotrophin signalling in axons might be responsible for axon degeneration, 
possibly due to rapid degradation of endocytosed growth factors and receptors, preventing them 
from reaching the nucleus, particularly in long axons of sensory and motor neurons primarily 
affected in CMT2B patients. 
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1.4 Amyotrophic lateral sclerosis and frontotemporal dementia 
1.4.1 Clinical symptoms and genetics 
Amyotrophic lateral sclerosis (ALS), also referred to as motor neuron disease (MND) or Lou 
Gehrig’s disease, originally described by Charcot in 1869 (Goetz, 2000; Kumar et al., 2011), is 
a progressive neurodegenerative disease characterised by heterogeneous clinical symptoms, 
including limb muscle weakness, stiff joints, difficulty in swallowing and speech and eventually 
respiratory failure (Kiernan et al., 2011; van Es et al., 2017). The risk of developing ALS peaks 
at 50-75 years of age and the average life expectancy of ALS patients is 2-3 years from the 
disease onset, with a small percentage surviving beyond 10 years (Talbot, 2009). There is no 
existing cure for ALS, only a small number of drugs, e.g., riluzole (Lacomblez et al., 1996) and 
edaravone (Sawada, 2017), to prolong the life span of ALS patients.  
The disease diagnosis is based on the evident loss of upper and/or lower motor neurons at spinal 
or bulbar level (Rowland and Shneider, 2001). Abnormal sensory nerve conductivity was 
reported in 2-10% of ALS patients (Heads et al., 1991; Isaacs et al., 2007), but whether the 
observed sensory neuropathy can be directly attributed to ALS remains controversial. 
Intriguingly, 50% of ALS patients experience behaviour and cognitive impairments akin to 
symptoms of frontotemporal dementia (FTD), characterised by alterations in personality and 
social functioning, but preserved orientation (Elamin et al., 2013; Phukan et al., 2012; Swinnen 
and Robberecht, 2014). In fact, 5-10% of patients with ALS are diagnosed with FTD (Turner et 
al., 2013). Similarly, 40% of FTD patients show motor neuron degeneration and 12.5% of 
patients with the behavioural variant of FTD (BV-FTD) develop ALS (Bang et al., 2015; 
Burrell et al., 2011), suggesting the close relationship between ALS and BV-FTD.  
ALS cases can be categorised as familial ALS (fALS), where a complete family history can be 
traced, or sporadic ALS (sALS), which shows incomplete penetrance or lack of complete family 
history (Ajroud-Driss and Siddique, 2014; Turner et al., 2017). sALS accounts for up to 95% of 
ALS cases. Both genetic and environmental risk factors involved in sALS have been identified 
(Beleza-Meireles and Al-Chalabi, 2009). Twin studies reveal genetic contribution to sporadic 
ALS is 61% (Al-Chalabi et al., 2010; Graham et al., 1997). Around 17% of sALS patients carry 
mutations in genes known to cause familial ALS (fALS) (Gibson et al., 2017). In particular, 
mutations of SOD1 accounts for 5% of sALS. On the other hand, most of the speculated 
environmental causes have not been confirmed, due to the methodological errors and small 
sample size. Nevertheless, high incidence of sALS is positively correlated with exposure to 
heavy metals, cyanobacterial neurotoxins (Arnold et al., 1953; Koerner, 1952), viral infection 
(Berger et al., 2000) and prion disease (Baier et al., 2010). 
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Most of the remaining 5-10% of fALS cases follow an autosomal dominant pattern of 
inheritance (Kuzma-Kozakiewicz and Kwiecinski, 2009; Siddique and Siddique, 2008). More 
than 30 different ALS-associated genes have been identified so far, including C9orf72 (40%), 
Cu/Zn superoxide dismutase gene (SOD1) (20%), Fused in Sarcoma (FUS) (1-5%) and TAR 
DNA-binding protein (TARBDP) (1-5%) (Renton et al., 2014), which are responsible for 60-80% 
of the familial ALS cases. SOD1 was the first fALS-related gene identified in 1993 (Rosen et al., 
1993). In SOD1, over 100 reported ALS-associated missense mutations spread over all five 
exons, converting soluble SOD1 proteins to insoluble aggregates in the brain and spinal cord of 
ALS patients (Forsberg et al., 2011). The recently discovered hexanucleotide repeat expansion 
in noncoding regions of C9orf72 accounting for 40% of fALS and 9% of sALS cases (Cruts et 
al., 2013), highly variable depending on ethnicity and geographic regions (Majounie et al., 2012; 
Smith et al., 2013), is considered as a major breakthrough in ALS genetics.  
In line with the concurrence of ALS and FTD clinical symptoms in ALS/FTD patients, most of 
the ALS-associated genes are also closely related with FTD. Accumulated evidence now 
supports the hypothesis that ALS and FTD are two extremes of a continuous spectrum of a 
single disease, with various subtypes of ALS/FTD within the continuum based on severity of 
each clinical symptom of the patient (Figure 1.5) (Devenney et al., 2015; van Es et al., 2017). 
Despite the significant progress that has been made over the past decades in searching for 
ALS/FTD-associated genes, we are still facing many challenges. Up to 80% of fALS and a 
small proportion of sALS cases can now be explained by genetic variations, but causes of the 
rest of them are not understood, indicating more genetic risk factors remained to be identified.    
1.4.2 Pathophysiology 
A neuropathological hallmark of ALS/FTD is the deposition of poorly soluble assemblies of the 
mutant proteins in the nucleus and cytoplasm of neurons in the brain and spinal cord of 
ALS/FTD patients. Most proteins present in these protein assemblies are mutated RNA-binding 
proteins (RBPs), such as TAR DNA-binding protein (TDP-43), FUS, ataxin2 and heterogeneous 
nuclear ribonucleoprotein (hnRNP) A1 and B2 (van der Zee and Van Broeckhoven, 2014), 
revealing a striking overlap with genetic findings. Strikingly, although TDP-43 and FUS 
mutation only accounts for a small proportion of ALS/FTD cases, their proteins are present in 
inclusions in majority of fALS and sALS cases (Deng et al., 2010; Keller et al., 2012; Neumann 
et al., 2006; Sreedharan et al., 2008). Furthermore, the post-translational modification of the 
RBPs has been demonstrated to involve in the formation of pathological aggregation. For 
instance, disease-associated TDP-43 tends to be hyperphosphorylated and ubiquitinated 
(Neumann et al., 2006). FUS inclusions in FTD patients were found to be hypomethylated 
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Figure 1.5 ALS and FTD are extremes on the phenotypic spectrum of a single disease.
ALS and FTD might be phenotypic extremes on a spectrum disorder (the so-called motor neuron 
disease–FTD continuum). About half of all patients with ALS only have motor involvement (classical 
ALS). Those patients with intact cognitive function at diagnosis appear to maintain cognitive function 
during the disease course. However, up to half of patients with ALS show some degree of cognitive 
impairment or behavioural changes, but without fulfilling the diagnostic criteria for FTD. The disease 
is categorised as ALS with evidence of executive dysfunction (ALS-eci) if there is evidence of 
executive dysfunction, ALS with no executive dysfunction but impairment in other cognitive domains 
(ALS-neci) if there is no executive dysfunction but impairment in other cognitive domains (e.g. 
memory), or ALS with behavioural changes (ALS-bi) if behavioural changes are present. About 
5–10% of patients with ALS also have FTD (ALS-FTD). Patients with motor neuron disease–FTD 
(FTD-MND) have a primary diagnosis of FTD and motor neuron involvement develops as the disease 
progresses but not to full ALS. FTD can be divided into two subtypes; behavioural variant (BV-FTD) 
and the primary progressive aphasia (PPA) characterised by language deficits. Adapted from (van Es 
et al., 2017)
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(Dormann et al., 2012).  
In addition to the general pathological features of ALS/FTD, different protein combination 
present in these cellular inclusions also distinguishes the mutation carrier from other patients. In 
ALS/FTD patients with C9orf72 expanded repeats, the protein assemblies in cerebellum and 
hippocampus are usually phosphor-TDP-43-negative, but p62- and UBLQN-positive (Al-Sarraj 
et al., 2011), distinguishing the expansion carriers from other subtypes of ALS/FTD. Another 
example is the absence of mutated FUS proteins in FUS-positive inclusions in FTD patients, 
while mutant FUS are often found in deposition of FUS in ALS cases (Neumann et al., 2011).  
The pathogenic significance of these intraneuronal assemblies has been the subject of much 
speculation. Hypotheses have included that they might (i) be irrelevant secondary phenomena, 
(ii) form conventional neurotoxic amyloids, or (iii) bind and trap crucial RNA sequences 
(Couthouis et al., 2011; Gendron et al., 2010; Neumann et al., 2007; Rademakers et al., 2012; 
Ticozzi et al., 2010). Although there are data to support the notion that these aggregates may be 
amyloid-like (Fang et al., 2014; Robinson et al., 2013), other evidence suggests that they are 
distinct from classical amyloids (Cairns et al., 2007; Dormann et al., 2009; Murakami et al., 
2012). Specifically, growing evidence has shown that in contrast to classical amyloids, 
pathological ALS/FTD-related RBP deposits do not bind amyloidophyllic dyes (e.g., Thioflavin 
T) (Johnson et al., 2008) and show a mixed granular/fibrillar appearance under electron 
microscopy. In addition, they are soluble in urea (Murakami et al., 2012) and have low β sheet 
content (Burke et al., 2015). When these aggregates are fluorescently labelled, they do not 
display the marked reductions in in vivo fluorescent lifetimes that are typical of conventional 
amyloids (Kaminski Schierle et al., 2011). 
Because many of the mutant proteins identified in ALS/FLD aggregates are RBPs, it raises the 
possibility that mutant ALS/FTD-associated RBPs might be incorporated into and alter the 
function of ribonucleoprotein (RNP) granules (Li et al., 2013; Mitchell and Parker, 2014; 
Ramaswami et al., 2013; Wolozin, 2012). Both TDP-43 and FUS are multifunctional DNA- and 
RNA-binding proteins shuttle between nucleus and cytoplasm. Although TDP-43 and FUS bind 
to distinct subsets of transcripts (Hoell et al., 2011; Lagier-Tourenne et al., 2012; Rogelj et al., 
2012; Tollervey et al., 2011) and no evidence suggests they act together, they are both known to 
involve in multiple steps of RNA processing including transcription, splicing, micro-RNA 
processing, RNA transport and translation (Figure 1.6) (Lagier-Tourenne et al., 2010). For 
example, the binding of TDP-43 to DNA regulatory elements including TAR DNA sequence 
and mouse SP-10 promoter suppresses transcription (Abhyankar et al., 2007; Buratti and Baralle, 
2008; Ou et al., 1995). FUS interacts with nuclear hormone receptors (Powers et al., 1998), 
transcription factors (Hallier et al., 1998; Uranishi et al., 2001) and transcriptional machinery 
34
Figure 1.6 Proposed physiological roles of TDP-43 and FUS.
(A) Summary of major steps in RNA processing from transcription to translation or degradation. 
(B) TDP-43 binds single-stranded TG-rich elements in promoter regions thereby blocking 
transcription of the downstream gene (shown for TAR DNA of HIV and mouse SP-10 gene). 
(C) FUS/TLS associates with TBP within the TFIID complex suggesting that it participates in the 
general transcriptional machinery. 
(D) In response to DNA damage, FUS/TLS is recruited in the promoter region of cyclin D1 
(CCND1) by sense and antisense non-coding RNAs (ncRNAs) and represses CCND1 transcription.
(E) TDP-43 binds a UG track in intronic regions preceding alternatively spliced exons and 
enhances their exclusion (shown for CFTR and apolipoprotein A-II). 
(F) FUS/TLS was identified as a part of the spliceosome.
(G) FUS/TLS was shown to promote exon inclusion in H-ras mRNA, through indirect binding to 
structural regulatory elements located on the downstream intron. 
(H) Both proteins were found in a complex with Drosha, suggesting that they may be involved in 
miRNA processing.
(I) Both TDP-43 and FUS/TLS shuttle between the nucleus and the cytosol.
(J) Both TDP-43 and FUS/TLS are incorporated in stress granules where they form complexes 
with mRNAs and other RNA binding proteins.
(K) TDP-43 and FUS/TLS are both involved in the transport of mRNAs to dendritic spines and/or 
the axonal terminal where they may facilitate local translation. Examples of such cargo transcripts are 
the low molecular weight NFL for TDP-43 and the actin-stabilizing protein Nd1-L for FUS/TLS.
Adapted from (Lagier-Tourenne et al., 2010). 
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(Bertolotti et al., 1996; Tan and Manley, 2010) to regulate transcription.  
Furthermore, increasing evidence suggests under cellular stress, TDP-43 and FUS are recruited 
to stress granules (Andersson et al., 2008; Moisse et al., 2009; Nishimoto et al., 2010), which 
are cytoplasmic translationally repressed RNP granules that dissolve when the stress abated. It 
has been proposed that protein deposits in ALS/FTD neurons accumulate due to the failure of 
disassembly of mutant TDP-43- or FUS-containing stress granules. Therefore, mRNAs and 
RBPs are trapped in these permanent RNPs in disease cells (Bentmann et al., 2013). More 
recently, another ALS/FTD-associated gene C9orf72 containing GGGGCC expansions in its 
first intron has been shown to undergo repeat-associated non-AUG (RAN) translation to 
produce 6 different aggregation-prone dipeptide repeat proteins (DPRs) that accumulate in the 
central nervous system (DeJesus-Hernandez et al., 2011; Freibaum and Taylor, 2017; Renton et 
al., 2011). Some of these DPRs are highly toxic to motor neurons and cause neurodegeneration 
(Liu et al., 2016; Wen et al., 2014). In particular, recent studies have implicated C9orf72 
mutations lead to impaired nucleocytoplasmic transport (Davidson et al., 2014; van Blitterswijk 
and Rademakers, 2015). 
In neurons, both TDP-43 and FUS are present in dendrites, where they regulate RNA 
localisation, local translation and degradation. FUS binds to mRNAs coding actin-related 
proteins, facilitating actin organisation in spines (Fujii and Takumi, 2005). TDP-43 and FUS 
RNP granules can be recruited to dendritic spines in an activity-dependent manner (Belly et al., 
2005; Elvira et al., 2006; Wang et al., 2008). Specifically, FUS was shown to interact with N-
methyl-D-aspartate (NMDA) receptors in dendrites (Selamat et al., 2009), potentially regulating 
local translation in excitatory synapses to modulate synaptic plasticity. Although the role of 
TDP-43 in dendritic translation is less established, it has been showed that the loss of TDP-43 
reduces dendritic branching and synaptic formation in cultured hippocampal neurons (Hicks et 
al., 2000) and Drosophila neurons in vivo (Feiguin et al., 2009; Lu et al., 2009b).  
Since axonal degeneration is the main feature of ALS/FTD, it is perhaps not surprising that 
physiological function of ALS/FTD-associated proteins in axon navigation, maintenance and 
survival is compromised in disease-affected neurons. Taking TDP-43 as an example, its 
mutations altered the proportions of anterograde versus retrograde transport of TDP-43-
containing RNP granules and their associated mRNAs in motor neuron axons (Alami et al., 
2014). In addition, motor neurons expressing TDP-43 mutants showed reduced axon outgrowth 
and disrupted cytoskeletal integrity (Tripathi et al., 2014).  
Intriguingly, whether axonal defects observed in ALS/FTD patients and animal models can be 
explained by a gain of toxicity or a loss of TDP-43 function remains controversial. Some 
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existing evidence favours the gain-of-toxicity theory. Clinical studies revealed an elevation of 
TDP-43 levels in familial and sporadic ALS cases (Gitcho et al., 2009; Swarup et al., 2011).  
Overexpression of wild-type TDP-43 proteins is sufficient to suppress axon outgrowth and 
branching, implying TDP-43 may act as a negative regulator in these axonal behaviours (Fallini 
et al., 2012). Mutations of TDP-43 potentially enhance the stability of this aggregation-prone 
protein and increase the amount of cytoplasmic protein deposition (Ling et al., 2010; Watanabe 
et al., 2013). On contrary, other studies suggest a loss of TDP-43 function causes axon 
degeneration. Under physiological conditions, wild-type TDP-43 is enriched in the nucleus.  
However, nuclear depletion of TDP-43 usually accompanies TDP-43 cytoplasmic aggregation 
in disease-related neurons (Arai et al., 2006; Mackenzie et al., 2010; Neumann et al., 2006). 
Knockdown of TDP-43 impaired axon outgrowth, axon branching and induced axon 
degeneration in invertebrate and mammalian models (Iguchi et al., 2013; Schmid et al., 2013; 
Yang et al., 2014).  
Similar to TDP-43, study of other ALS/FTD-related proteins also reveals complex molecular 
and cellular mechanisms to cause axon degeneration, involving multiple interconnected 
pathological processes, including glutamate excitotoxicity, dysregulation of neurotrophic factors 
and axon guidance molecules, axonal RNP transport defects, Golgi and mitochondrial 
dysfunction, aberrant RNA processing and impaired protein synthesis (Gitler and Tsuiji, 2016; 
Redler and Dokholyan, 2012; Shang and Huang, 2016), highlighting the challenges in 
elucidating the disease aetiology. 
1.4.3 The role of FUS in ALS/FTD 
FUsed in Sarcoma (FUS), first identified as a fusion protein in human myxoid liposarcoma 
(Crozat et al., 1993), is an RNA binding protein involved in RNA transcription, splicing, 
transport and in the regulation of local RNA metabolism and translation in subcellular niches 
such as axon terminals and dendritic spines (Sephton and Yu, 2015).  
The FUS protein has 526 amino acids and is composed of a SYGQ (serine, tyrosine, glycine and 
glutamine)-rich region at its N-terminus, an RNA-recognition motif (RRM), multiple RGG 
(arginine, glycine and glycine)-repeat regions, a zinc finger motif and a nuclear localization 
signal (NLS) at its C-terminus. Both RRM and zinc finger motif are known to mediate the 
protein’s recognition of RNA targets (Iko et al., 2004; Liu et al., 2013; Schwartz et al., 2013). 
GGUG was indicated as a preferable FUS-binding motif (Lerga et al., 2001) but cannot explain 
all cases of FUS binding (Hoell et al., 2011). High-throughput sequencing studies suggest both 
structure and sequence of RNAs may recruit FUS: RNA targets of FUS tend to readily form 
secondary structures (Ishigaki et al., 2012), or rich in either GC (Lagier-Tourenne et al., 2012) 
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or AU (Hoell et al., 2011) contents. Due to the C-terminal NLS, under physiological conditions, 
intracellular FUS predominantly localised to nucleus with a small proportion shuttling between 
nucleus and cytoplasm (Zinszner et al., 1997).  
Interestingly, first observed by Steven McKnight’s group, purified FUS proteins in vitro 
undergoes rapid, physiologically reversible phase transitions between dispersed, liquid:liquid 
droplet and hydrogel states (Han et al., 2012; Kato et al., 2012). These phase transitions are 
driven by its C-terminal low complexity (LC) domain, and typically occur over time scales of 
seconds to minutes (Brangwynne et al., 2009; Brangwynne et al., 2011; Weber and Brangwynne, 
2012). Low complexity domain (LCD) refers to regions of protein sequence with biased amino 
acid composition. In the LCD of FUS, over 80% of LCD is composed of only 4 amino acids, 
glycine, serine, glutamine and tyrosine, while 9 amino acids are completely absent. LCDs of 
different proteins share little sequence homology but they are abundant in eukaryotic proteome 
(Alba et al., 2007; Marcotte et al., 1999), especially among proteins related to various 
neurodegenerative and developmental diseases (Brown and Brown, 2004; Gatchel and Zoghbi, 
2005; Uversky et al., 2008). A subset of LCD is referred to as prion-like domain (PLD), 
enriched in uncharged polar amino acids and glycine, resembling the yeast prion protein 
(Couthouis et al., 2011). PLDs have been identified in over 70 human RNA-binding proteins, 
including TDP-43, FUS, TATA-binding protein-associated factor 15 (TAF15), Ewing sarcoma 
breakpoint region 1 (EWSR1), hnRNPA1 and hnRNPA2, increasing the aggregation and 
misfolding propensity of the RBPs contributing neurodegenerative diseases (King et al., 2012). 
Given the high pathogenic potential of LCDs and PLDs, their abundance in eukaryotic genome 
seems paradoxical. In fact, an emerging concept related the normal physiological role of LCDs 
is that they allow proteins to form transient micron or sub-micron membrane-free assemblies, 
such as RNP granules. These dynamic structures take-up, sequester, transport and then release 
key RNA and protein cargos that mediate the regulation of local RNA and protein metabolism 
in subcellular niches such as axon terminals and dendrites (Murakami et al., 2015). Indeed, gene 
ontology (GO) annotations reveal a third of human proteins with LCD functions in RNA-
binding (March et al., 2016), supporting its role in RNP formation. Other potential functions of 
LCD may include protein-protein interaction (Xiao and Jeang, 1998) and protein subcellular 
localization (Salichs et al., 2009).  
A broad range of clinical phenotypes has been reported to associate with FUS mutations, 
including some of the most severe, juvenile-onset from of ALS (Conte et al., 2012). In fact, 
mutations in FUS account for 35% of fALS patients younger than 40 years old, while they are 
only found in less than 5% of fALS cases of all ages (Millecamps et al., 2012). To date, more 
than 50 mutations in FUS have been found in ALS cases (Deng et al., 2014) and most of them 
are clustered in the C-terminal region, encoded by exons 14 and 15, important for DNA and 
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RNA binding as well as nuclear localisation (Hewitt et al., 2010; Zakaryan and Gehring, 2006). 
In contrast to TDP-43, the gain of toxicity from mutant or mislocalised FUS proteins is believed 
to be the main cause of motor neuron degeneration (Scekic-Zahirovic et al., 2016; Shiihashi et 
al., 2016), as FUS loss of function alone does not cause axon degeneration in FUS knockout 
mice (Sharma et al., 2016). In addition, one study in rats expressing human wild-type or R521C 
mutant of FUS reported that postnatal induction of FUS(R521C) expression led to paralysis and 
death by 70 days of age, whereas comparable wild-type FUS-overexpressing rats survived 
normally (Huang et al., 2011). 
In the nervous system, mutations of FUS lead to various dendritic, axonal or synaptic defects. In 
FUS-R521C and FUS-R521G transgenic mice, the complexity of dendritic arbours and synaptic 
density of motor and cortical neurons were significantly reduced (Qiu et al., 2014; Sephton et al., 
2014). Mouse cortical neurons transfected with FUS-R521C showed axon outgrowth, branching 
and growth cone defects (Groen et al., 2013). Moreover, synaptic defects including aberrant 
presynaptic active zone structure, reduced quantal contents and miniature presynaptic currents 
and impaired synaptic transmission, were observed in Drosophila motor neuron synapses 
preceding soma and axon degeneration (Shahidullah et al., 2013). In addition, FUS mRNA is 
present in retinal axons (Zivraj et al., 2010) and recent unpublished data from the lab studying 
axonal proteome demonstrated FUS is locally translated in Xenopus RGC axons. Collectively, 
these findings underline the role of FUS in nervous system, especially in neuronal 
compartments distal from the cell bodies.  
Besides mutations identified in ALS/FTD families, aberrant post-translational modification of 
FUS may also contribute to FUS-regulated disease cases. Both wild-type and mutant FUS have 
been shown to undergo extensive arginine methylation (Du et al., 2011) by forming a complex 
with PRMT1 and PRMT8 for asymmetric dimethylation of FUS (Scaramuzzino et al., 2013). 
Subcellular localization of FUS can be regulated by arginine methylation states (Suarez-Calvet 
et al., 2016; Tradewell et al., 2012). Specifically, arginine methylation reduces the binding of 
FUS to Transportin-1, which is a component of cytoplasmic FUS inclusions (Brelstaff et al., 
2011) and imports FUS into the nucleus (Dormann et al., 2012). Unmethylated and 
monomethylated FUS showed a higher affinity of Transportin-1 compared to the 
asymmetrically dimethylated form (Suarez-Calvet et al., 2016). Unexpectedly, even though 
ALS and FTD share FUS deposition as a common feature, only FTD-related FUS granules 
contain monomethylated and unmethylated FUS together with Transportin-1, while ALS-
associated FUS inclusions are mainly composed of dimethylated FUS mutants (Suarez-Calvet et 
al., 2016), implying different phenotypes of the two diseases may be explained by their distinct 
pathomechanisms.   
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1.5 Focus of this thesis 
Dysregulated translation has been shown as an underlying cause of numerous neurological 
disorders. However, the link between axonal protein synthesis and neurological disorders has 
not been established. In this thesis, using two neuropathies CMT2B and ALS/FTD as examples, 
I examined the potential common mechanism responsible for clinically distinct 
neurodegenerative diseases - impaired axonal protein synthesis, and thus illustrated the 
importance of local translation in axon development and survival.  
The first aim was to develop reliable tools to quantitatively measure protein synthesis in axonal 
compartments. Global translation of axonal mRNAs can be visualised in situ by FUNCAT or 
puromycin labelling in fixed neurons. Combination of puromycylation and proximity ligation 
assay (Puro-PLA) allows detection of specific protein synthesis. To investigate temporal 
dynamics of axonal translation, single molecule translation imaging approaches, such as 
SunTag and Venus-based strategies could be applied to obtain instantaneous rates of translation 
in response to external stimuli.  
Equipped with these imaging tools, I next focused on the relationship between axonal 
translation and peripheral motor and sensory neuropathy, CMT2B. Mutations of late 
endosomes-associated small GTPase Rab7a, which has been reported in CMT2B cases, 
attenuated axonal protein synthesis. Surprisingly, puromycin labelling revealed mutations of 
Rab7a primarily affected local translation occurring on late endosomes in axons. To confirm 
this finding, I investigated whether mRNAs and translational machinery were recruited on 
endosomal outer surface, which is the premise of mRNA translation. Furthermore, to explore 
how defective late endosome-site translation led to axonopathy, I showed nuclear-encoded 
mitochondrial proteins were translated on late endosomes adjacent to mitochondria, while 
disease mutations of Rab7a perturbed this process, resulting in mitochondria defects.   
Finally, I sought to understand how ALS/FTD-related mutations and hypomethylation of FUS, 
which represents a group of intrinsically disordered proteins closely associated with 
neurodegenerative diseases, led to a reduction in axonal protein synthesis. Live imaging of 
axons expressing FUS proteins with mutations in different functional domains or treated with a 
methyltransferases inhibitor indicated pathological FUS mutants or hypomethylated FUS had a 
tendency to form stable axonal granules, possibly irreversibly trapping key translational 
components, such as RNA molecules. Consequently, the efficiency of local protein synthesis 
decreased, leading to defective axonal phenotypes. 
 
40
      
2 MATERIALS AND METHODS 
2.1 Xenopus Laevis embryos 
Xenopus laevis embryos were fertilised in vitro and raised in 0.1x Modified Barth’s Saline 
(8.8mM NaCl, 0.1 mM KCl, 0.24mM NaHCO3, 0.1 mM HEPES, 82µM MgSO4, 33µM 
Ca(NO3)2, 41µM CaCl2) at 14-20°C and staged according to the tables of Nieuwkoop and Faber 
(Nieuwkoop and Faber, 1994). All animal experiments have been regulated under the Animals 
(Scientific Procedures) Act 1986 Amendment Regulations 2012 following ethical review by the 
University of Cambridge Animal Welfare and Ethical Review Body (AWERB) 
2.2 Primary retinal cultures 
Eye primordia were dissected from Tricaine Methanesulfonate (MS222) (Sigma) anesthetised 
Xenopus laevis embryos at the indicated stages and cultured on 10µg/ml poly-L-lysine- (Sigma) 
and 10µg/ml laminin- (Sigma) coated glass bottom dishes (MatTek or ibidi for OMX super-
resolution imaging) in 60% L-15 medium (Gibco) at 20°C for 24 or 48 hours before performing 
immunohistochemistry or live imaging. For single molecule imaging, culture dishes were pre-
treated with 5M KOH (Sigma) for 1 hour, followed by 5 rinses with deionized water (Sigma). 
2.3 Fluorescent noncanonical amino acid tagging (FUNCAT) 
For metabolic labelling and subsequent click chemistry, Click-iT reagents and buffers (Life 
Technology) were used. After 18 hours, the complete L15 culture medium was replaced with 
methionine-free L15 culture medium (60% methionine-free L15 + antibiotics, GIBCO) and 
further incubated for 6 hours to deprive intracellular methionine stock. 300µM HPG (Life 
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Technology) was added into the cultures for 30 minutes to detect baseline translation. 
Afterwards, the HPG-containing medium was washed out with methionine-free medium 5 times, 
10 minutes each. Subsequently, retinal cultures were stimulated with 600ng/ml Netrin-1 (R&D 
Systems) for 0, 10, 20, 30, 40 and 50 minutes. No Netrin-1 was added in the control dishes. 
300µM AHA (Life Technology) was added into the culture during the last 10 minutes of Netrin-
1 incubation. After a few quick washes with methionine-free medium, cultures were fixed in 4% 
formaldehyde/15% sucrose and permeabilized in 0.1% Triton in PBS. Click-chemistry reactions 
with Alexa Fluor 594 azide (Life Technology) for labelling HPG and Alexa Fluor 488 alkyne 
(Life Technology) for labelling AHA were sequentially performed for 30 minutes each. Finally, 
the cultures were mounted in FluorSave (EMD Millipore). 
2.4 Puromycin labelling assay on retinal cultures 
After 24 or 48 hours, retinal cultures were treated with 10µg/ml puromycin (Sigma) for 10 
minutes. Subsequently, the cultures were fixed in 4% formaldehyde/15% sucrose, 
permeabilized with 0.1% Saponin (Sigma) or 0.1% Triton X-100 (Sigma) and blocked in 5% 
heat-inactivated goat serum, then labelled with Alexa Fluor 488- or 647-conjugated anti-
puromycin antibody (1:250, Millipore) overnight. For Axon-only puromycin labelling, axons 
were severed from their cell bodies prior to puromycin treatment. 
2.5 Image acquisition and quantitative immunofluorescence (QIF) 
analysis 
Noncollapsed growth cones were imaged using a Nikon Optiphot inverted microscope equipped 
with a 60x oil-immersion objective and a CCD camera (Hamamatsu). Growth cones were 
chosen randomly to avoid biased selection of immunofluorescence. Bright-field and fluorescent 
images at 488nm, 594nm and/or 647nm of a growth cone and/or an axon segment of 40-60µm 
were captured with constant exposure time and below pixel saturation. For quantitation of 
immunofluoresent intensity, the outline of a growth cone was manually drawn on a bright field 
imaged with the “freehand tool” in Volocity software (Perkin Elmer) and it defined the region 
of interest (ROI). Both the growth cone central domain and filopodia were included in the 
growth cone measurement. Fluorescence of a 20µm segment of axon shaft 20µm away from the 
base of the growth cone was referred to as the axonal signals. The same ROI was then placed in 
the adjacent area of the growth cones or axons without any cellular material to measure 
background fluorescent intensity. The background reading was subtracted from the growth cone 
or axon reading to obtain the background-corrected intensity. Samples from independent 
experiments were stained, imaged and analysed under identical conditions. In each independent 
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experiment, fluorescent intensity was normalized to the control groups. 
2.6 Puro-PLA 
Proximity ligation assay steps were carried out according to the manufacturer’s protocol 
(Sigma). Eyes were severed from retinal explants after 24 or 48 hours of outgrowth. Cultures 
were treated with 10µg/ml puromycin for 10 minutes at RT, fixed in 4% formaldehyde/15% 
sucrose in PBS for 20 minutes at 20°C, washed 3 times in PBS with 0.001% Triton X-100, 
permeabilized for 3-5 minutes in 0.1% Triton X-100 in PBS, washed three times in PBS, 
blocked with 5% heat-inactivated goat or horse serum in PBS for 30 minutes at room 
temperature and subsequently incubated with two primary antibodies overnight at 4°C. Primary 
antibodies were diluted at 1:500 for unconjugated mouse anti-puromycin (MABE343, 
Millipore), 1:200 for rabbit anti-LaminB2 (ab97513, Abcam) and 1:500 for goat anti-VDAC2 
(ab37985). Dishes were washed twice for 5 minutes with 0.002% Triton X-100 in PBS and 
incubated with anti-rabbit (+) or anti-goat (+) and anti-mouse (-) PLA probes for 1 hour at 37°C, 
with ligase for 30 minutes at 37°C and with the polymerase mix with red fluorescence for 100 
minutes at 37°C. The samples were subsequently mounted with the mounting medium (Sigma) 
and imaged using a Nikon Eclipse TE2000-U inverted microscope equipped with an EMCCD 
camera. For quantification of Puro-PLA signals, the number of discrete fluorescent puncta 
within a randomly chosen 20µm axon segment in each image was counted using Volocity. 
2.7 Targeted eye electroporation 
Targeted eye electroporation was performed as previously described (Falk et al., 2007). The 
retinal primordial of stage 26-30 embryos were injected with electroporation mixture, which 
contains DNA or morpholinos, followed by electric pulses of 50ms duration at 1000ms intervals, 
delivered at 18V. The embryos were recovered and continued to be raised in 0.1X MBS until 
the desired embryonic stage for experiment. For SunTag imaging, SunTag-β-actin and scFv-
GFP constructs in pCS2+ vectors were mixed according the ratio described in the text, making 
up the total concentration of 1.8µg/µl. For SMTI imaging, Venus-β-actin plasmids were diluted 
to 1µg/µl final concentration.  
2.8 SunTag imaging 
Eye primordia of stage 34 embryos were cultured on laminin-coated dishes. After 24 hours, 
continuous imaging of distal axons at maximal speed was performed under a Perkin Elmer 
Spinning Disk UltraVIEW ERS, Olympus IX81 inverted microscope with a 60x 1.4NA silicone 
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oil objective and an ORCA-Flash4.0 camera (Hamamatsu) for 3 minutes in 5-slice stacks with 
500nm gaps between layers. Exposure times were set between 300-500ms. Laser power of 
488nm laser line was set to 50% of maximal intensity. Time-lapse images were recorded by 
Volocity software.  
2.9 Optical setup for Single Molecule Translation Imaging 
(SMTI) 
Imaging was performed on a custom-made inverted single-molecule fluorescence microscope 
built around a commercial microscope frame (Olympus IX73). The illumination laser 
wavelength was at 488 nm (Coherent Sapphire) for excitation of the YFP derivate Venus in 
combination with a 525/645 emission filter (Semrock) and a dichroic beam splitter (Chroma 
ZT405/488/561/640rpc). The laser beam was circularly polarized to excite fluorescent proteins 
homogeneously regardless of their orientation. The microscope was equipped with an EM-CCD 
camera (Andor iXon Ultra 897) with effective pixel size on the sample of 118 nm. A 100x 
NA=1.49 oil immersion TIRF objective (Olympus) was used.  
2.10 Retinal axon SMTI 
Prior to imaging, the dissected and cultured eyes were pre-incubated with 40nM PP1 inhibitor 
tautomycin (Sigma) for 30 minutes to modulate the CamKII and PP1 balance in growth cones in 
favour of attractive turning towards netrin-1 and, in the negative control case, also pre-incubated 
with the translation inhibitor puromycin (Sigma). An outgrowing fluorescent growth cone was 
then selected and, prior to the bleaching step, imaged with low irradiance (<2W/cm2) in both 
fluorescence and bright field mode to generate an outline image. The growth cone was then 
photobleached for 10s with an irradiance of 1.5 kW/cm2 and the flash-like recovery of Venus 
fluorescence recorded with an exposure time of 200 milliseconds for 60 seconds to generate a 
basal baseline. A reduced laser intensity of 0.3 kW/cm2 was used to ensure survival of the axons 
while simultaneously bleaching newly synthesized Venus proteins. Then a drop of either 
600ng/ml netrin-1 (Sigma) or culture medium as a control was added to the dish, while imaging 
was continued for another 120 seconds. After that another bright field image was taken to check 
for survival. Retracted growth cones were excluded from analysis. All imaging steps were 
performed under epifluorescence illumination. An EM gain of 200 was used on the EMCCD 
camera to ensure single molecule sensitivity. The field of illumination was twice the size of the 
imaged field of view to bleach diffusing or transported fluorescent proteins from outside the 
growth cone before entering the field of view. 
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2.11 HEK293T cell culture 
HEK293T cells were maintained in DMEM medium (ThermoFisher Scientific) supplemented 
with 10% FBS (ThermoFisher Scientific) in a 37°C humidified incubator containing 5% CO2. 
Transfection was performed with jetPRIME (Polyplus transfection) following the manufacturer 
recommendations. 1µg Venus-β-actin plasmids was used for transfection. 
2.12 HEK293T cell SMTI  
Prior to imaging, the HEK293T cells were bathed in the translation inhibitor puromycin (Sigma), 
or left untreated (control). The cells were then photobleached for 5 seconds with an irradiance 
of 1 kW/cm2 under episcopic illumination and Venus SMTI recorded with an exposure time of 
10 milliseconds for 25 seconds under TIRF illumination. The same intensity of 1 kW/cm2 was 
used for SMTI imaging as for bleaching due to the much higher translation rate in HEK293T 
cells near the nucleus. Imaging was performed with an additional EM gain of 200 to ensure 
single molecule sensitivity.  
2.13 SMTI data analysis 
Localisations of individual protein translation events were retrieved using maximum likelihood 
estimation with a Gaussian model fit via the software package rapidSTORM (Wolter et al., 
2012). A threshold of ~6700 ADC, corresponding to ~500 photons per localization, was applied 
to filter out noise and non-Venus blinking events. This threshold was found by manual selection 
of Venus flashes and determination of the “average” photon budget of a single emitting Venus 
molecule. The tracking option of rapidSTORM was used to recombine photons emanating from 
the same Venus protein over multiple frames. In the growth cone experiments all events in a 
small area around the growth cones were included for analysis due to the high mobility of 
filopodia. Results are given as translation events per second and with the standard error of the 
mean as error bar.  
In the HEK293T cell experiments, events happening inside and outside the cell were 
distinguished using an outline image generated from the SMTI acquisition and normalised the 
measured rate to the cell surface to ensure comparability of differently sized HEK293T cells. 
This was done via custom-written macros and software for ImageJ and MATLAB and yielded 
the translation rate density in translation event/s/µm2. Note that this area normalisation step was 
not performed in the primary retinal culture assay, as the objective’s depth of field was large 
enough to capture events from almost every axial position in the growth cones. The developed 
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code for SMTI data analysis is freely available online under 
https://github.com/laseranalyticsgroup/SMTI. 
2.14 Gradient assay 
Gradients of diffusible Netrin-1 (or control) were established as described (Campbell and Holt, 
2001; de la Torre et al., 1997). As soon as the Venus-β-actin expressing growth cones were 
photobleached, a gradient of Netrin-1 was generated through pulsatile injection of 5µg/ml 
Netrin-1 solution from a glass pipette placed at 90° to the direction of the axon shaft. The 
distance between the micropipette and the growth cone is 30µm. Growth cones were 
continuously imaged for 1 minute immediately after the pulsatile injection of Netrin-1 started, 
followed by a 4-minute gap with no imaging or photobleaching. Then another 1 minute SMTI 
were performed to record the translation events. For analysis, the growth cone was bisected into 
two equal areas by a line drawn through the axon shaft (90° to the pipette) by an experimenter 
blind to the direction of the gradient. The number of translation events during 1 minute on either 
side of the dividing line were calculated for both of the 1-minute imaging session. 
2.15 Blastomere microinjection 
DNA and RNA were microinjected into both of the dorsal blastomeres at four- or eight-cell 
stage as previously described (Leung and Holt, 2008). Embryos were de-jellied with 2% 
cysteine (Sigma) in 1x MBS (pH 8), washed 3 times in 0.1X MBS and aligned on a grid in 4% 
Ficoll (Sigma) in 0.1x MBS, 1% penicillin (100 U/ml), streptomycin (100 mg/ml) and 
fungizone 0.25 mg/ml (Antibiotic-Antimycotic, Gibco). Injections of 5 nl of volume were 
performed using glass capillary needles (1.0 mm OD x 0.5 mm, Harvard Aparatus) and a 
microinjector (Picospritzer, General Valve). Cy3-UTP (PerkinElmer) was injected at 100µM 
concentration. Mito-GFP plasmid was injected at 25ng/µl concentration. RNA of GFP- or RFP-
tagged wild-type or mutant Rab5a and Rab7a, eGFP-Vg1RBP, GFP-tagged wild-type or mutant 
FUS, and mCherry-TNPO1 were injected at a concentration of 200ng/µl, GFP RNA were 
injected at a concentration of 100ng/µl due to the smaller molecular weight of the plasmid. 
Capped mRNA was in vitro transcribed using mMessage mMachine SP6 Transcription Kit 
(ThermoFisher), and polyadenylated using Poly(A) Tailing Kit (ThermoFisher). 
2.16 Live imaging in Xenopus retinal ganglion cell axons 
Cultured axons were imaged under a Perkin Elmer Spinning Disk UltraVIEW ERS, Olympus 
IX81 inverted microscope with a 60x 1.4NA silicone oil objective for 2 to 5 minutes with 
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exposure times set between 300-500ms. Volocity software was used for manual tracking of 
Rab7a or Rab5a-positive endosomes associated with either Cy3-RNA or eGFP-Vg1RBP 
labelled granules. Colocalising granules were defined by their association for >2s in 
static/oscillatory motion if no directional transport further than 2µm within 60 seconds was 
observed. Movies of Rab7a positive-endosomes and mitochondria were taken every 2 second 
for 5 minutes directly after the cultures were incubated for 20 minutes in 50nM MitoTracker red 
CMXRos (Invitrogen) dissolved in DMSO and washed 5 times with culture medium. To 
quantify mitochondrial membrane potential, retinal cultures were incubated with 20nM 
tetramethylrhodamine, methyl ester (TMRM) (ThermoFisher Scientific) for 20 minutes, 
followed by two washes and immediate image acquisition of single frames. Object detection 
analysis on Volocity was then used to quantify the mean intensity of the TMRM signal in each 
mitochondrion. GFP-tagged FUS (and Cy5-RNA)-expressing axons were imaged at maximal 
speed for 1 minute. 
2.17 Analysis of Cy3-labelled RNPs in RGC axons 
Particle movements were extracted from raw data movies with the plusTipTracker package 
(Applegate et al., 2011). The Watershed-based option in the Detection Settings was used for all 
movies. To detect individual features (granules) the movies were denoised with 2 gaussian 
Kernels of size 1 pixel and 3 pixels respectively. This corresponds to the sigma 1 & 2 in the 
Detection Settings of the plusTipTracker package. The K-Value (local threshold) was set to 
values between 2-5 depending on the background noise in the movies. The Tracking settings 
were held constant for all movies: Search Radius Range = 3-10, Minimum Sub-Track length = 4 
frames (to discard background fluctuations), Maximum Gap Length = 3 (frames for which a 
particle is not detected due to overlap with another particle), Max Shrinkage Factor = 0, 
Maximum angle Forward/Backward= 30/0, Fluctuation Radius = 1.5. After running this 
analysis, we are left with several tracks (x-y coordinates) for each movie. 
The movies were post processed in a self-written MATLAB script. First, a segmented line was 
drawn along the neurite towards the anterograde direction. Then each (average) track direction 
was calculated. If the average direction points within 162 degrees of the forward/anterograde 
direction of the drawn neurite the track is classified as anterograde and vice versa. Furthermore, 
tracks that displace less than 2µm from their origin were classified as oscillatory. To calculate 
the track/granule intensity a background region was drawn by hand and the average pixel 
intensity in this region subtracted from the average intensity of the granule for each track 
(Individual granule intensities are calculated in the detection part of the plusTipTracker script). 
The average track velocity was calculated as the average of all frame-to-frame velocities. 
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2.18 Pixel intensity and area coverage analysis of fluorescently 
labelled granules 
Images of fluorescently labelled granules of Cy3-RNP in contact with GFP-Rab5a, GFP-Rab7a, 
or mitochondria were analysed using custom-written scripts within the MATLAB R2016b 
(MathWorks, Inc.) environment. All greyscale fluorescent images were binarized using Otsu’s 
thresholding method (Otsu, 1979). The binary images were segmented using a modified 
watershed method to obtain masks of labelled granules from each fluorescent channel. The 
resulting images were then visually inspected and the threshold was adjusted where granules 
were misidentified. The masks from the two channels of each pair were compared spatially and 
Cy3-RNA granules that overlapped with GFP-Rab5a, GFP-Rab7a or mitochondria, by at least 
one pixel, were identified. The Cy3-RNA granules were thus grouped as overlapping and non-
overlapping. The area of each granule was defined as the total number of pixels of its mask and 
was normalized to the smallest and largest granule areas within one image (typically of a single 
axon). Since the mask areas of brighter granules tended to be larger, we calculated the mean 
intensities of the brightest pixels within each mask to remove any possible dampening of the 
signal due to mask size. The number of brightest pixels to be included was separately 
determined for each of Cy3-RNP pairs and set as half of the average area of Cy3-RNA granule 
masks in that pair. Pixel intensities of the granules were obtained from the original greyscale 
image and normalized such that the minimum value would equal the binarization threshold and 
the maximum value was that of the brightest pixel within the corresponding image’s masks. 
2.19 Immunoprecipitation and quantitative PCR 
GFP, GFP-Rab5a or GFP-Rab7a expressing Xenopus brains were dissected from stage 35/36 
embryos and homogenized in lysis buffer (Tris 20mM, NaCl 100mM, 10mM MgCl2 0.25% 
NP40, 10% Glycerol, 100µg/ml cycloheximide (Sigma)) supplemented with EDTA-free 
protease inhibitor cocktail (Roche), phosphatase inhibitor (Pierce) and 100U/ml SUPERase In 
RNase inhibitor (Ambion) for 10 minutes on ice. Following centrifugation for 5 minutes at 
13200rpm, the supernatant was collected. For immunoprecipitation, the protein extracts were 
incubated for 90 minutes at 4°C with GFP-Trap_MA beads (Chromotek). Beads were washed 
three times with lysis buffer and samples were eluted from the beads by adding RLT buffer 
(Qiagen) and vortexing for 2 minutes. RNA was isolated from eluted samples using the RNeasy 
Mini kit (Qiagen) and reverse transcribed into cDNA using random hexamers and the 
SuperScript III First-Strand Synthesis System (Thermo Fisher Scientific). The cDNA was used 
to prepare triplicate reactions for qPCR according to manufacturer’s instructions (QuantiTect 
48
      
SYBR Green PCR kit, Qiagen) and plates were centrifuged shortly and run on a LightCycler 
480 (Roche) using the following PCR conditions: denaturation for 15s at 94°C; annealing for 
30s at 60°C; extension for 30s at 72°C. The levels for each condition were corrected with their 
own input. The following primers were used for qPCR: for β-actin, 5’-
CCAGAAGAACACCCAGTGCT-3’ and 5’-CAGGGACAACACAGCTTGGA-3’; for 18S 
rRNA, 5’-GTAACCCGCTGAACCCCGTT-3’ and 5’-CCATCCAATCGGTAGTAGCG-3’; for 
28S rRNA, 5’-AACGGCGGGAGTAACTATGA-3’ and 5’-TAGGGACAGTGGGAATCTCG-
3’; for laminB2, 5’-GCAAGTGAAGATGTACAAGGAAGAA-3’ and 5’-
CGTCGCTCAGTTAATTCTTCTAGGG-3’; for vdac2, 5’-ACTCGCATGCAGCCATATCT-3’ 
and 5’-TACCAGCGCAGAAAGTGTGA-3’. 
2.20 Immunohistochemistry 
Retinal cultures were fixed in 4% formaldehyde/15% sucrose in PBS for 20 min at 20°C, 
permeabilized for 3-5 min in 0.1% Triton in PBS and blocked with 5% heat-inactivated goat 
serum in PBS for 30 min at 20°C. Primary antibodies were incubated overnight, followed by 
Alexa Fluor-conjugated secondary antibodies for 45 min at 20°C in dark. Cultures were 
mounted in FluorSave (Calbiochem) or Vectashield (Vector Laboratory) for super-resolution 
microscopy. Antibodies were used at the following dilutions. Primary antibodies: 1:1000 mouse 
anti-GFP (ab1218, Abcam), 1:200 rabbit anti-RPL10A (16681-1-AP, Proteintech), 1:200 rabbit 
anti-RPS3A (14123-1-AP, Proteintech), 1:10 mouse anti-eIF4E (sc-27227, Santa Cruz 
Biotechnology), 1:800 rabbit anti-phospho-S6 Ribosomal Protein (Ser235/236) (#2211, Cell 
Signaling), 1:200 rabbit anti-SFPQ (ab38148, Abcam) and 1:200 for rabbit anti-TLS/FUS 
(ab70381, Abcam). Secondary antibodies: 1:500 goat anti-mouse Alexa Fluor 488 (Invitrogen) 
or goat anti-rabbit Alexa Fluor 568 (Invitrogen) for RPL10A, RPS3A, eIF4E and FUS, 1:1600 
goat anti-rabbit Alexa Fluor 568 for phospho-S6, 1:1000 goat anti-rabbit Alexa Fluor 568 
(Invitrogen) for SFPQ immunohistochemistry.  
2.21 OMX super-resolution microscopy 
Super-resolution 3D SIM images were acquired using a Deltavision OMX 3D SIM System V3 
from Applied Precision (a GE Healthcare company) equipped with 3 EMCCD Cascade cameras 
from Photometrics, 488nm and 592.5 nm diode laser illumination, an Olympus PlanSApo 100× 
1.40 NA oil objective, and standard excitation and emission filter sets. Imaging of each channel 
was performed sequentially using three angles and five phase shifts of the illumination pattern 
as described (Gustafsson et al., 2008). The refractive index of the immersion oil (Cargille) was 
adjusted to 1.513 to minimize spherical aberrations. Sections were acquired at 0.1µm z steps. 
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Raw OMX data were reconstructed and channel registered in the SoftWoRx software (Applied 
Precision, a GE Healthcare company). Reconstructions were carried out using channel-specific 
Optical Transfer Functions (OTFs) and channel-specific K0 angles. OTFs were generated 
within the SoftWoRx software by imaging 100 nm beads (Life Technologies) using appropriate 
immersion oils to match the data. Channel registration was carried out using the Image 
Registration parameters generated within the SoftWoRx software and checked for accuracy by 
imaging Tetraspeck beads (Life Technologies). Channel registration was accurate to one pixel. 
Further data analysis was performed using Fiji.  
2.22 Polysome fractionation 
Xenopus brains and eyes from approximately 75 embryos were dissected from stage 35/36 
embryos and lysed in polysome buffer (10mM Tris, pH 7.4, 300mM KCl, 10mM MgCl2) 
supplemented with 100µg/µl cycloheximide (Sigma), 1% n-octylglucoside (Sigma), 100U 
SUPERase In RNase inhibitor (Ambion) and EDTA-free protease inhibitors (Roche) on ice for 
20 minutes. After centrifugation for 10 minutes at 16000g at 4°C the supernatant was loaded 
onto a 10-50% (w/v) sucrose gradient (prepared in polysome buffer with 100µg/µl 
cycloheximide and 0.5mM DTT (Sigma). For EDTA treatment, lysis buffer and gradients were 
made with polysome buffer containing 25mM EDTA instead of 10mM MgCl2. Gradients were 
centrifuged in a SW40Ti rotor in a Beckman L-80 ultracentrifuge at 35000rpm at 4°C for 
160min. Fractions were collected with continuous monitoring at 254nm using an ISCO UA-6 
UV detector. Proteins from the fractions were processed for SDS-Page followed by blotting for 
rabbit anti-Rab7 1:1000 (ab137029, Abcam), mouse anti-Rab5 1:100 (sc-46692, Santa Cruz), 
mouse anti-RPL19 1:500 (ab58328, Abcam) and mouse anti-RPS23 1:500 (ab57644, Abcam) as 
described above. 
2.23 Differential gene expression analysis 
To analyse axonal translation of mitochondria-related genes, we used the RNA-seq data of our 
previous translatome study (Shigeoka et al., 2016). We analysed the levels of ribosome-bound 
mRNAs (FPKM) for all axonally translated genes (DEGs) that are annotated with at least one of 
the offspring GO terms of “mitochondrion organization (GO:0007005)”. For the GO analysis, 
we analysed the enrichment of these offspring GO terms for gene sets that are translated in 
axons and in retinas of stage P0.5 mice. The enrichment scores were calculated using topGO 
version 2.22.0 on R version 3.2.2. For heatmap representation, we selected GO terms that are 
significantly enriched (Fisher’s P values < 0.05) in axonally translated genes (P0.5).  To analyse 
the targets of the mTOR pathway, we used a set of genes whose translation is suppressed (fold 
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decrease > 1.5) by at least one of three mTOR inhibitors, Torin1, Rapamycin and pp242 in 
previous studies (Larsson et al., 2012; Thoreen et al., 2012).  An mRNA was determined as 
5’TOP-like if it contained a sequence of at least five consecutive pyrimidine bases which starts 
within four nucleotides from 5’end of the mouse cDNA sequence. 
2.24 RGC pathway visualization and analysis 
Embryos were fixed at stage 45 in 4% formaldehyde in PBS at 4°C overnight and washed 3 
times with filtered PBS. RGC axons of one eye per embryo were labelled by intraocular 
injection of fluorescent lipophilic dye, DiI (Invitrogen). Embryos were left in PBS for 48 hours 
allowing the diffusion of the dye into the optic tract. The contralateral (or non-dye injected side) 
brain hemisphere was later dissected, mounted in PBS and visualized using confocal under 
568nm laser line. Brains with less than 30 visible axons were categorized as defective axonal 
projection phenotypes. 
2.25 Expression, purification, and gelling of recombinant FUS LC 
domain constructs 
cDNAs for FUS LC residues 2–214 and its variants were cloned (pOPINS vector) and 
expressed in E. coli BL21(DE3), purified on Ni-NTA resin, buffer exchanged into either droplet 
buffer (50 mM Tris and 150 mM NaCl [pH 7.5]) or gelation buffer (50 mM Tris and 500 mM 
NaCl [pH 7.5]). For gelling experiments, FUS samples were concentrated to 1 mM, transferred 
to thin-walled PCR tubes and incubated at 4°C, and transferred to 23°C to induce melting. 
2.26 Viscosity measurement by single particle tracking analysis in 
FUS gels 
Samples were imaged on a Nikon TE-300 inverted wide-field fluorescence microscope and 
laser illumination (Cobalt, 488 nm wavelength laser attenuated to 2 mW/cm2 intensity on the 
specimen for imaging GFP, and Toptica iBeam smart 640 nm laser at 20 mW/cm2 for imaging 
fluorescent spheres). Images were captured from a focal plane 15 mm above the coverslip to 
ensure the observations measured the particles in the bulk specimen and not any adhering to the 
coverslip. Particle track analysis was performed as described (Rees et al., 2013). Each repeated 
measurement of viscosity was obtained from a separate specimen, and at least four image stacks 
were measured for each. 
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2.27 Western blot for FUS and demethylated FUS 
Stage 35/36 eye and/or brain lysates were prepared in ice-cold RIPA buffer (150 mM NaCl, 1% 
NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) andresolved by 10% SDS-
PAGE. It was then and transferred to nitrocellulose membrane (Bio-Rad), which were blotted 
using the following primary antibodies: 1:1000 rabbit anti-TLS/FUS (ab70381, Abcam), 
1:10000 mouse anti-α-tubulin (T6074, Sigma), 1:1000 mouse anti-GFP (ab1218, Abcam). 
1:20000 goat anti-rabbit or anti mouse HRP-conjugated secondary antibodies (Abcam) were 
used in combination with a chemiluminescence-based detection system (Amersham ECL, GE 
Healthcare). 
2.28 Cryosection 
Stage 45 Xenopus embryos were anesthetized and fixed in 4% formaldehyde, treated with 30% 
sucrose in PBS (w/v) overnight, and embedded in optimal cutting temperature compound 
(OCT), rapidly frozen on dry ice, sectioned by a cryostat with 12µm thickness, and mounted 
with DAPI-containing mounting medium. 
2.29 Expression and purification of FUS proteins from Sf9 cells 
Construct encoding full-length FUS was cloned into pACEBac2 vector with a TEV cleavable 
N-terminal MBP tag and an EmGFP-6xHis-C terminal tag. Proteins were expressed and 
purified from insect Sf9 cells infected with the baculovirus. After four days of infection cells 
were harvested by spinning at 4000rpm for 30 minutes. Cell pellets were mixed with the 
resuspension buffer containing 50mM Tris, 1M KCl, 0.1% CHAPS, 1mM DTT, 5% glycerol at 
pH 7.4, and proteins purified using three steps purification scheme including, Ni-NTA affinity 
column, Amylose affinity column followed by size exclusion chromatography in the buffer 
containing 50mM Tris, 1M KCl, 1mM DTT, 5% glycerol at pH 7.4. For the preparation of 
hypomethylated FUS samples, the insect cell cultures were subjected to a repeated dose of 
25µM AdOx solubilised in DMSO for four days. Western blotting of mock or AdOx-treated 
FUS proteins used a rabbit anti-dimethyl-Arginine antibody (ASYM24, Merck Millipore) and a 
rabbit anti-TLS/FUS antibody (AV40278, Sigma). 
2.30 Statistical analysis 
Each experiment was repeated at least three times. Details of statistical analysis are included in 
figure legends or main text. Statistical analysis was performed using Prism (GraphPad).  
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3 VISUALISING 
SPATIOTEMPORAL 
DYNAMICS OF NETRIN-1-
STIMULATED PROTEIN 
SYNTHESIS IN AXONS 
3.1 Introduction 
During neurodevelopment, the growth cone navigates to its remote target by sensing 
extracellular cues, including four evolutionary conserved families – netrins, ephrins, slits and 
semaphorins (Dickson, 2002; Kolodkin and Tessier-Lavigne, 2011; O'Donnell et al., 2009). 
Before reaching its destination, the growth cone responds to these guidance cues by turning, 
advancing, or pausing in a timely manner. Given the significant distance between the axon 
terminal and the cell body, growth cones must possess a high degree of autonomy in order to 
react precisely and rapidly. Previous studies have provided evidence that local protein synthesis 
contributes to the fast and local responses of navigating axons (Campbell and Holt, 2001; Leung 
et al., 2006; Piper et al., 2006; Welshhans and Bassell, 2011; Wu et al., 2005; Yao et al., 2006). 
However, the precise underlying molecular mechanisms induced by different guidance cues 
remain elusive. 
Biochemical methods including ribosome profiling (Ingolia et al., 2009) and mass spectrometry 
analysis of labelled nascent peptides (Ong et al., 2002; Yoon et al., 2012) have been widely 
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applied in identifying newly synthesised proteins. However, the challenge in studying local 
translation in axons using biochemical strategies lies in the limitation in amount of starting 
materials. Axon-only cultures can be prepared with various approaches separating axons from 
their cell bodies, e.g. Campenot chamber, modified Boyden chamber, microfluidic device and 
laser capture method (Kim and Jung, 2015; Zivraj et al., 2010). However, in the case of primary 
neuronal cultures, only a limited amount of axon material can be collected from dissected tissue 
explants and the entire preparation process can be tedious and time-consuming. The 
implementation of imaging approaches in axon compartments offers to opportunity to compile 
more precise spatiotemporal information of local protein synthesis from minimal amount of 
materials.  
As an example, I focus on Netrin-1 in this chapter to explore and optimise various imaging 
techniques to study cue-induced local protein synthesis in growth cones. Through investigation 
of the temporal dynamics of Netrin-1-induced total protein synthesis using two different 
labelling techniques, I gathered an overall picture of protein synthesis in the growth cone at 
different timepoints after cue stimulation, which serves as a starting point for further study of 
sophisticated phenomena involving complex signalling pathways. For instance, growth cone 
receptor adaptation enables growth cones to readjust their sensitivity to guidance cues when 
they are migrating in an environment where the concentration of guidance cues vary 
dramatically (Loschinger et al., 2000; Rosentreter et al., 1998). It has been observed that when 
growth cones are exposed to Netrin-1, they undergo consecutive phases of desensitization and 
resensitization (Ming et al., 2002). The desensitization phase is dependent on rapid endocytosis 
but the possibility of downstream signalling pathway modulation is not excluded. The 
resensitization phase is mostly protein synthesis-dependent mediated by MAPK signalling 
(Piper et al., 2005). Therefore, investigating the change of growth cone proteomes during 
growth cone adaptation may provide insights into the cellular mechanisms underlying this 
crucial behaviour during axon navigation.   
Specifically, it is well documented that Netrin-1 induces β-actin protein production in 
developing growth cones. β-actin is a key structural component of growth cones associated to 
its motility (Shestakova et al., 2001). β-actin mRNA is localised to axons (Bassell et al., 1998) 
and neurotrophin-3 (NT-3) stimulation increased the transport of β-actin mRNA into axons 
(Zhang et al., 1999). Therefore, β-actin has been a major candidate protein for local translation. 
Indeed, asymmetric spatial distribution of β-actin in the growth cone can be observed in vitro 
upon 5 to 10-minute stimulation with Netrin-1 (Leung et al., 2006) or brain-derived 
neurotrophic factor (BDNF) gradient (Yao et al., 2006). However, since these experiments were 
based on immunocytochemistry on fixed samples, translation events could not be probed at the 
single molecule level. Moreover, the temporal information was limited to a minute scale and 
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could not be monitored in real time. Because the kinetics of de novo protein synthesis in axons 
are likely to change rapidly to actively prepare for the growth cone steering, gaining this precise 
spatiotemporal information is important for understanding the mechanistic contribution of 
locally synthesized β-actin in axon navigation. To preserve the spatiotemporal information of 
local translation during cue-stimulation, single molecule live imaging techniques including 
fluorescence amplification via multi-epitope tagging methods (Wang et al., 2016a; Wu et al., 
2016; Yan et al., 2016) and fluorescent protein-based single protein translation imaging (SMTI) 
(Ifrim et al., 2015; Tatavarty et al., 2012) offer dynamic readouts of protein synthesis at 
subcellular locations in real time. Equipped with these powerful tools, we will be able to 
address more questions regarding local protein synthesis in growth cones. For example, it is not 
known where in the growth cone new proteins are synthesised, how fast synthesis occurs in 
response to a cue and whether it occurs repetitively in the same spot or singly in diverse sites 
indicative of polysomal versus monosomal translation respectively. 
In this chapter, several imaging techniques for studying local protein synthesis on fixed and live 
axons are tested and optimized. Time-series experiments using FUNCAT and puromycin 
labelling techniques reveal the temporal dynamics of cue-stimulated de novo protein synthesis 
in retinal growth cones and axons. The combination of puromycylation and proximity ligation 
assay offers a convenient and robust tool to visualize specific protein synthesis in situ. Finally, 
real-time single molecule translation imaging measures Netrin-1-induced β-actin translation in 
growth cones with unprecedented spatiotemporal resolution. Particularly, further developments 
of the Venus-based SMTI approach through protocol optimization and analytical methods 
demonstrate it to be a powerful tool for the quantification of translation dynamics in retinal 
ganglion cell (RGC) growth cones, leading to the discovery of a remarkably rapid increase of β-
actin translation within 20 seconds of Netrin-1 application.    
3.2 Visualising axonal translation with Fluorescent Noncanonical 
Amino Acid Tagging method 
In order to measure total protein synthesis in RGC axons, we employed a metabolic labelling 
approach allowing in situ visualization of nascent proteins, based on one of the widely used 
Click chemistry reactions, Copper(I)-Catalysed Azide-Alkyne Cycloaddtion (CuAAC) (Figure 
3.1 A). This method, known as Fluorescent noncanonical amino acid tagging (FUNCAT) 
(Dieterich et al., 2010), was developed from the Bioorthogonal amino acid tagging (BONCAT) 
technique working effectively in various biological systems from bacteria to mammalian 
neurons (Dieterich et al., 2006; Hinz et al., 2012; Mahdavi et al., 2014) First, an amino acid 
methionine analogue, L-azidohomoalanine (AHA), bearing an azide group, is introduced into 
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Figure 3.1 Detecting new protein synthesis in Xenopus retinal cultures by FUNCAT.
(A) Schematic of Copper(I)-Catalysed Azide-Alkyne Cycloaddition (CuAAC).
(B) Chemical structures of L-azidohomoalanine (AHA) covalently bonded and labelled by Alexa 
Fluor 488 alkyne.
(C) Chemical structures of L-homopropargylglycine (HPG) covalently bonded and labelled by 
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(D) Experimental procedures of labelling de novo protein synthesis in retinal cultures using 
FUNCAT.
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the cell and incorporated into the newly synthesized proteins. After fixation, AHA covalently 
binds with alkyne-bearing fluorophores in the presence of the catalyst Copper(I), revealing the 
localization and the amount of newly synthesized proteins in the cell (Figure 3.1 B). Moreover, 
the introduction of another methionine analogue, L-homopropargylglycine (HPG), an alkyne 
that can be labelled by an azide-modified fluorophore (Figure 3.1 C), made it possible for 
sequential labelling of two distinct proteomes by adding the two analogues before and after any 
treatment. 
To study the cue-stimulated kinetics of total protein expression in retinal growth cones and 
axons using FUNCAT, we took advantage of the dual colour labelling, using HPG as the basal 
translation label and AHA as the cue-stimulated translation indicator. The ratio between AHA 
and HPG incorporation was computed to normalize the Netrin-1-stimulated protein expression 
rate to the baseline in each growth cones, which could be a useful trick to reduce the variability 
of translation rate between different axons. In this assay, L15 culture medium was first replaced 
with methionine-free medium after 18 hours culture from stage 33-34 embryos. Subsequently, 
HPG was added into the cultures 6 hours post-methionine depletion to label the baseline 
translational rate. Immediately after HPG was washed off with methionine-depleted medium, 
the retinal cultures were incubated with 600ng/ml Netrin-1 for 0 to 60 minutes with 10-minute 
intervals between each of the seven groups. At the beginning of the last 10 minutes of Netrin-1 
incubation in each dish, AHA was also pipetted into the Netrin-1-containing medium to label 
the newly synthesized proteins at different timepoints after Netrin-1 stimulation. HPG and AHA 
incorporated into de novo synthesized proteins were labelled with Alexa Fluor 594 azide and 
Alexa Fluor 488 alkyne, respectively (Figure 3.1 D). Fluorescent intensity per unit area at each 
timepoint was normalized to the non-stimulated control for both HPG and AHA measurement 
(Figure 3.2).  
In this experimental design, HPG incorporation for 30 minutes before Netrin-1 bath application 
served as an indicator of baseline-level translation. So it would be reasonable to expect that its 
fluorescent intensity remains relatively constant independent of the following treatments. 
However, we observed an increase of HPG incorporation when extending the duration of 
subsequent Netrin-1 incubation (Figure 3.2 A). One of the possible explanations might be that 
this is due to the slow uncharging of HPG from the tRNA. Although 5 times washes was 
performed after 30-minute HPG incubation, HPG molecules already loaded onto the 
intracellular tRNAs could not be removed so they continue to be incorporated even after the 
washing step. However, whether the increase is mostly due to the subsequent Netrin-1 
stimulation or simply longer incubation or the combination of both factors cannot be deduce 
from this result. Additional dishes serving as non-stimulated controls for each timepoint can be 
useful to address this question. If the HPG signals in the control cultures show similar pattern as 
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Figure 3.2 HPG and AHA incorporation in RGC axons upon Netrin-1 stimulation.
(A) HPG incorporation during a 30-minute period in RGC growth cones and 20µm distal axon 
segments prior to different Netrin-1 stimulation time, normalised to the control without subsequent 
Netrin-1 incubation.
(B) AHA incorporation during a 10-minute period in RGC growth cones and axon shafts 
stimulated by Netrin-1 for different durations, normalised to the unstimulated control.
(C) Representative bright field and fluorescent images revealing HPG and AHA incorporation in 
a distal axon with 30-minute Netrin-1 stimulation
Mean±s.e.m.; n.s., not significant, *P<0.05, **P<0.01, ***P<0.001, unpaired t-test. N=number of 
growth cones/axons analysed from 6 replicates. Scale bars: 5μm.
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those shown in Figure 3.2 A, the prolonged incubation time itself contributes to most of the 
increase. If controls the HPG incorporation remains unchanged over time, the increase should 
be attributed to Netrin-1 stimulation. Nevertheless, from the results, we concluded HPG-tagging 
was not a suitable tool for labelling baseline protein translation in this experiment. AHA 
fluorescent intensity only, instead of normalising to HPG signals is therefore used throughout 
the study. 
AHA labelling in both growth cones and axons showed an initial decrease at the first 10 minutes 
by 30% and recovered to the basal level at 20 minutes. Afterwards, it continued to increase and 
reached a peak at 30 minutes with 1.5 fold increase compared with the non-stimulated control 
group. The reading went down to 20% above basal level from 40 minutes and levelled off until 
the end of the hour. No significant difference could be found between the fluorescent signals in 
growth cones and in distal axon shafts in all measurements (Figure 3.2 B), indicating the 
coordinate changes in distal axonal compartments.  
Bath application of Netrin-1 in retinal culture from stage 35/36 embryos has been shown to 
induce axonal phosphorylation of the translation initiation factor 4EBP in axons from stage 
35/36 embryos (Campbell and Holt, 2001). The amount of phosphorylated 4EBP reflects the 
rate of cap-dependent translation initiation, because hypophosphorylated 4EBP sequesters the 
rate-limiting translation initiation factor eIF-4E and thus inhibits translation initiation (Gebauer 
and Hentze, 2004). Total protein synthesis measured by 3H-Leucine incorporation (Campbell 
and Holt, 2001) and BONCAT (Yoon et al., 2012) was also upregulated by Netrin-1. In contrast, 
we observed a significant decrease of the protein translation during the first 10 minutes. To 
understand the cause of this discrepancy, we investigated whether the intial decrease in AHA 
incorporation was an artifact due to the technical problem of FUNCAT in our system.  
A previous study in rat hippocampal dendrites showed that after 1-hour AHA incubation 
following the bath application of BDNF, a guidance cue shown to increase global protein 
translation (Kang and Schuman, 1996), only a modest increase of AHA incorporation could be 
detected in the distal regions of the dendrites compared to the control, while a larger increase 
were observed in the proximal dendrite segments (Dieterich et al., 2010). The authors suggested 
that this might be due to the low signal-to-noise ratio in tiny processes in the distal parts 
compared to the relatively thicker dendrite segments in the proximal areas. In our case, we also 
sought to measure protein changes in small compartments (i.e. growth cones and distal axon). 
Therefore, in addition to the previous experiment to investigate the kinetics of Netrin-1-
stimulated protein expression, we also designed tests to verified the sensitivity and fidelity of 
the FUNCAT technique applied in Xenopus RGC system. 
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We first tested the minimal incubation time for AHA incoporation to detect new protein 
synthesis in distal axon compartments. After the initial 6-hour methionine depletion, AHA was 
administered into the medium for 5, 10 and 60 minutes. No AHA was added in the control 
group, but Click reaction was performed as usual. The results suggest that fluorescent signals 
with 5, 10 or 60 minutes AHA incubation were all significantly enhanced compared to the 
control (Figure 3.3 A). In particular, the increase of fluorescence with 5 or 10 minutes 
incubation was around 35%, while one hour AHA incubation resulted in a 2-fold increase, 
which indicated AHA incorporation, even with only 5-minute pulse labelling, was sufficiently 
sensitive to reveal basal translation in growth cones. 
When focusing on the staining patterns of the fluorescent images, we noticed HPG signals were 
discrete and puntate (Figure 3.3 B, left), while Alexa 488-labelled AHA displayed more diffuse 
fluorescence (Figure 3.3 B, right). To understand whether the different patterns were due to the 
intrinsic properties of the chemicals or the sequence of adding these two methionine analogues 
into the medium, we reversed the order of using these two chemicals - AHA acting as a baseline 
indicator and HPG showing the Netrin-1-stimulated protein levels. With this procedure, the 
patterns of the two analogues were reversed. AHA signals became more punctate (Figure 3.3 C, 
left) while HPG staining displayed relatively diffuse patterns (Figure 3.3 C, right). Therefore, 
the methionine analogue added immediately after methionine starvation in cultures tends to 
exhibit punctate labelling whereas the one applied after is more diffuse. The punctate signals 
suggest bursts of translation at specific locations along the axons and in the growth cones. If this 
is indeed the case, part of the newly synthesized proteins labelled by the first-administered 
analogue consists of nascent peptides translated during the bursts of translation, triggered by the 
sudden release from the methionine starvation process. Therefore, if Netrin-1 is applied 
immediately after the methionine depletion, the translation caused by the release from starvation 
may mask the cue-stimulated translation. In our experimental design, the usage of one analogue 
prior to the Netrin-1 stimulation granted the advantage of “waking up” the cells from their 
methionine-starving mode, minimizing the burst of translation when exiting starvation.   
In sum, FUNCAT fulfils the goals of this study to certain extent by visualising the kinetics of 
Netrin-1-stimulated protein synthesis with the HPG and AHA incorporation and detection. 
However, as it has been discussed previously, the continuous HPG incorporation after the 
washout and the observation of the differences in staining patterns revealed some limitations of 
the technique. Particularly, the essential step of methionine starvation prior to HPG or AHA 
addition might stress the neurons and alter the location within the cells for synthesizing new 
proteins or induce a burst of translation occuring after the release from amino acid starvation. 
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Figure 3.3 Sensitivity and fidelity of FUNCAT application in RGC axons.
(A) Quantification and representative images of AHA incorporation in RGC growth cones with 
different incubation time, normalised to the control with no AHA addition.
(B) HPG and AHA fluorescent signals when HPG was used for basal level detection and AHA for 
stimulated translation labelling.
(C) AHA and HPG fluorescent signals when AHA was used for basal level detection and HPG for 
stimulated translation labelling.
Mean±s.e.m.; ***P<0.001, unpaired t-test. N=number of growth cones analysed from 3 replicates. 
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3.3 Puromycin labelling revealed temporal dynamics of global 
protein synthesis in axons 
Given the limitations of applying FUNCAT in RGC axons and growth cones, an alternative 
approach for visualizing global protein synthesis in axons appealed to us. Puromycin labelling 
has been reported to successfully detect nascent peptides in Xenopus retinal cultures by anti-
puromycin western blot (Lin et al., 2009), or direct visualization by immunohistochemistry in T 
cells (Schmidt et al., 2009) and hippocampal dendrites (tom Dieck et al., 2015). As a structural 
analogue of the 3’ end of aminoacyl-tRNA, puromycin enters the A site of a ribosome and can 
be transferred and incorporated into the carboxyl termini of nascent polypeptide chains, 
terminating translation and releasing the synthesizing peptide from the ribosome (Figure 3.4 A 
left). When administered at a low concentration, puromycin labels all newly synthesized 
proteins including full-length and N-terminal fragments (Miyamoto-Sato et al., 2000; Nathans, 
1964). The puromycin-incorporated released peptides can be recognized by an anti-puromycin 
antibody and imaged in situ (Figure 3.4 A right). In addition to the less time-consuming 
experimental procedures, another advantage of puromycin labelling compared to FUNCAT is 
the absence of amino acid starvation step, increasing the readout fidelity.   
To test whether puromycin-labelling strategy is suitable for visualization new protein synthesis 
in RGC axons and growth cones, we first verified the signals revealed by anti-puromycin 
antibody are indeed translation-dependent by applying protein synthesis inhibitor 
cycloheximide (CHX), which interferes with the translocation step during elongation (Obrig et 
al., 1971; Schneider-Poetsch et al., 2010), at 25-200µM in the retinal cultures 10 minutes before 
puromycin administration. At all concentrations tested, puromycin incorporation measured at 
growth cones and 20µm distal axon shafts were significantly inhibited by 40% - 80% (Figure 
3.4 B, C). As another negative control for validating the Alexa Fluor-conjugated anti-puromycin 
antibody specificity, no puromycin was added to the retinal cultures before fixation, while all 
the following immunohistochemistry procedures were performed as usual.  In this case, the 
fluorescent signal was completely absent (Figure 3.4 B, C), indicating the high specificity of the 
antibody in Xenopus RGC axons. 
Next, we employed puromycin labelling to investigate the temporal dynamics of global mRNA 
translation in retinal axons and growth cones. Similar to the experimental design in FUNCAT, 
the retinal cultures from stage 33-34 embryos were stimulated with 600ng/ml Netrin-1 for 0 to 
60 minutes with 10-minute intervals between each of the seven groups. In the last 10 minutes, 
1.8µM puromycin was added to label the newly synthesized proteins. Surprisingly, an initial 
decrease of translation was again observed in both growth cones and axon shafts, with the 
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Figure 3.4 Visualising axonal protein synthesis by puromycin labelling.
(A) Schematic of puromycin incorporation to nascent peptides and detection by a conjugated 
anti-puromycin antibody.
(B) 10-minute puromycin incorporation in RGC growth cones and axon shafts when translation is 
inhibited by protein synthesis inhibitor cycloheximide (CHX) or no puromycin was added.
(C) Representative images of puromycin incorporation in growth cones and distal axon shafts 
detected by Alexa-488-conjugated antibody when 50μM CHX or no puromycin was applied. 
Mean±s.e.m.; ***P<0.001, unpaired t-test. N=number of growth cones/axons analysed from 3 
replicates. Scale bars: 5μm.
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maximal decrease found around 20-30 minutes. Afterwards, the protein synthesis rate was 
recovered, yet still below the basal levels (Figure 3.5 A). Despite the difference in the time scale 
and the extent of the changes in translation kinetics, the same trend of Netrin-1 induced 
translation immediately following the stimulation was confirmed by two independent methods – 
FUNCAT and puromycin labelling.  
To reconcile this enigma, we sought to understand if different stages of embryonic development 
could affect the translational dynamics. Therefore, we cultured eye primordial from younger 
embryos at stage 24 when RGC axons only start to develop, instead of stage 33-34 embryos 
used in the previous experiment when the axons have crossed the optic chiasm. Meanwhile, the 
coating of the dishes was replaced by fibronectin. With a brief 10 minutes Netrin-1 stimulation, 
the puromycin incorporation was increased by approximately 50% in both growth cones and 
axon shafts of stage 24 cultures on fibronectin (Figure 3.5 B, C), in contrast to the 40% decrease 
in cultures from older-stage embryos on laminin-coated dishes. This finding supports the idea 
that growth cones at different stages and coatings respond to Netrin-1 stimulation in drastically 
different ways, possibly through the modulation of cue-induced signalling pathways by cAMP 
activity that declines with age and in presence of laminin (Hopker et al., 1999; Piper et al., 2007; 
Shewan et al., 2002).  
3.4 Detecting specific mRNA translation in axons using Puro-
PLA 
The dynamics of global protein synthesis measured by FUNCAT or puromycin labelling 
provides an overview of the local translation alternation upon cue stimulation. However, it is 
intuitive that when cells respond to external stimulation, not all the proteins change in the same 
amount, or even to the same direction in order to cope with the environment and maintain 
intracellular homeostasis. For instance, under non-lethal stressful situations, cells activate their 
“stress-coping” pathways via coordinated protein expression to adapt to the stress (Holcik and 
Sonenberg, 2005). Global translation is largely inhibited in response to most of the cellular 
stress to save energy. However, the translation of a small subset of proteins, such as activating 
transcription factor-4 (ATF4) and Bip/GRP78, is upregulated to increase the chance of cell 
survival under the stress (Fusakio et al., 2016; Harding et al., 2000). However, such exceptional 
changes of individual mRNA translation cannot be recapitulated by the ensemble readout of 
FUNCAT or puromycin labelling. Methods detecting specific protein synthesis are needed to 
study local translation in greater detail.  
To study specific protein synthesis in axons, we turned to a developed puromycin labelling and 
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Figure 3.5 Puromycin incorporation in RGC axons upon Netrin-1 stimulation.
(A) Puromycin incorporation during a 10-minute period in RGC growth cones and axon shafts 
stimulated by Netrin-1 for different durations, normalised to the unstimulated control.
(B) Puromycin incorporation during a 10-minute period in RGC growth cones and axon shafts 
cultured from young embryos (stage 24) upon 10-minute Netrin-1 stimulation.
(C) Representative images of puromycin incorporation during a 10-minute period in RGC growth 
cones and distal axon shafts cultured from young embryos (stage 24) upon 10-minute Netrin-1 
stimulation.
Mean±s.e.m.; n.s., not significant, *P<0.05, **P<0.01, ***P<0.001, unpaired t-test. N=number of 
growth cones/axons analysed from 3 replicates. Scale bars: 5μm.
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proximity ligation assay (PLA)-based approach (Puro-PLA) visualizing the localization of 
specific newly synthesized proteins (tom Dieck et al., 2015). Essentially, this technique reports 
the spatial coincidence of an anti-puromycin antibody and another antibody recognizing a 
protein of interest. Following the incubation of two primary antibodies raised in different 
species, a pair of species-specific secondary antibodies attached to different short DNA strands 
(plus and minus PLA probes) are introduced. When the two PLA probes are adjacent to each 
other (<40nm), they interact through linker oligonucleotides and a ligase promoting circle-
formation. Subsequently, they are amplified by rolling circle amplification using a polymerase 
and labelled in situ by fluorophore-conjugated probes complementary to the amplified 
sequences (Figure 3.6 A).  
As a proof of principal, we performed LaminB2 (LB2) Puro-PLA in retinal axons. Despite 
being a component of nuclear lamins, LB2 was found to be axonally synthesized and important 
for axon survival (Cosker et al., 2016; Yoon et al., 2012). Clear puncta are visible along axons 
and in growth cones and the density of the fluorescent puncta was reduced upon treatment with 
CHX or the mTOR inhibitor PP242 (Figure 3.6 B, C), demonstrating the signals revealed by 
LB2 Puro-PLA are most likely to be authentic since they responded to translational blockers. 
Next, we aimed to study the translational dynamics of β-actin, a well-documented target of 
Netrin-1 stimulation in axons (Leung et al., 2006). However, the feasibility of a Puro-PLA 
experiment highly relies on the availability of specific primary antibodies from two different 
species. Unfortunately, only mouse anti-puromycin antibody was commercially available, and 
none of the unconjugated anti-β-actin antibodies from other species we tested was specific and 
revealed the distinct filamentous actin staining (Figure 3.6 D) or a single band at the correct 
molecular weight in western blot (data not shown), precluding the β-actin Puro-PLA. Moreover, 
because a significant proportion of synthesizing peptides labelled by puromycin are C-
terminally truncated resulting from the premature termination triggered by puromycin entering 
the ribosomes, the antibody epitope located in the N-terminus of the targeted proteins is crucial 
to the success of the assay. Therefore, due to the strict criteria in primary antibody selection, 
Puro-PLA may not be applicable to every protein of interest. One possibility to tackle this 
problem is substitute puromycin molecules with puromycin conjugated to fluorophores or small 
molecules like biotin, which allows a greater flexibility when choosing primary antibodies 
(Starck et al., 2004).  
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Figure 3.6 Visualisation of specific mRNA translation in axons using Puro-PLA.
(A) Schematic of Puro-PLA labelling of specific new protein synthesis, detecting the close 
proximity of an anti-puromycin antibody marking the nascent peptide chain and another antibody 
recognising the protein of interest (POL).
(B) Representative images of Lamin B2 Puro-PLA in growth cones and axon shafts treated with 
CHX or mTOR inhibitor PP242.
(C) Relative number of LB2 Puro-PLA puncta in a 50μm distal axon segment treated with CHX 
or PP242, normalised to the control.
(D) β-actin immunohistochemistry in growth cones with FITC-conjugated (ab6277) or 
non-conjugated (ab6276) anti-β-actin antibody.
Mean±s.e.m.; ***P<0.001, unpaired t-test. N=number of axon segments analysed from 3 replicates. 
Scale bars: 5μm.
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3.5 Real-time imaging of β-actin mRNA translation in axons 
using the SunTag system 
The past decade has witnessed the development of various useful tools for live imaging of 
mRNAs and proteins (Buxbaum et al., 2015; Chao et al., 2012; Lee et al., 2016; Wu and 
Jaffrey, 2016). In particular, we are interested in methods allowing the real-time visualization of 
new protein synthesis. Temporal information on long-term changes in RNA localization can be 
obtained from fixed samples at different time points, creating time-series data over minutes, 
hours or days. To study the dynamic mechanisms underlying RNA localization, including RNA 
transport, time-series data require a fine temporal resolution in the range of milliseconds or 
seconds. Compared to Puro-PLA, which works with fixed samples, live imaging offers the 
temporal resolution for tracking the highly dynamic events taking place in the motile axons. A 
recently developed strategy, SunTag, based on a protein-tagging system designed to amplify 
protein fluorescent signals (Tanenbaum et al., 2014) to detect the translation of a specific 
protein has been reported in several studies conducted in different biological systems (Wang et 
al., 2016a; Wu et al., 2016; Yan et al., 2016). Essentially, SunTag makes use of a recombinant 
single-chain variable fragment (scFv) antibody that recognizes peptides from the yeast Gcn4 
protein. The protein of interest carries 24 tandem repeats of the peptide epitope, referred to as 
the SunTag sequence, whereas the scFv fused to GFP is encoded separately. As a result, each 
newly synthesized peptide can bind to 24 molecules of GFP, which is sufficiently brighter than 
the diffuse background GFP to visualize single molecules in wide-field microscopy.  
To apply this technique to visualise real-time β-actin translation in RGC axons, we first 
constructed two plasmids in the pCS2+ vector containing a constitutive CMV promoter to 
facilitate the protein expression in Xenopus cells (Figure 3.7 A). The first plasmid consists of 
Xenopus β-actin coding sequence and tandem repeats of 24 SunTag sequences fused to its N-
terminus, flanked by both β-actin UTRs to retain the proper mRNA localization and translation 
regulation. The second plasmid encodes a superfolder GFP (sfGFP)-tagged single-chain 
antibody (scFv) that binds to one of the SunTag epitopes in nascent SunTag-β-actin peptides.  
Next, we experimentally determined the concentrations of the two plasmids for targeted eye 
electroporation. As a general guideline, the SunTag-β-actin proteins should be in excess to the 
scFv-sfGFP to obtain the optimal signal-to-noise ratio and avoid potential GFP aggregation in 
axons and growth cones. Three different molar ratios of the two DNA constructs adding up to 
the same total concentration (1.8 µg/µl) were tested. As expected, when SunTag-β-actin DNA 
concentration doubles the scFV-sfGFP, clear puncta were observed in growth cones (Figure 3.7 
B) and axon shafts (Figure 3.7 C). An equimolar mixture resulted in a strong ubiquitous GFP 
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Figure 3.7 Real-time imaging of β-actin mRNA translation using SunTag.
(A) SunTag-β-actin and scFv-sfGFP constructs in pCS2+ vector for visualising β-actin translation 
in RGC axons.
(B) Fluorescence of RGC growth cones and distal axons electroporated with different ratios of 
SunTag-β-actin and scFv-sfGFP constructs. Visible puncta are indicated by yellow arrowheads. 
(C) Fluorescent puncta (white arrowheads) labelling SunTag-β-actin in an axon shaft.
(D) Representative time-lapse images showing the appearance (white and blue arrows), 
movement (yellow, white and blue arrows), persistence (magenta arrows) and disappearance (red, 
yellow, white and blue arrows) of fluorescent puncta in a growth cone.
(E) Time-lapse images showing a moving punctum in a growth cone filopodia. 
(F) Time-lapse images showing a moving punctum in a growth cone filopodia. 
Scale bars: 5μm in B, D; 2μm in C; 50nm in E, F.
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expression, masking any potential local GFP enrichment, while lower concentration of scFv-
sfGFP did not provide sufficient GFP molecules for peptide labelling, leading to weak signals. 
When imaging continuously in cultured RGC growth cones, moving and static puncta were 
visible in the growth cone central (magenta arrows) and peripheral (yellow and red arrows) 
domains and the base of filopodia (white arrows) (Figure 3.7 D). In some cases, the sfGFP 
puncta even entered the narrow filopodia (Figure 3.7 E, F), implying β-actin can be synthesized 
in these fine structures located at the most distal regions of axons. The average duration of 
visible sfGFP puncta is approximately 20 seconds with some only appearing for a few seconds 
and others lasting for up to 2 minutes, which is considerably shorter than the 3-minute 
anticipated translation time with a vertebrate translation rate of approximately 5 amino acids (aa) 
per second (Ingolia et al., 2011) for a 951 amino acid peptide consisting of SunTag repeats (576 
aa) and β-actin (375 aa). One of the possible explanations could be due to photobleaching 
during continuous imaging. In fact, during a 52 second imaging session, a significant proportion 
of free scFv-sfGFP had been photobleached, resulting in much lower diffuse GFP background 
within the growth cone when compared to the fluorescence at time=0 (Figure 3.7 D). Because 
of the dynamic feature of growth cones, it would be difficult to reduce the imaging frequency 
for tracking individual peptides. However, it might be helpful to apply the minimal laser power 
and take to advantage of the automated particle tracking programs to aid signal identification 
under low illumination conditions.  
Another caveat when interpreting the punctate signals is that some of them could be pre-existing 
SunTag-β-actin proteins that are away from their initial translating site. Due to the lack of 
associated degradation signals escorting the SunTag-β-actin proteins to proteasomes or other 
degradation pathways, it is difficult to distinguish the pre-existing and newly synthesized 
polypeptides from the images alone. One of the solutions is to visualise the SunTag-β-actin 
mRNA simultaneously using the MS2-MCP system (Bertrand et al., 1998), by incorporating an 
array of RNA stem-loops derived from the MS2 phage into the 3’UTR region, which can be 
subsequently recognized by MS2 coat proteins (MCP) tagged with RFP. When the green puncta 
labelling the SunTag epitopes colocalise with red puncta indicating the SunTag-β-actin mRNA, 
the polypeptides are likely to undergo translation. Therefore, the implementation of SunTag 
system in quantifying local protein synthesis in RGC axons requires further modification of the 
current expression constructs and optimisation of the imaging protocol. 
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3.6 Single molecule translation imaging visualizes the 
spatiotemporal dynamics of local β-actin synthesis in retinal 
axons 
Evaluating the pitfalls and caveats associated with applying the SunTag system in retinal axons, 
we decided to explore an alternative single molecule translation imaging strategy to allow 
comparison of the two approaches. We adapted a reported fluorescent protein-based strategy to 
visualise mRNA translation in hippocampal dendrites (Tatavarty et al., 2012). In this method, 
the fast-folding and fast-bleaching fluorescent protein Venus (Xie et al., 2008) is fused to the 
protein of interest, β-actin, flanked with the β-actin 5’ and 3’ UTRs and cloned into the pCS2+ 
vector with a constitutive CMV promoter. For our experiment, the Venus-β-actin plasmid DNA 
is introduced into Xenopus RGC neurons by targeted eye electroporation, followed by retinal 
culture from stage 32-35 embryos (Figure 3.8 A). Live imaging was performed with 24-hour 
cultures in phenol red-free medium. As part of our single molecule translation imaging (SMTI) 
protocol, existing fluorescence is photobleached with a brief pulse of 488nm laser. Under 
continuous laser illumination, each newly synthesized Venus then emits a short burst of photons 
within approximately 400 milliseconds before bleaching (Figure 3.9 A). This fluorescence burst 
therefore signifies an individual translation event, which can be identified spatially via single-
molecule localization procedures and temporally as part of a time-resolved acquisition (Figure 
3.8 B).  
Analysing the optical properties of the fluorescent flashes, on average, each burst of 
fluorescence lasts 400ms (Figure 3.9 A) and emits 510 photons (Figure 3.9 B). Therefore, we 
chose a camera exposure time of 200ms for SMTI image acquisition. The measured point 
spread function (PSF) value is 278 nm (Figure 3.9 C), which is slightly bigger than the 
theoretical size of a Venus PSF of 208 nm This is due to out-of-focus flashes in the 
measurements, which widen the PSF. We therefore used the wider PSF cut-off for automated 
particle identification as it supports localization of Venus flashes above and below the focal 
plane required for whole growth cone imaging. Hereby, rapid folding of the fluorescent protein 
is essential to the timely detection of translation sites as the translation is happening or recently 
completed and Venus has been a top choice among commonly used fluorescent proteins (Nagai 
et al., 2002).  
Under baseline conditions, single molecule translation of Venus-β-actin proteins in RGC growth 
cones was detected at an average rate of 10-20/min and located predominantly in the central 
domain. In contrast to HEK293T cells, which exhibit “hotspots” of repetitive Venus-β-actin 
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Figure 3.8 SMTI imaging procedures.
(A) The reporter construct coding for Venus and a full-length β-actin sequence electroporated into 
stage 26 Xenopus eye primordial and cultured at stage 32-35.
(B) During imaging, a fluorescent image of a growth cone is acquired to segment the outline for 
later processing. Existing fluorescence is then bleached using a brief pulse of laser irradiation. 
Subsequently, the translation of individual β-actin is recorded as individual molecules of Venus 
emission are measured. Translation events are localised and processed to yield spatial translation maps 
and rates.
Scale bars: 5μm.
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Figure 3.9 Translation density maps generated from an optimised SMTI setup.
(A) Distribution of Venus-β-actin molecule bleaching time. Gaussian fitting of the distribution 
yielded an average “on-time” of a Venus molecule τbleach = 399ms before bleaching.
(B) Distribution of Venus-β-actin molecule photon budgets. On average, 510 photons are emitted 
from an individual fluorophore. 
(C) Distribution of the sizes of fluorescent flashes measured by PSF fitting. The measured value 
is PSFFWHM = 278 nm.
(D) Representative Venus-β-actin translation density maps of an RGC growth cone and a 
HEK293T cell generated from images acquired during a 3-minute continuous imaging.
Scale bars: 5μm.
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single molecule translation during a 30-second period (Figure 3.9 D, left), or hippocampal 
dendrites where activity-regulated cytoskeletal-associated protein (ARC) and fragile X mental 
retardation protein (FMRP) undergo similar burst-like translation (Tatavarty et al., 2012), 
translation in RGC growth cones was sporadic with limited events reoccurring at the same 
location (Figure 3.9 D, right). The paucity of translational hotspots in axons could reflect 
growth cone motility and mRNA dynamics, or more intriguingly, the possibility of axonal 
translation predominantly by monosomes instead of the well-accepted polysomal translation. 
Evidence of monosomal translation has been shown in a yeast study (Heyer and Moore, 2016) 
and has been directly observed in U2OS cells using SunTag labelling (Yan et al., 2016).  
In order to perform an imaging session over a few minutes interval, we investigated the levels 
of photodamage inherent to this approach and change of growth cone morphology during 
imaging. Around 70% of the growth cones survived a 3-minute imaging session after the initial 
photobleaching step (Figure 3.10 A). For surviving growth cones, we did not notice any sign of 
collapse or retraction after SMTI (Figure 3.10 B), and hence, we ensured all measurements were 
carried out within the window of low photodamage (< 3 min). Furthermore, the morphology and 
location of the growth cones were not substantially altered before and after SMTI. Only 
filopodia and peripheral areas of the growth cone were highly motile (Figure 3.10 C). Therefore, 
a field of view around the growth cones was chosen for analysis, which takes the movement of 
filopodia during SMTI into account. 
We then validated the flashing spots captured by SMTI denoted real translation events through 
translation inhibition using protein synthesis inhibitor puromycin. 15-minute incubation with 
puromycin had no significant effect in the average translation rate detected in growth cones 
(Figure 3.10 D), which could be a result of the already low baseline translation and the 
variability among different growth cones overshadowing the effect of puromycin. In fact, the 
incomplete abolishment of baseline translation in growth cones has been reported (Leung et al., 
2006; Murakami et al., 2015). To further validate the effect of translation inhibitors, we tested 
the translation blocking in HEK293T cells, where Venus-β-actin synthesis occurred at much 
higher basal levels. Indeed, incubation with puromycin significantly reduced the translation rate 
in HEK293T cells (Figure 3.10 E, F), confirming the flashes represent genuine translational 
events. 
Next, we investigated the effect of Netrin-1 on β-actin translation in RGC growth cones.  From 
the previous puromycin experiments, we learnt that the effect of Netrin-1-stimulation on axonal 
protein synthesis depends on the age of the RGC neurons (Figure 3.5). In order to simplify the 
question and minimise variables, we intentionally increased the cAMP levels in retinal cultures 
when investigating Netrin-1-induced Venus-β-actin translation in growth cones, synchronising 
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Figure 3.10 Axon survival rate during SMTI and the effect of puromycin.
(A) Survival rate of RGC growth cones during SMTI. After 3 minutes of continuous imaging with 
0.8 kW/cm2 laser power around 30% of axons started to retract, while 4 minutes of imaging caused 
over 80% growth cone collapse (n=46).
(B) Phase contrast images of a growth cone remaining healthy in morphology after 3 minute 
continuous imaging.
(C) Bright field images taken just before and right after SMTI imaging. The change in position of 
growth cone bodies was limited, whereas filopodia were highly motile. Hence, a field of view around 
the growth cones was chosen for analysis, which takes movement of filopodia during SMTI imaging 
into account.
(D) Translation rate of growth cone pre-treated with puromycin compared to the culture 
medium-treated control. The already low number of translations in growth cones might overshadow 
the effect of puromycin. 
(E) Representative translation density maps and the corresponding event rates of untreated and 
puromycin-treated HEK293T cells. 
(F) Average HEK293T cell translation rate density in events/s/μm2 of untreated and puromycin 
treated cells during a 3-minute imaging. SMTI imaging was performed with TIRF illumination due to 
the cell thickness. 
Mean±s.e.m.; n.s., not significant, *P<0.05, unpaired t-test. N=number of growth cones analysed. 
Scale bars: 5 μm.
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their response to Netrin-1 independent of the age or coating of the cultures. Primary RGC 
cultures were pre-incubated with 40nM of PP1 inhibitor tautomycin or mock treatment for 30 
minutes prior to Netrin-1 or mock treatment to modulate the CamKII and PP1 balance in growth 
cones in favour of attractive turning towards Netrin-1 (Wen et al., 2004). When growth cones 
were attracted towards Netrin-1, β-actin translation increases on the near side of the growth 
cone (Leung et al., 2006). Based on these previous findings, we tested whether Venus-β-actin 
translation in growth cones attracted to Netrin-1 is enhanced upon Netrin-1 bath application. 
The MATLAB-based analysis package we developed allows quantification and localization of 
the translation events across an acquisition as translation density maps, showing the event rate 
varying between 0-0.15 events/s (Figure 3.11 A). It also provides temporal information as a 
curve of instantaneous rate as a function of time. Remarkably, Netrin-1 stimulation led to a 
burst of Venus-β-actin translation starting ~20 seconds post treatment and lasting for ~30 
seconds before gradually returning to lower, above baseline, levels (Figure 3.11 B, C). The 
decline after the peak likely reflects the rapid desensitization of Netrin-1 receptors on the 
growth cone surface known to occur within 1-2 minutes (Piper et al., 2005). The increase in 
translation is clearly visible in a cumulative translation events plot, with the baseline translation 
of approximately 15 events/min and the event number doubled within the first minute after 
Netrin-1 application (Figure 3.11 D). The observation of translation events was confirmed by 
pre-incubation of the samples with puromycin as a translation inhibitor, attenuating the Netrin-
1-stimulated increase in translation (Figure 3.11 B, D). 
To examine the spatial distribution of the translational events, we performed a Sholl analysis: 
Each growth cone was divided into five evenly spaced concentric arcs, labelled A1-A5 from 
central to peripheral. Arc A5 was set to circumscribe the outermost part of the growth cone 
(Figure 3.12 A). The percentage of β-actin translation events located in the central arcs 
decreased upon Netrin-1 stimulation, whereas translational events located at the growth cone 
periphery increased (Figure 3.12 B, C). This is in line with the observation of peripheral 
translocation of β-actin mRNA upon Netrin-1 stimulation (Lu, 2013). Moreover, Netrin-1 
stimulation was found to promote disassociation of the Netrin-1 receptor DCC and components 
of the translational machinery, enhancing protein synthesis in the vicinity of DCC, notably in 
the growth cone periphery including filopodia tips (Tcherkezian et al., 2010). The upregulation 
of growth cone peripheral translation detected by SMTI could be a result of Venus-β-actin 
mRNA movement and increased availability of DCC-associated translational machinery.  
To investigate the contribution of each aspect, we sought to visualize mRNAs simultaneously 
with protein synthesis by making use of the in vitro synthesised fluorophore-tagged mRNA 
from the Venus-β-actin construct. To fluorescently label the synthetic mRNA, a quarter of the 
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Figure 3.11 Netrin-1 increasing Venus-β-actin translational rate.
(A) Translation density maps for RGC growth cones treated with culture medium, 600ng/ml 
Netrin-1, or Netrin-1 with puromycin pre-incubation.
(B) Respective translation rates of example growth cones shown in A.
(C) Difference in translational rates of netrin-1 and culture medium treated growth cones. 
Netrin-1 stimulation leads to a transient peak in translation rate compared to the control with culture 
medium treatment. Treatment was performed at t=0. The peak starts at around 20 seconds post 
treatment and tails off around 60 seconds post treatment.
(D) Cumulative event rates for growth cones treated with culture medium, Netrin-1, or Netrin-1 
with puromycin pre-incubation.
Mean±s.e.m.; *P<0.05, **P<0.01, two-way ANOVA. n: number of growth cones/cells analysed. Scale 
bars: 2μm.
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Figure 3.12 Netrin-1 bath application shifting Venus-β-actin translation sites to growth cone 
periphery.
(A) Sholl analysis on growth cone density maps revealing the spatial distributions of translational 
events. The centre of 5 concentric circles is located at the base of the growth cone, with the outermost 
circle intersecting the furthest boundary of the growth cone. The radii are equidistant. A1 denotes the 
most central arc, while A5 indicates the most peripheral arc. Intracellular events within each arc are 
counted manually. The percentages within each arc are calculated.
(B) Representative translation density maps of culture medium-treated growth cones and 
Netrin-1-stimulated growth cones indicating the spatial shifts of translation sites. 
(C) Average percentages of translation events within each arc in the control and Netrin-1-treated 
growth cones.
(D) A representative image of growth cones expressing Cy5-labelled Venus-β-actin mRNAs (red) 
and the localisation of Venus-β-actin translation events (green).
Mean±s.e.m.; n.s., not significant, *P<0.05, **P<0.01, unpaired t-test. Scale bars: 5μm.
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uridine-5’-triphosphate (UTP) in the nucleoside 5’triphosphate (NTP) mix was replaced with 
the Cy5-conjugated UTP during in vitro transcription. The Cy5-labelled Venus-β-actin mRNA 
was electroporated into eye primodia stage 30 embryos and the eyes were cultured immediately 
after 1-hour recovery post electroporation to minimize RNA degradation. For imaging setup, the 
Cy5 (λex=620nm) channel and the Venus (λex=620nm) channel were acquired simultaneously by 
a beam splitter separating the emitted light beams into two and captured by two cameras. The 
flashes of nascent Venus-β-actin proteins showed the same kinetics and optical properties when 
it was imaged alone. However, the Cy5-labelled mRNAs were photobleached rapidly even with 
the lowest laser power to visualize the signals. Therefore, we were not able to track the 
synthetic mRNA during the whole imaging period. Nevertheless, we still extracted the 
information from the first few images of Cy5 signals to locate the Venus-β-actin mRNAs within 
the growth cone. Strikingly, majority of sites of Venus-β-actin protein synthesis surrounded 
Cy5-mRNA granules (Figure 3.12 D), indicating the spatial correlation of Venus-β-actin mRNA 
and its de novo translated proteins. Unfortunately, due to the fast photobleaching of Cy5 
fluorescence, we were not able to examine the effect of Netrin-1 stimulation on mRNA 
translocation. An alternative way to explore in the future is to incorporate the MS2 hairpin-
loops into the Venus-β-actin construct and co-express a plasmid encoding MCP-RFP to 
fluorescently label the mRNAs.  
When RGC axons navigate in the brain in vivo, they often encounter a gradient of guidance cues 
instead of searching in a homogenous environment. In fact, the growth cone is known to be to 
the most sensitive cellular devise to differentiate such gradients. In the aforementioned assays, 
Netrin-1 was bath applied to stimulate protein synthesis, resulting in a uniform Netrin-1 
increase around growth cones. To simulate Netrin-1 gradients in the in vivo scenario, we 
combined a growth cone gradient assay with SMTI to study the spatial distribution of 
translation sites for Venus-β-actin.  A gradient of Netrin-1 was generated by pulsatile injection 
from a glass micropipette close to the bottom of the dish and positioned 30µm away 
perpendicular to the advancing direction of the imaged growth cone (Figure 3.13 C). First, we 
tested if our setup was able to generate a gradient of chemicals by pulsing a fluorine dye 
Rhodamine 6G into the medium. Indeed, a circular gradient was visible around the micropipette 
tip (Figure 3.13 A), and axons near the pipette tip retained the dye at the near side (Figure 3.13 
B). Bright field and initial fluorescent images of the growth cone and the pipette tip were 
acquired before photobleaching, allowing the differentiation of the “near” and “far” sides of the 
growth cone (Figure 3.13 C). Strikingly, we observed a shift of Venus-β-actin translation sites 
from evenly distribution throughout the growth cone central domain to the near side in 5 
minutes (Figure 3.13 D), highlighting the ability of a growth cone to rapidly modulate β-actin 
local translation spatially in response to extracellular gradients of guidance cues. However, we 
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Figure 3.13 Netrin-1 gradient causing asymmetric translation of Venus-β-actin in growth cones.
(A) A Rhodamine 6G gradient generated by pulsatile ejection from a micropipette.
(B) Axons within the Rhodamine 6G gradient retained the dye at the side facing the micropipette.
(C) The experimental design showing the pipette tip positioned 30μm from the growth cone at an 
angle of 90°. A dashed line divides the growth cone into the “near” and “far” sides with respect to the 
pipette. 
(D) An example translation localisation map showing Netrin-1 gradient shifting the evenly 
distributed Venus-β-actin translation sites during the first minute to the near side at the fifth minute in 
the same growth cone and experimental setup shown in C.
Scale bars: 10μm in A, B; 2μm in C, D.
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are yet to collect enough samples for statistically analysis. 
To summarize, the SMTI methodology enables direct visualization of translation dynamics of 
individual, living cells with high spatiotemporal resolution. Using SMTI we were able to 
measure the effects of Netrin-1 on growth cones. We discovered that Netrin-1 transiently 
increases Venus-β-actin translation within 20 seconds, although the possibility that previously 
synthesised but not-yet folded fluorophores partially contributed to these events. We also found 
that bath application causes relocation of potentially monosomal translation sites to the growth 
cone periphery, or to the near side in a Netrin-1 gradient. This result is in line with a previously 
described shift in translation activity inside of growth cones, which were exposed to an external 
gradient of guidance cues (Leung et al., 2006), but is now recapitulated with direct evidence at a 
single-molecular level with unprecedentedly high spatiotemporal resolution.  
3.7 Discussion 
In this chapter, several interesting observations on Netrin-1-stimulated axonal protein synthesis 
were made using various optimized imaging methods. FUNCAT and puromycin labelling 
techniques revealed the kinetics of the global protein synthesis in Xenopus RGC growth cones 
and axons. Although there are discrepancies between the timing and relative translation rates 
measured using the two methods (Figure 3.2 B and 3.5 A), both results showed that protein 
expression levels decreased initially and recovered close to the basal level after 30-minute 
Netrin-1 incubation, which suggests that despite the continued presence of Netrin-1 in the 
culture, the attenuation of protein synthesis does not persist for more than 30 minutes.  
As mentioned in the introduction, the kinetics of the Netrin-1-stimulated protein synthesis can 
be informative to understand growth cone behaviours, such as growth cone adaptation. For 
instance, it will be interesting to see whether the initial decrease and the subsequent restoration 
of global translation after 30 minutes can be temporally correlated to the desensitization and 
resensitization phases during growth cone adaptation. Turning assays with Netrin-1 gradient in 
Xenopus spinal neurons indicated a desensitization phase starting at 30 minutes and 
resensitization phase after 60-90 minutes (Ming et al., 2002). In contrast, 10 minutes Netrin-1-
induced collapse assays in Xenopus RGC growth cones revealed rapid desensitization from 1 
min and resensitization occurred at 5 minutes, showing the adaptation happened at a much faster 
time scale (Piper et al., 2005). Clearly, the time courses of the two phases of adaptation can 
vary between experiments depending on the type of neurons, the assay used and the batch of 
Netrin-1. In addition, the stage of the cultures and the coating of the dishes are likely to alter the 
intracellular cAMP activity (Piper et al., 2007). Therefore, without a physiological readout, it is 
difficult to draw a clear line between the two phases of growth cone adaptation.  
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Recapping the effect of Netrin-1 on axonal translation discussed in this chapter, Netrin-1 
stimulation inhibited total protein synthesis in stage 33-34 axons on laminin coating but 
increased translation in stage 24 axons on fibronectin-coated dishes. On the other hand, bath 
application of Netrin-1 led to a burst of Venus-tagged β-actin translation on tautomycin-pre-
treated stage 33-34 growth cones, and Netrin-1 gradient resulted in an increase of Venus-β-actin 
translation on the near side to the centre of the gradient. Unpublished data from our lab by 
Cagnetta and colleagues studying cue-stimulated axonal proteomes in Xenopus RGC neurons 
using a pSILAC approach showed endogenous β-actin translation in stage 35-36 axons was 
reduced upon 5-15 minutes Netrin-1 stimulation, while β-actin protein synthesis in same-age 
axons cultured in identical conditions pre-incubated with tautomycin was significantly increased 
by Netrin-1. Bath application of tautomycin has been previously shown to convert growth cone 
repulsion to attraction in response to a Netrin-1 gradient on laminin-coated dishes, which is 
modulated by CaMKII/Calceneurin(CaN)-phosphatase-1(PP1) binary switch (Wen et al., 2004). 
As a PP1-specific phosphatase inhibitor, tautomycin attenuates PP1 activity (MacKintosh and 
MacKintosh, 1994). Inactivation of PP1 that mediates growth cone repulsion lifts the inhibition 
of CaMKII, resulting in attractive turning towards Netrin-1 (Figure 3.14) (Han et al., 2007). In 
this model, protein kinase A (PKA), which is activated by high concentration of cAMP as in 
stage 24 axons on fibronectin instead of stage 33-34 axons on laminin, phosphorylates PP1 and 
acts similarly to tautomycin to convert repulsion to attraction. Although the effect of age, 
coating and tautomycin in axonal translation has not been analysed systematically in this study, 
the current data appear to support the previously proposed model.  
In SunTag-β-actin translation imaging, moving spots were observed in growth cones and 
filopodia (Figure 3.7 D-F), reminiscent of motile polysomes in HeLa cells and dendrites 
detected using the SunTag strategy reported recently (Wang et al., 2016a). The study showed 
that in cytoplasmic non-perinuclear regions of HeLa cells, the speed of translating ribosomes 
was found significantly higher than perinuclear regions. Remarkably, in dendrites of cultured 
hippocampal neurons, an even larger proportion of translating ribosomes exhibited directed 
motion with average speed of 2µm/s. However, these findings are in contrast to the previous 
observations where translation of GFP reporters and fusion proteins in dendrites was found 
concentrated in stationary “hotspots” (Aakalu et al., 2001; Raab-Graham et al., 2006), which led 
to the hypothesis that transported mRNAs are translationally repressed until they reached their 
destination (Besse and Ephrussi, 2008). The disparity between the results obtained from SunTag 
and fluorescent reporters imaging is likely due to their different lag time between peptide 
synthesis and detection as well as their detection sensitivity. The fluorophore maturation time in 
fluorescent reporter approach cannot be neglected, which in some cases can take up to 30 
minutes, so the detected hotspots could be sites of synthesised protein accumulation instead of 
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Figure 3.14 The role of CaMKII/CaN–PP1 switch in growth cone turning.
In this model, a local imbalance of CaMKII and PP1 activity is the key for generating distinct turning 
responses. A higher CaMKII or lower PP1 activity favors attraction, whereas a lower CaMKII or 
higher PP1 activity leads to repulsion. Inactivation of PP1 by tautomycin shifts the balance towards 
growth cone attraction. Adapted from (Han et al., 2007).  
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translating sites. Furthermore, hotspots of fluorescent reporters likely represent more than one 
fluorescent protein, but moving spots detected by SunTag rarely join each other, suggesting 
motile nascent polypeptides tend to travel in isolation. Therefore, the fluorescent reporter 
strategies lack of signal amplification may not be able to detect these individual peptides. The 
finding of moving nascent peptides indicates a subset of transported mRNAs can undergo 
translation en route. It also demonstrates the power of the SunTag approach in retrieving spatial 
information of translation at a single molecule level.  
Using Venus-based single molecule translation imaging (SMTI), we observed a rapid 
stimulating effect of Netrin-1 on Venus-β-actin local translation in RGC growth cones in real-
time and the concomitant shift of its translation towards the periphery of the growth cones. 
Furthermore, in collaboration with Professor Clemens Kaminski, we present protocol 
optimization and analysis tools capable of exploiting the rich content of SMTI data. We note 
that the time at which the stimulation was observed (increase in event rate) is dependent on both 
the diffusion time of Netrin-1 in the solution and the variance in folding times of Venus. Better 
fluorescent proteins featuring shorter folding and higher quantum yield may lead to 
improvements in the method’s temporal resolution and detection sensitivity. The ability to 
quantitatively measure local translation rates in space and time at the single molecule level in 
delicate cellular systems such as axonal growth cones paves the way to understanding signal-
driven subcellular responses. 
In comparison to SunTag system, Venus-based SMTI comes with limitations due to the 
comparatively high illumination intensities, which shorten the imaging duration of time-courses 
as phototoxic effects swiftly start to become problematic. Hence, for tracking of individual 
ribosomes over extended periods of time the SunTag approach is a more suitable alternative. 
However, as SunTag multi-epitope tagging requires labelling of a single protein with up to 24 
fluorophores, a potential perturbation of cellular functions cannot be ruled out completely. In 
this respect Venus-based SMTI is favourable as only a single fluorescent protein is linked to the 
protein of interest. Also, the need for co-expression of different proteins makes the SunTag 
system less straightforward to use in Xenopus RGC axons. Due to the low efficiency and mosaic 
incorporation of DNA plasmids when introduced by eye-targeted electroporation, the chance of 
identifying axons with all proteins well expressed is small. Together with the SMTI analysis 
software package developed by our collaborators, SMTI is a ready-to-use technique for 
studying fast translation dynamics.  
The most essential ingredient for successful SMTI is a both fast-folding and fast-bleaching 
reporter FP. In this study we built upon earlier work, which utilised Venus FP as it features a 
maturation half-time of under 2 minutes in vitro (Tatavarty et al., 2012). Chaperones, enzymes 
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and post-translational modifications possibly accelerate this process in vivo. Other fast-folding 
fluorescent proteins like folding reporter GFP or the even faster superfolder GFP (Pedelacq et 
al., 2006) are alternatives to Venus but are comparatively photostable. This often-desirable 
property of fluorescent proteins is prohibitive for SMTI as effective photobleaching then 
requires higher, more phototoxic, illumination intensities. In terms of fast-bleaching, 
mNeonGreen (Shaner et al., 2013) might be better although it is still 10 times more photostable 
than Venus. Here, certain red fluorescent proteins like eqFP611 (Wiedenmann et al., 2005) 
might offer a potential work around. Upon translation eqFP611 swiftly forms a green 
fluorescing intermediate before maturing into a red fluorophore. Exploitation of this transient 
step in maturation might eliminate the need for fast bleaching. Unfortunately, new SMTI 
reporter proteins are being developed at a slow pace due to the particular need for short folding 
times and low photostability, a requirement which is not in line with conventional aims of 
fluorescent protein research. Nevertheless, more specialised probes will aid to the more 
widespread use of SMTI in future studies of high-speed protein translation dynamics. 
To date, most of the published single molecule translation imaging studies relied on exogenous 
expression of the reporter constructs. Interestingly, one study combines SunTag with CRISPR 
genome editing to visualise the translation of endogenous housekeeping gene, large subunit of 
RNA polymerase II (POLR2A), in HeLa cells (Pichon et al., 2016), indicating the great 
potential for single molecule translation imaging methods to monitor endogenous translation 
activity.  
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4 LATE ENDOSOME-SITED 
TRANSLATION IN AXONS 
AND IMPLICATIONS FOR 
CMT2B DISEASE 
4.1 Introduction 
A closer analysis of the fluorescent images of puromycin incorporation into nascent peptides in 
wild-type RGC axons reveals discrete fluorescence enrichment at specific locations in distal 
axons (Figure 4.1A, yellow arrowheads). This prompted me to explore if any subcellular 
structure or organelle is present adjacent to the translation foci. Interestingly, GFP-tagged 
Rab7a, a small GTPase associated with late endosomes (Chavrier et al., 1990), expressed in 
RGC axons, highly colocalises with the sites of puromycin enrichment (Figure 4.1B white 
arrowheads), suggesting the potential involvement of endosomes and endocytic pathways in 
axonal protein synthesis.  
Previous studies suggest that endosomes are major sites of mRNA storage and transport 
(Blower, 2013). Components of endosomes were found to colocalise with a specific marker of 
cytoplasmic P-bodies (Gibbings et al., 2009), storage sites of translationally repressed mRNAs 
(Parker and Sheth, 2007). Fully functional endosomal sorting complex required for transport 
(ESCRT)-II that sorts ubiquitinated cargos between different types of endosomes, is required 
for bicoid mRNA localization in Drosophila oocytes (Irion and St Johnston, 2007). In axons, 
ESCRT-II was shown to colocalise and co-transport with exogenous β-actin mRNAs, and 
90
AB
Wild-type Xenopus RGC axons
Xenopus RGC axons expressing GFP-Rab7a
Ph
as
e 
co
nt
ra
st
Pu
ro
m
yc
in
Ph
as
e 
co
nt
ra
st
Pu
ro
m
yc
in
G
FP
-R
ab
7a
M
er
ge
Figure 4.1 Newly synthesised proteins enriched around GFP-Rab7a vesicles in axons.
(A) Puromycin labelling reveals nascent proteins accumulated at specific locations along distal 
axons (yellow arrowheads).
(B) Puromycin enrichment highly colocalised with GFP-Rab7a positive vesicles (white 
arrowheads).
Scale bars: 5μm.
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knockdown of ESCRT-II components impaired axonal protein synthesis (Konopacki et al., 
2016). Moreover, a recent discovery in Ustilago maydis illustrated that septin Cdc3 protein 
accumulated on shuttling endosomes in fungal hyphae only in presence of cdc3 mRNA and 
ribosomal proteins, which strongly supports the hypothesis cdc3 mRNA is translated on 
endosomes. These findings suggest the important role of endosomes in local protein synthesis 
(Baumann et al., 2014). However, whether endosomes are mainly responsible for mRNA 
trafficking and localisation, local recruitment of translation machinery or other steps of 
translation remains obscure.  
Interestingly, mutations of late endosome-associated Rab7a have been shown to be causative 
Charcot-Marie-Tooth disease type 2B (CMT2B), a inherited peripheral neuropathy 
characterised by progressive weakening of distal muscles and prominent distal sensory loss, 
usually accompanied by foot ulcers and recurrent infections leading to amputation of toes (De 
Jonghe et al., 1997; Kwon et al., 1995). Based on the genetic studies on CMT2B families, 
mutations in Rab7, later renamed as Rab7a to distinguish from the Rab7b controlling 
endosome-to-Golgi transport (Progida et al., 2010; Yang et al., 2004), are solely responsible for 
the disease (Auer-Grumbach et al., 2000; Kwon et al., 1995; Verhoeven et al., 2003). To date, 
five missense CMT2B-associated mutations of Rab7 (L129F, K157N, N161T/I, V162M) have 
been identified (Houlden et al., 2004; Meggouh et al., 2006; Verhoeven et al., 2003; Wang et al., 
2013). Intriguingly, in spite of the ubiquitous expression of Rab7a in all cell types, CMT2B-
associated Rab7a mutations seem to predominantly affect axon maintenance and survival in 
long sensory and motor neurons, stimulating debates among scientists and physicians about 
cellular mechanisms accounting for this cell-type specific pathology.  
The work presented in this chapter was carried out in collaboration with colleagues in Christine 
Holt laboratory - Jean-Michel Cioni, Anne Holtermann, Max Koppers and Toshiaki Shigeoka; 
Afnan Azizi from Bill Harris laboratory and Maximilian Jakobs from Kristian Franze laboratory 
in the department. The detailed contribution of individual researchers is specified in the 
Declaration in the thesis Preface. A manuscript based on this work, in which I am a co-first 
author, is now under review.  
In this study, we report that late endosomes act as platforms for local protein synthesis in retinal 
ganglion cell (RGC) axons. This chapter focuses on two small GTPases marking early and late 
endosomes, Rab5a and Rab7a, among over 70 different human Rab proteins identified so far 
(Colicelli, 2004). Live tracking of endogenous RNAs showed that RNPs were associated with 
the outer membrane of late endosomes, where de novo protein synthesis took place. 
Interestingly, we found that mRNAs encoding mitochondria-related proteins were translated on 
late endosomes in axons and live imaging analysis revealed Rab7a positive-late endosomes 
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docked in the vicinity of mitochondria, suggesting the possibility of subcellular targeting of 
protein translation for use on-site. In axons where Rab7a function was perturbed by CMT2B-
associated mutations, this process was impaired, inducing a reduction in local protein synthesis 
and mitochondrial dysfunction. Our findings thus reveal a key role for endosome-sited mRNA 
translation in the spatial control of the axonal proteome, and provide new insights into CMT2B 
axonopathy by linking late endosome-associated translation to mitochondria morphology and 
function. 
4.2 RNPs display distinct classes of transport in RGC axons 
As mentioned in the introduction, previous evidence demonstrated the endosome involvement 
of endosome in RNA trafficking (Jansen et al., 2014). Therefore, to gain a better understanding 
of axonal endosomal system, the first question to ask is whether endosomes play a role in 
axonal RNA transport, using an unbiased approach to visualise RNA molecules and measure 
total RNP dynamics in axons. To achieve this goal, global endogenous RNAs were labelled by 
blastomere injection of Cy3-tagged uridine-5’-triphosphates (Cy3-UTPs) in Xenopus central 
nervous system (CNS) (Piper et al., 2015). Subsequently, Cy3-UTPs became incorporated into 
RNAs during their synthesis, allowing the visualisation of Cy3-RNA granules (or Cy3-RNPs) in 
retinal explant cultures (Figure 4.2 A). A large number of stationary or moving granules were 
visible along RGC axons with varied sizes and fluorescent intensity (Figure 4.2 C). To 
characterize the movement of axonal Cy3-RNPs, an automated fluorescent particle tracking 
program was adapted from the published MATLAB-based software plusTipTracker (Applegate 
et al., 2011). The vast majority of the registered Cy3-RNPs displayed a static/oscillatory motion 
(77.92%, n=1676), compared to anterograde (12.88%, n=277) and retrograde transport (9.2%, 
n=198) (Figure 4.2 B). Detailed analysis of individual tracking revealed the presence of 
oscillatory (Figure 4.2 C1), slow moving (Figure 4.2 C2) and fast moving states of RNP 
movements (Figure 4.2 C3), with the possibility to switch from one state to another.  
Interestingly, the speed distribution of transported RNPs could be resolved into two kinetically 
distinct classes of anterograde or retrograde transport: a slow and a fast component. The average 
speed of RNPs undergoing slow transport was 0.29µm/sec anterogradely and 0.40µm/sec 
retrogradely, with a maximum speed of 1.23µm/sec and 1.01µm/sec, respectively. Whereas 
RNPs showing fast axonal movement were observed moving up to 2.52µm/sec in anterograde 
and 2.33µm/sec in retrograde transport (Figure 4.3 A). Moreover, average speed of individual 
Cy3-RNPs was negatively correlated with their fluorescent signal intensities (Figure 4.3 B). 
Time-lapse imaging of axonal Cy3-RNPs revealed that several RNPs could be locally 
concentrated by merging with each other, resulting in an RNA granule with higher fluorescent 
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Figure 4.2 Cy3-labelled RNPs display distinct classes of axonal transport.
(A) Schematic of labelling endogenous RNA in Xenopus retinal axons. Cy3-UTP was 
microinjected into both CNS-fated blastomeres at the four-cell stage, and incorporated into 
endogenous RNA. The injected eye primordia from stage 35/36 embryos were dissected and cultured 
for live imaging
(B) Proportions of axonal Cy3-RNPs displaying different motion types, with most granules 
categorised static or oscillatory.
(C) A representative cultured distal axon shaft and growth cone containing Cy3-labeled RNA 
granules undergoing (1) oscillatory motions, (2) slow movement and (3) fast movement.
Scale bars: 5μm in C; 1μm in C1, C2 and C3.
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Figure 4.3 Anterogradely and retrogradely transported Cy3-RNPs display fast and slow 
movement.
(A) Speed distribution curves generated from the average velocities of Cy3-RNPs and 
decomposed into fast-moving and slow-moving populations in both anterograde (blue) and retrograde 
(red) directions. The blue/red distributions stem from a Gaussian mixture model fit in MATLAB. 
N=1022 Cy3-RNPs in 38 axons.
(B) Granule velocity as a function of granule intensity. The data was binned from 0-10, 10-20, and 
20-30 (pixel intensity from background). Average speed of Cy3-RNPs is negatively correlated to the 
fluorescent pixel intensity. Mean±s.e.m.; N=4869 Cy3-RNPs in 38 axons.
(C) Separate Cy3-RNA granules with lower pixel intensity (blue and yellow arrowheads) merged 
during movement to form a brighter oscillatory granule.
Mean±s.e.m.; ***P<0.01, unpaired t-test. Scale bars: 2μm.
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intensity (Figure 4.3 C). Taken together, the results suggest a bimodal axonal transport of RNPs, 
which could be explained by their association with different motor proteins or cellular structures.  
4.3 RNPs are locally associated with endosomes in axons 
Using the Cy3-UTP injection approach, we next investigated whether RNPs could be 
transported on moving endosomes along axons. Endosomal types are specified by their 
associated Rab GTPases (Huotari and Helenius, 2011; Stenmark, 2009). For instance, early 
endosomes tend to be Rab5 positive, which coordinates clathrin-dependent endocytosis, 
biogenesis of early endosomes and their fusion. Rab7, on the other hand, marks later stages of 
the endocytic pathway, and regulates the maturation from early to late endosomes and the 
fusion of late endosomes with lysosomes.  
RGC axons expressing GFP-Rab5a or GFP-Rab7a introduced by blastomere injection exhibit 
punctate signals, labelling early and late endosomes respectively (Falk et al., 2014). In retinal 
cultures co-expressing GFP-Rab5a or GFP-Rab7a with Cy3-labeled RNPs, Cy3-RNA granules 
were found to anchor to early and late endosomes in growth cones (Figure 4.4 A and B) and 
distal axon shafts (Figure 4.4 C). Quantification revealed a preferential association of Cy3-
RNPs with GFP-Rab7a- (45.95±3.7%, n=16) compared to GFP-Rab5- (23.76±1.38%, n=17) 
positive endosomes in the axon shaft. Notably, the colocalization of Cy3-RNPs with GFP-
Rab5a or GFP-Rab7a is significantly higher than randomly distributed Cy3-RNP fluorescence 
within the analysed axon segment. 
Time-lapse images demonstrated that slow moving RNPs could associate with oscillatory and 
slow moving endosomes (Figure 4.5 A, white arrows). Strikingly, in the presence of larger 
endosomes, RNPs anchored to the outer surface of the endosomes were clearly visible (Figure 
4.5 A). Detailed analysis identified oscillatory/static movement as the most prevalent motion 
among RNPs associated with early or late endosomes (Figure 4.5 B). Measuring the speed of 
the isolated RNPs and those associated with endosomes along the same axons revealed that 
RNPs anchored to GFP-Rab5a- or GFP-Rab7a-positive endosomes moved significantly slower 
than RNPs transported independently (Figure 4.5 C). Indeed, RNPs on endosomes displayed 
only slow transport, with a maximum speed of 0.5µm/sec and 0.32µm/sec in GFP-Rab5a- and 
GFP-Rab7a-expressing axons, respectively. In fact, the average pixel intensity and the size of 
Cy3-RNPs in contact with GFP-Rab5a- or GFP-Rab7a-positive vesicles were significantly 
higher and larger than the isolated Cy3-RNPs (Figure 4.5 D and E), in accordance with local 
accumulation of Cy3-RNPs on early and late endosomes.  
To further test whether optimal levels of Rab GTPase activity is important for RNP transport 
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Figure 4.4 Cy3-RNPs colocalise with early and late endosomes in distal axons.
(A) Cy3-RNA granules colocalising with GFP-Rab5a positive early endosomes (white arrows) in 
growth cones.
(B) Cy3-RNA granules colocalising with GFP-Rab7a positive late endosomes (white arrows) in 
growth cones.
(C) Colocalisation of Cy3-RNA granules with early and late endosomes associated with 
GFP-Rab5a and GFP-Rab7a respectively in RGC axons (white arrows).
Scale bars: 5μm in A left panel, B left panel and C; 2.5μm in A right panel and B right panel.
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Figure 4.5 RNPs are associated with early and late endosomes in axons.
(A) Time-lapse images illustrating Cy3-RNPs (white arrows) associated with the surface of 
oscillatory GFP-Rab5a or GFP-Rab7a positive endosomes.
(B) Proportions of different motions observed in Cy3-RNA granules colocalising with GFP-Rab5a or 
GFP-Rab7a.
(C) The speed of Cy3-RNPs moving with or without GFP-Rab5a or GFP-Rab7a positive endosomes.
(D) Average pixel intensity of Cy3-RNPs away from or in contact with GFP-Rab5a- or GFP-Rab7a 
positive vesicles, normalised to brightest pixel within each axon.
(E) Average area of Cy3-RNPs away from or in contact with GFP-Rab5a- or GFP-Rab7a- positive 
vesicles, normalised to the area of the largest granule.
Mean±s.e.m.; **P<0.01, ***P<0.001, unpaired t-test. Scale bars: 5μm in A.
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along axons, the automated-tracking analysis was applied to study Cy3-RNP movement in 
axons expressing GFP-Rab5a and GFP-Rab7a wild-type or mutant proteins. First, 
overexpression of wild-type GFP-Rab5a, constitutive-active (CA) form (GFP-Rab5aQ80L) or 
dominant-negative (DN) form (GFP-Rab5aS35N) did not alter RNP speed distribution profiles or 
directed motions compared to GFP control (Figure 4.6 A and C). Likewise, axons 
overexpressing wild-type GFP-Rab7a, CA form GFP-Rab7aQ67L or DN form GFP-Rab7aT22N 
showed no difference in RNP speed distribution (Figure 4.6 B) or proportions of anterogradely 
and retrogradely transported RNPs (Figure 4.6 D). These observations illustrate the alteration of 
Rab5a and Rab7a activity has minimal effect on global RNA transport in axons. 
Collectively, these results suggest that the majority of RNPs are transported and distributed in 
axons in an endosome-independent manner but a subset of slow-moving RNPs are associated 
with and concentrated onto the surface of early and late endosomes. 
4.4 Translation machinery is present on endosomal outer 
membrane 
RNP granules are mainly composed of RNAs associated with ribosomal proteins, RNA-binding 
proteins, initiation factors and cytoskeleton-associated proteins (Elvira et al., 2006; Kanai et al., 
2004). To explore the molecular components of RNPs associated with endosomes, co-
sedimentation profiles of endogenous Rab5 and Rab7 was obtained by sucrose density gradients 
with stage 34 embryonic brain extracts (Figure 4.7 A). Fractionation of polysomes by sucrose 
density gradient centrifugation allows the separation of mRNPs, ribosomal subunits, less 
translated mRNAs associated with monosomes and more efficiently translated mRNAs on 
polysomes (Gandin et al., 2014). Dissected brains were first lysed in polysome buffers 
containing cycloheximide to immobilise ribosomes on the mRNA. The lysate was then 
separated on sucrose gradient by ultracentrifugation. The positioning of each fraction was 
determined by a UV absorbance profile at 254nm. Both Rab proteins co-sedimented in free 
RNP, ribosomal subunits, monosome and polysome fractions. Their binding to polysomes was 
validated by dissociating 80S ribosomes with EDTA treatment, which shifted Rab5 and Rab7 
towards lower density fractions (Figure 4.7 A). To further confirm the association of Rab5a and 
Rab7a with ribosomes, endosome pull-down assays with brain extracts followed by qRT-PCR 
revealed a significant enrichment of small subunit 18S and large subunit 28S ribosomal RNAs 
that co-precipitated with GFP-Rab5a and GFP-Rab7a, compared to those with GFP control 
(Figure 4.7 B), suggesting the presence of fully formed ribosomes on endosomes. 
To focus on axonal endosomes, immunocytochemistry on retinal explants showed 
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Figure 4.6 Cy3-RNP motions in axons expressing wild-type or mutant GFP-Rab5a or 
GFP-Rab7a. 
(A) Average speed of Cy3-RNPs in axons expressing GFP, GFP-tagged wild-type Rab5a (Rab5a) 
or Rab5a mutants (Rab5aQ80L, Rab5aS35N). Number of granules analysed: GFP control=547, 
Rab5a=1064, Rab5aQ80L=695, Rab5aS35N=524.
(B) Average speed of Cy3-RNPs in axons expressing GFP, GFP-tagged wild-type Rab7a (Rab7a) 
or Rab7a mutants (Rab7aQ67L, Rab7aT22N). Number of granules analysed: GFP control=475, 
Rab7a=788, Rab7aQ67L=657, and Rab7aT22N=811.
(A and B) For each of the three biological replicates we calculated a frequency distribution of speeds 
for the following bins: -2.5 to -2, -2 to -1.5, -1.5 to -1, -1 to -0.5,-0.5 to 0, 0 to 0.5, 0.5 to 1, 1 to 1.5, 
1.5 to 2, 2 to 2.5, and 2.5 to 3. For each bin the bar plot represents the mean of the 3 replicates. 
(C) Proportions of Cy3-RNPs transported anterogradely or retrogradely in axons expressing GFP 
as control, GFP-tagged wild-type Rab5a or Rab5a mutants Rab5aQ80L, Rab5aS35N. Data from all repeats 
was pooled. Number of axons in GFP control=21, Rab5=18, Rab5aQ80L =16, Rab5aS35N =17.
(D) Proportions of Cy3-RNPs transported anterogradely or retrogradely in axons expressing GFP 
as control (CT), GFP-tagged wild-type Rab7a (WT) or Rab7a mutants Rab7aQ67L, Rab7aT22N. Data 
from all repeats was pooled. Number of axons in GFP control =17, Rab7a =18, Rab7aQ67L =20, 
Rab7aT22N =20.
Mean±s.e.m.
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Figure 4.7 Translation machinery is present on endosomal outer membrane. 
(A) Rab5 and Rab7 proteins are associated with free RNP, ribosomal subunits, monosomes and 
polysome fractions obtained from sucrose density gradients polyribosome fractionation on Xenopus 
brain extracts. Small subunit protein RPS23 and large subunit protein RPL19 serves as positive 
controls for purity validation. Treatment of brain lysates with EDTA dissociates ribosomal subunits, 
resulting in the shift of all proteins towards lower density fractions.
(B) qRT-PCR of cDNA synthesized from RNAs co-precipitated with GFP, GFP-Rab5a and 
GFP-Rab7a revealing a significant enrichment of small subunit 18S and large subunit 28S ribosomal 
RNAs in GFP-Rab5a- and GFP-Rab7a-expressing brain extracts (N=3 biological replicates). 
(C) Quantification of spinning disc confocal images showing approximately half of the eIF4E, 
RPL10A and RPS3A fluorescent puncta colocalising with GFP-Rab5a- or GFP-Rab7a- positive 
endosomes in axons. 
(D) Super-resolution microscopy revealing the presence of RPL10A and RPS3A puncta on the 
outer membrane of GFP-Rab5a- or GFP-Rab7a-containing vesicles in axons (white arrows).
Mean±s.e.m. **P<0.01, unpaired t-test. Scale bars: 1μm in D, left panel; 300nm in D, right panel.
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approximately 50% of RPL10A, RPS3A and eIF4E puncta colocalising with GFP-Rab5a- and 
GFP-Rab7a-positive endosomes in RGC axons (Figure 4.7 C). Imaging the same specimens 
with OMX super-resolution microscopy based on structured illumination (SIM) and localization 
microscopy, showed the presence of RPL10A and RPS3A on the external membrane of the 
GFP-Rab5a- and GFP-Rab7a-positive vesicles (Figure 4.7 D), resembling the endosomal 
membrane tethering of Cy3-RNPs (Figure 4.5 A). 
To then test whether RNA-binding proteins and mRNAs can also associate with endosomes in 
axons, a well-characterized RNA-binding protein Vg1RBP (Xenopus zipcode-binding protein-1) 
and its associated β-actin mRNA (actb) were examined (Leung et al., 2006; Welshhans and 
Bassell, 2011). Time-lapse imaging of eGFP-Vg1RBP with RFP-Rab5a (Figure 4.8 A) or RFP-
Rab7a (Figure 4.8 B) showed 32.2±3.7% and 23.2±5.2% of colocalization respectively (Figure 
4.8 C). In accordance with the previously observed Cy3-RNP movements, the vast majority of 
Vg1RBP associated with endosomes displayed static/oscillatory motion (89.29±5.7% and 
80.3±10.7% for GFP-Rab5a and GFP-Rab7a, respectively) (Figure 4.8 D). In both cases, only 
local association instead of long distance transport of Vg1RBP was observed on slow moving 
and oscillatory endosomes (Figure 4.8 A and B). In addition, Vg1-RBP-associated actb mRNA 
was precipitated with GFP-Rab5a and GFP-Rab7a, confirming its presence on endosomes 
(Figure 4.8 E). 
To summarize, these results suggest that the translation machinery and mRNAs can be locally 
associated with the outer membrane of oscillatory and slow moving endosomes in axons. 
4.5 Late endosomes are essential for intra-axonal protein 
synthesis 
The observation of local association of RNPs composed of ribosomes, initiation factors, RNA-
binding proteins and mRNAs to endosomal outer surface suggests the possibility that local 
translation takes place on endosomes. To address this possibility, I first investigated the role of 
different components of the endosomal pathway on de novo axonal protein synthesis in Xenopus 
RGC axons (Figure 4.9 A). Newly synthesized proteins can be visualised by puromycin 
labelling (Lin et al., 2009; Murakami et al., 2015; Schmidt et al., 2009). Axon only cultures 
(Figure 4.9 B) were pulse labelled with a low concentration of puromycin. Perturbing early 
steps of the endocytic pathway by expressing equivalent quantities of GFP-Rab5a CA mutant 
GFP-Rab5aQ80L or DN mutant GFP-Rab5aS35N did not induce any effect on basal protein 
synthesis measured in growth cones compared to GFP control. In contrast, a significant 
reduction of local translation was observed in growth cones expressing GFP-Rab7a CA mutant 
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Figure 4.8 RNA-binding protein Vg1RBP is associated with endosomal outer membrane.
(A) Time-lapse imaging illustrating eGFP-Vg1RBP locally associated with slow-moving RFP-Rab5a 
positive endosomes (yellow arrowheads) in axons.
(B) Time-lapse imaging illustrating eGFP-Vg1RBP locally associated with slow-moving 
RFP-Rab7a-positive endosomes (yellow arrowheads) in axons.
(C) Percentage of Vg1RBP colocalising with RFP-Rab5a- or RFP-Rab7a-positive endosomes.
(D) A large proportion of Vg1RBP colocalising with static or oscillatory instead of moving endosomes.
(E) qRT-PCR of cDNA synthesized from RNAs co-precipitated with GFP, GFP-Rab5a and 
GFP-Rab7a revealing a significant enrichment of β-actin mRNA in GFP-Rab5a- and 
GFP-Rab7a-expressing brain extracts (N=3 biological replicates).
Mean±s.e.m. **P<0.01, unpaired t-test. Scale bars: 2μm.  
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Figure 4.9 Late endosomes are essential for intra-axonal protein synthesis.
(A) Schematic of endocytic pathway and the targeting steps of dynamin inhibitor dynasore, 
endosomal acidification inhibitor chloroquine, constitutively active (Rab5aQ80L, Rab7aQ67L) and 
dominant negative (Rab5aS35N, Rab7aT22N) mutants.
(B) Schematic of the axonal newly synthesised protein labelling with puromycin. The eye was 
separated from the axons prior to puromycin administration to eliminate any potential effect 
contributed by the cell body within the retinal explant.
(C) Representative phase contrast images and heat maps indicating relative puromycin 
fluorescent intensity in RGC growth cones.
(D) Quantitative immunofluorescence (QIF) analysis of puromycin incorporation showing 
GFP-Rab5a mutants (GFP-Rab5aQ80L, GFP-Rab5aS35N) expression has no effect on de novo protein 
synthesis, but expressing GFP-Rab7a mutants (GFP-Rab7aQ67L, GFP-Rab7aT22N) causes a significant 
decrease in nascent protein synthesis in growth cones.
(E) QIF analysis of puromycin incorporation upon acute pharmacological treatments. Protein 
translation inhibitor cycloheximide (CHX) significantly reduces new protein synthesis. Endocytosis 
inhibitor dynasore has no effect, while pre-treatment of Chloroquine leads to a significant decrease of 
local protein translation in growth cones.
Mean±s.e.m.; N, number of growth cones analysed in D, E; n.s., not significant, ***P<0.001, unpaired 
t-test. Scale bars: 5μm in C.
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GFP-Rab7aQ67L (0.74±0.03) or DN mutant GFP-Rab7aT22N (0.81±0.04) (Figure 4.9 C and D). To 
circumvent a potential secondary effect due to the expression of the mutants during axonal 
growth, endosomal sorting was acutely perturbed pharmacologically (Figure 4.9 E). I first 
validated that application of the translation inhibitor cycloheximide (CHX) significantly 
reduced axonal translation activity. In accordance with the previous results, inhibition of 
endocytosis with dynasore, a small GTPase inhibitor targeting dynamin, did not affect new 
axonal protein synthesis. However, administration of the endosomal acidification inhibitor 
chloroquine was found to significantly attenuate de novo protein synthesis (0.76±0.03), 
suggesting that late endosome maturation is critical for intra-axonal protein synthesis. 
To then investigate whether endosome are physically associated with local synthesis of proteins, 
the pattern of puromycylation was examined along axon shafts. There was a clear enrichment of 
puromycin signal in the vicinity of GFP-Rab7a, but not GFP-Rab5a, vesicles (Figure 4.10 A-C), 
suggesting that late, but not early, endosomes could be translational hotspots in axons. 
Furthermore, puromycin enrichment was observed in a smaller proportion of axonal vesicles 
associated with GFP-Rab7aQ67L or GFP-Rab7aT22N compared to those associated with wild-type 
GFP-Rab7a (Figure 4.10 C), confirming that optimal Rab7a activity is essential for late 
endosome-sited translation.  
Collectively, these results indicate that late endosomes are sites where axonal mRNA translation 
takes place. Impaired Rab7a activity or disruption of late endosome maturation results in 
compromised axonal protein synthesis and late endosome-sited translation.  
4.6 Mitochondria-related proteins are translated on late 
endosomes 
Molecular control of local translation in axons can be achieved through mTORC1 modulation 
of cap-dependent translation initiation (Jung et al., 2014). Interestingly, blockage of early to late 
endosome conversion inhibits mTORC1 signalling measured by ribosomal protein S6 kinase 1 
(S6K1) (Flinn et al., 2010). Moreover, mTORC1 has been shown to control mitochondrial 
activity and biogenesis by selectively stimulating the translation of a subset of mRNAs that 
encode mitochondria-related proteins (Morita et al., 2013). Some of the axonally translated 
nuclear-encoded mitochondrial proteins, such as LaminB2 and Bclw, are required for axon 
maintenance and survival (Cosker et al., 2013; Yoon et al., 2012). To explore this functional 
crosstalk between endosomes, mitochondria and mTOR signalling pathway in axons, we first 
examined the locally translated genes in mouse RGC axons (Shigeoka et al., 2016). RGC axon-
specific translatome by translating ribosome affinity purification (TRAP) analysis revealed 95 
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genes with direct Gene Ontology (GO) terms related to mitochondrion organization and 
physiology (Figure 4.11 A and B) (P-Value: 1.78E-09; Fisher’s test). Among them, we 
identified an enrichment of known targets of mTORC1 (3.97 fold enrichment; P-Value: 
0.000443; Fisher’s test), approximately 30% of which contained a 5’ terminal oligopyrimidine 
(TOP)-like motif (P-Value: 0.000444; Fisher’s test) (Morita et al., 2013; Thoreen et al., 2012), 
supporting mTORC1 as a key translational regulator in axons.  
Therefore, the role of late endosomes in mTORC1-regulated translation was interrogated by 
measuring the axonal abundance of phosphorylated ribosomal protein S6 (p-S6) as a readout of 
TOR pathway activity in Xenopus RGC axons, which could be efficiently reduced by the 
selective TOR blocker PP242 (Figure 4.12 A and B). Expression of GFP-Rab7aQ67L or GFP-
Rab7aT22N mutants led to a significant decrease in p-S6 levels in axons (Figure 4.12 A and B), 
with a similar trend observed for global protein synthesis, indicating an optimal Rab7a activity 
is important for axonal TOR-mediated translation. This result also hinted that TOR pathway 
partially participates in late endosome-sited translation, but close examination of endosome-
enriched translation hotspots when TOR is inhibited is necessary to address this question. 
Mitochondria-related mRNAs have been found near the outer membrane of mitochondria for 
local translation on-site (Marc et al., 2002; Williams et al., 2014). To then investigate the spatial 
relations between RNPs, mitochondria and late endosomes in RGC axons, mitochondria were 
labelled using MitoTracker in cultured explants expressing GFP-Rab7a and Cy3-RNPs. A 
subset of Cy3-RNPs were associated with late endosomes adjacent to mitochondria along axons 
(Figure 4.12 C). In some instances, Rab7a-positive endosomes and their associated RNPs were 
found docking for several minutes upon encountering stationary mitochondria (Figure 4.12 D 
and E, white and yellow arrows). Particularly, the Cy3-RNA granules in contact with 
mitochondria were found brighter than those away from mitochondria (Figure 4.12 F), implying 
a possible local Cy3-RNP recruitment and enrichment on late endosome during the docking 
phase. Moreover, significantly more late endosomes with anchored RNPs were in contact with 
mitochondria compared to those traveling alone (27.56±2.7 compared to 6.58±1.7%, Figure 
4.12 G), suggesting a targeted late endosome tethering to mitochondria when loaded with Cy3-
RNPs for potential local translation of proteins required for mitochondrial function.  
To interrogate the translational state of late endosome-associated RNPs in presence of 
contiguous mitochondria, newly synthesized proteins were puromycin-labelled in RFP-Rab7a- 
and Mito-GFP-expressing axons, where puromycin signal was enriched on late endosomes in 
contact with mitochondria (Figure 4.13 A and B). Specifically, late endosomes in close 
proximity of mitochondria appeared to be slightly more translationally active, as 55.81% of late 
endosomes with enriched puromycin signals were in contact with mitochondria (Figure 4.13 C), 
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Figure 4.11 Mitochondrial proteins are highly translated in RGC mouse axons.
(A) Heat map showing a hierarchical clustering of mitochondria-related genes on the levels of 
translated mRNAs in the RGC axon and retina of the P0.5 mouse. The colour of the heat map 
represents the normalised level (log2 (FPKM)) of translated mRNAs (grey = not detected).
(B) Heat map of mitochondria-related GO terms enriched in mouse RGC axons. The colour of the 
heat map represents the log2 value of the fold enrichment for each GO term (red = enriched, blue = 
depleted, grey = not detected).
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Figure 4.12 Late endosomes pause in close vicinity of axonal mitochondria. 
(A) Representative phase contrast images and heat maps indicating relative phospho-S6 levels in 
growth cones treated with selective TOR inhibitor PP242 or expressing Rab7a mutants. 
(B) PP242 treatment decreases the amount of phospho-S6 ribosomal proteins in growth cones. 
Retinal cultures expressing GFP-Rab7aQ67L or GFP-Rab7aT22N also showed reduced p-S6 signals 
measured in growth cones compared to the GFP-expressing control. 
(C) Colocalisation of GFP-Rab7a-positive vesicles, Cy3-RNPs and mitochondria labelled with 
MitoTracker Deep Red FM (white arrows) in axons. 
(D) Time-lapse imaging revealing the recruitment of a Cy3-RNP associated late endosome to an 
axonal mitochondria (yellow arrows) and the separation of the three components (white arrows).
(E) Kymographs of the axon segment shown in B showing the merging and splitting of 
GFP-Rab7a-positive granules (green), Cy3-RNPs (red) and mitochondria (blue) (white and yellow 
arrows indicating the same granules shown in C).
(F) Average pixel intensity of Cy3-RNPs away from or in contact with mitochondria, normalised 
to brightest pixel within each axon.
(G) A larger proportion of GFP-Rab7a overlapping with mitochondria when colocalising with 
Cy3-RNPs than observed alone.
Mean±s.e.m.; *P<0.05, **P<0.01, ***P<0.001, unpaired t-test. Scale bars: 5μm in A, C; 1μm in D.
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Figure 4.13 Spatial relations between late endosomes, mitochondria and newly synthesised 
proteins.
(A) Representative images of distal axon segments expressing Mito-GFP (green) and RFP-Rab7a 
(red) in which newly synthesized proteins are visualized using puromycin labelling (blue). Puromycin 
signal is enriched on RFP-Rab7a-associated endosomes (red arrows) in proximity to mitochondria 
(green arrows). 
(B) Quantification of fluorescent intensity along the axon segment in (A) showing the enrichment 
of puromycin fluorescence in on RFP-Rab7a-positive endosomes (red arrows) adjacent to 
mitochondria (green arrows).
(C) Percentage of puromycin-enriched RFP-Rab7a-positive endosomes contacting or not 
contacting mitochondria in axons.
(D) The same axon segment expressing Mito-GFP (green) and RFP-Rab7a (red) immediately 
before and after 20min formaldehyde fixation.
(E) Alignments of the Mito-GFP and RFP-Rab7a signals immediately before (cyan) and after 
(megenta) fixation showing little changes of mitochondria and endosome positions during fixation.
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indicating a modest correlation between endosome-sited mRNA translation and neighbouring 
mitochondria. A caveat to this experiment is the locations of mitochondria and endosomes 
might change during the first short period of the fixation step, resulting in inaccurate positional 
information. Therefore, to investigate whether mitochondria and endosomes can move during 
fixation, live axons were fixed for 20min under microscope and images of Mito-GFP and RFP-
Rab7a signals were captured immediately before and after fixation (Figure 4.13 D). Alignments 
of the before- and after-fixation images revealed little positional variations of Mito-GFP or 
RFP-Rab7a during the fixation step, validating that formaldehyde fixation preserved spatial 
information of Mito-GFP and RFP-Rab7-labelled organelles in axons (Figure 4.13 E).  
This spatial coincidence of mitochondria and nascent proteins on late endosomes likely provides 
an endosome platform for local translation of mitochondria-related genes for onsite use. Thus, I 
next sought to understand whether the accumulation of late endosome associated with RNPs in 
close proximity to mitochondria supports local translation of nuclear-encoded mitochondrial 
proteins. Splicing factor proline and glutamine rich (SFPQ) protein is an RNA-binding protein 
(RBP) that coordinates the translation of mitochondria-related mRNAs, and is enriched near 
mitochondria and ribosomes in axons (Cosker et al., 2016). In axons expressing GFP-Rab7a, 
SFPQ proteins colocalised with Rab7a-positive endosomes (47.45%±4.3% of GFP-Rab7a 
endosomes colocalising with SFPQ) (Figure 4.14 A), in agreement with mass spectrometry 
studies (Debaisieux et al., 2016).  
To directly visualize the translation of LaminB2 mRNA (lmnb2), one of the SFPQ-regulated 
mRNAs important for mitochondria integrity (Cosker et al., 2016; Yoon et al., 2012), I used a 
puromycylation and proximity ligation assay (PLA)-based method (Puro-PLA), that reports the 
spatial coincidence of an anti-puromycin antibody detecting newly synthesized proteins and 
another antibody recognizing the protein of interest (tom Dieck et al., 2015). An enrichment of 
LaminB2 (LB2) Puro-PLA signal was detected in proximity to Rab7a-endosomes (Figure 4.14 
B). These results were further confirmed by super-resolution images showing the localization of 
LB2 Puro-PLA puncta around Rab7a positive vesicles with diameters around 250-500nm, 
consistent with the reported mature late endosomes diameter of 250-1000nm (Huotari and 
Helenius, 2011), supporting local translation of laminB2 occurring on the outer membrane of 
the late endosome (Figure 4.14 C). Finally, application of chloroquine, cycloheximide and 
PP242 significantly reduced the amount of LB2 Puro-PLA puncta in axons (Figure 4.14 D), 
indicating late endosome maturation and TOR signalling involvement in regulating axonal LB2 
translation.  
To test if axonal translation of other mitochondrial proteins are also affected by aberrant activity 
of endocytic and TOR pathways, the same pharmacological treatments were applied to somaless 
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Figure 4.14 Late endosomes couple translation and the use of mitochondria-related proteins.
(A) Colocalisation of GFP-Rab7a with SFPQ in axons (white arrowheads).
(B) Colocalisation of GFP-Rab7a with PLA signals between LB2 and puromycin in axons.
(C) Super-resolution microscopy analysis revealed PLA signals between LB2 and puromycin 
present in the close vicinity of a representative GFP-Rab7a-positive vesicle.
(D) LB2 Puro-PLA signals significantly decreasing when disrupting endocytic pathway with 
Chloroquine, inhibiting protein synthesis with cycloheximide (CHX) or blocking mTOR pathway 
with PP242.
(E) VDAC2 Puro-PLA signals significantly decreasing when disrupting endocytic pathway with 
Chloroquine, inhibiting protein synthesis with cycloheximide (CHX) or blocking mTOR pathway 
with PP242.
Mean±s.e.m.; ***P<0.001, unpaired t-test. Scale bars: 5μm in A; 500nm in C.
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axons and investigated their effects on another axonally translated protein essential to 
mitochondria physiology, the Voltage-dependent anion-selective channel protein 2 (VDAC2) 
(Shigeoka et al., 2016), involved in exchanging solutes across outer mitochondrial membrane 
(Naghdi and Hajnoczky, 2016; Shigeoka et al., 2016). Likewise, chloroquine, CHX and PP242 
reduced VDAC2 Puro-PLA signal in axons, although to a lesser extent (Figure 4.14 E). Taken 
together, these results suggest that late endosomes in axons, acting as translation platforms, can 
sustain mitochondria-related mRNA translation in the vicinity of mitochondria. 
4.7 Charcot-Marie-Tooth 2B associated Rab7a mutations perturbs 
axonal synthesis of mitochondria-related proteins  
Our findings that optimal Rab7a activity is needed in late endosomes for intra-axonal translation, 
especially of mitochondria-related mRNAs, might have important clinical implications. Indeed, 
missense mutations of four amino acids in human rab7a gene have been described to be 
associated with the autosomal-dominant neurological disorder Charcot-Marie-Tooth type 2B 
(CMT2B) (Cogli et al., 2009). This rare neuropathy primarily affects the peripheral 
sensorimotor systems, leading to distal sensory loss and muscle weakness and atrophy. Previous 
biochemical and functional studies have mostly focused on understanding the functional effect 
of CMT2B-associated mutations on Rab7a activity. Most of the evidence accumulated to date 
links Rab7a CMT2B-related mutations with a gain-of-function of the protein (BasuRay et al., 
2010; Cogli et al., 2010; Janssens et al., 2014; Liu and Wu, 2017; Ponomareva et al., 2016; 
Spinosa et al., 2008). Yet the mechanisms proposed to explain how these mutations can induce 
an axonopathy remain elusive. The amino acid sequence of Xenopus Rab7a is 96% identical to 
human Rab7a, including the four mutated residues identified among CMT2B patients (L129F, 
K157N, N161T/I and V162M) (Figure 4.15 A), suggesting that Xenopus could be a useful 
model for CMT2B. We therefore generated and injected the four GFP-tagged pathological 
mutants Rab7aK157N, Rab7aL129F, Rab7aV162M, Rab7aN161T in the Xenopus embryo central nervous 
system. In distal RGC axons expressing CMT2B-linked mutants, discrete vesicles were clearly 
visible, resembling patterns observed in wild-type GFP-Rab7a and CA GFP-Rab7aQ67L, instead 
of the diffuse expression of DN GFP-Rab7aT22N (Figure 4.15 B).  
Visualisation of RGC axon projections by anterograde lipophilic dye (DiI) labelling at stage 45, 
when most of the retinotectal connections have been established (Figure 4.15 C), revealed 
severe defects in more than 50% of the embryos, with significantly less axons in the tectum as 
well as a reduction of axon terminal complexity (Figure 4.15 D and E). These results indicate a 
dominant effect in vivo of CMT2B-related Rab7a mutants overexpression on the development 
and maintenance of retinotectal projections in the Xenopus model, consistent with the results 
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Figure 4.15 Phenotypes of axons expressing wild-type or mutant Rab7a.
(A) Alignment of human and Xenopus Rab7a coding sequences revealing a high degree of amino 
acid homology (96%). The five missense mutations identified in CMT2B cases (L129F, K157N, 
N161T/I and V162M) are indicated by the red boxes and the amino acids below.
(B) Morphology of wild-type or mutant GFP-Rab7a vesicles in cultured axons.  
(C) Schematic of fluorescent dye labelling of stage 45 RGC axons in vivo. RGC axons of one eye 
per fixed embryo are labelled by intraocular injection of lipophilic dye, DiI. The dye is diffused along 
the optic tract and can be visualised in the contralateral brain hemisphere. OT: optic track.
(D) Representative images of RGC axon projections in stage 45 embryos expressing wild-type 
Rab7a or disease mutants.
(E) Percentage of embryos with defective RGC projections composed of less than 30 axons.
Mean±s.e.m.; n.s., not significant, *P<0.05, **P<0.01, ***P<0.001, unpaired t-test. Scale bars: 10μm 
in B; 100μm in D.
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obtained in disease mutant-expressing zebrafish (Ponomareva et al., 2016). 
Next, the effect of the disease-related Rab7a mutants on intra-axonal translation was 
investigated. A significant decrease in nascent protein synthesis was found in growth cones of 
somaless RGC axons expressing GFP-tagged Rab7aK157N, Rab7aL129F, Rab7aV162M, Rab7aN161T 
compared to GFP-Rab7a or GFP control (Figure 4.16 A and B). Consistent with the 
measurement in growth cones, the percentage of CMT2B disease mutant-positive vesicles with 
enriched puromycin signals significantly decreased compared to wild-type GFP-Rab7a 
endosomes (Figure 4.16 C), indicating that CMT2B-related Rab7a-associated endosomes do not 
retain the ability to facilitate mRNA translation. Furthermore, TOR activity, as measured by the 
amount of p-S6 in growth cones, was reduced when Rab7a pathological mutants were expressed 
(Figure 4.16 D). 
Next, I investigated whether axonal translation of two identified mitochondria-related proteins 
LaminB2 and VDAC2 was affected when the Rab7a GTPase activity was compromised. 
Overexpression of GFP-Rab7a led to around 20% decrease in the number of LB2 Puro-PLA 
puncta, suggesting that LB2 local translation is sensitive to mild change of Rab7a activity in 
axons. However, expression of all four GFP-tagged CMT2B disease mutants caused a 
significantly larger drop (approximately 35% decrease) in new LB2 synthesis (Figure 4.17 A 
and B). Three out of four mutants, but not GFP-Rab7a resulted in a reduction in VDAC2 Puro-
PLA puncta (Figure 4.17 C).  
To summarise, these results suggest that Rab7a CMT2B-associated mutations affect axonal 
homeostasis by perturbing protein synthesis occurring on late endosomes, leading to defective 
phenotypes of RGC projections in vivo. In particular, mitochondria-related mRNA translation 
essential for axon growth and maintenance is attenuated in pathogenic mutant-expressing axons. 
4.8 CMT2B-associated mutations of Rab7a cause a dominant 
effect on mitochondria function and integrity 
Mitochondrial abnormalities have been identified in several neurological disorders, including 
Parkinson’s disease, amyotrophic lateral sclerosis and Huntington’s disease (Johri and Beal, 
2012). In fact, mutations in four genes encoding mitochondrial proteins account for several 
types of CMT neuropathy (Niemann et al., 2006). Thus, our finding that expression of CMT2B-
associated Rab7a mutants was sufficient to downregulate axonal translation of mitochondrial 
proteins raised the question whether mutant-expressing axons show any prominent disease-
linked mitochondrial phenotype. To address this question, mitochondria morphology in RGC 
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Figure 4.16 CMT2B-associated Rab7a mutations perturb axonal translation.
(A) Representative phase contrast images and heat maps indicating relative puromycin fluorescent 
intensity in RGC growth cones expressing GFP, GFP-Rab7a and its disease mutants.
(B) Quantitative immunofluorescence (QIF) analysis of puromycin incorporation showing 
GFP-tagged CMT2B-associated Rab7a mutations reduce protein translation significantly in growth cones.
(C) Percentage of GFP-Rab7a disease mutant-positive vesicles with puromycin enrichment in axon 
shafts is significantly decreased compared to wild-type GFP-Rab7a-positive vesicles.
(D) QIF analysis of phospho-RPS6 in growth cones expressing GFP, GFP-Rab7a and its disease 
mutants.
Mean±s.e.m.; N, number of growth cones analysed in B and D, number of vesicles analysed in C; n.s., not 
significant, *P<0.05, ***P<0.001, unpaired t-test. Scale bars: 5μm in A.
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Figure 4.17 CMT2B-associated Rab7a mutations perturb axonal synthesis of mitochondria-related 
proteins.
(A) Representative PLA signals between LB2 and puromycin indicating newly synthesised LB2 
proteins in axons.
(B) The abundance of LB2 Puro-PLA puncta within 20μm long axon segments normalised to the 
control.
(C) The abundance of VDAC2 Puro-PLA puncta within 20μm long axon segments normalised to the 
control.
Mean±s.e.m.; N, number of axon segments analysed. n.s., not significant, *P<0.05, ***P<0.001, unpaired 
t-test. Scale bars: 5μm in A.
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axons expressing the four CMT2B Rab7a mutants was first analysed. MitoTracker-labelled 
mitochondria in GFP-tagged CMT2B-associated Rab7a mutant-expressing axons showed an 
elongated shape (Figure 4.18 A), with significantly longer average lengths than GFP-Rab7a or 
the GFP control (Figure 4.18 B), while the mitochondria density remained unchanged (Figure 
4.18 C). These results are consistent with the mitochondrial phenotypes seen when local 
LaminB2 synthesis was inhibited (Yoon et al., 2012).  
As defective mitochondrial trafficking is a sign of altered mitochondrial physiology (Roque et 
al., 2016; Sheng and Cai, 2012), mitochondrial dynamics in axons expressing Rab7aK157N and 
Rab7aV162M was evaluated during 5 minutes time-lapse imaging intervals. In wild-type axons, 
around 70% of mitochondria are stationary or oscillatory. Only less than 3% moved 
retrogradely and the rest were transported in anterograde directions (Figure 4.18 D). This 
observation agrees with reported statistics of mitochondria trafficking in axons revealing 70-90% 
of mitochondria are stationary, and mobile mitochondria exhibited a bias towards anterograde 
transport (Misgeld et al., 2007; Pilling et al., 2006; Wang and Schwarz, 2009). On the other 
hand, in axons expressing CMT2B-associated Rab7a mutants, significantly fewer mitochondria 
underwent anterograde transport, concomitant with a higher proportion of mitochondria moving 
retrogradely compared to GFP expressing axons (Figure 4.18 D), which may lead to regional 
energy deficits and disrupting energy homeostasis at distal axons where high energy is in 
demand (Sheng, 2017). 
Finally, mitochondrial membrane potential (ΔΨm), critical for maintaining the physiological 
function of the mitochondria respiratory chain for ATP production, was measured by 
quantifying the accumulation of the cationic fluorescent probe tetramethylrhodamine methyl 
ester (TMRM) in axonal mitochondria. TMRM is a fluorescent lipophilic cation dye that 
accumulates in active mitochondrial due to its positive charge and solubility in inner 
mitochondrial membrane and matrix space that bear negative charges (Ehrenberg et al., 1988; 
Scaduto and Grotyohann, 1999). 10-minute TMRM incubation in culture medium followed by a 
quick washing step revealed a mild but significant ΔΨm reduction in Rab7aV162M-expressing 
axons compared to wild-type Rab7a control (Figure 4.18 E), implying the less efficient ATP 
production by mitochondria in disease mutant-expressing axons to support energy supply.  
In sum, these results suggest that Rab7a CMT2B-associated mutations specifically perturb an 
intricate functional interaction between late endosomes, local protein synthesis and 
mitochondrial integrity in axons, and provide an integrated explanation for the molecular 
mechanisms underlying CMT2B axonopathy (Figure 4.19). 
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Figure 4.18 CMT2B mutations of Rab7a cause a dominant effect on mitochondria function and 
integrity.
(A) Representative images of MitoTracker-labelled mitochondria illustrating the variation in 
mitochondrial morphology in axons expressing GFP-tagged Rab7a CMT2B-associated mutants.
(B) Axonal mitochondria labelled with MitoTracker showing an increase in mitochondrial length in 
axons expressing disease mutants compared to wild-type GFP-Rab7a- or GFP-expressing axons.
(C) The density of mitochondria within each 25μm axon segment remains the same in axons 
expressing GFP, GFP-Rab7a or disease mutants.
(D) The percentage of mitochondria transported anterogradely significantly decreases in axons 
expressing CMT2B-associated mutants, while the percentage of mitochondria transported retrogradely 
increases compared to the GFP control.
(E) Mitochondrial membrane potential measured by TMRM fluorescent intensity showing a decrease 
in axons expressing Rab7a disease mutant GFP-Rab7aV162M compared to the control.
Mean±s.e.m.; n.s., not significant, ***P<0.001, unpaired t-test. Scale bars: 5μm in A.
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Figure 4.19 Proposed model of endosome-sited translation.
mRNAs and translation machinery are associated with late endosome outer membrane. The late endosome 
then targets all these components to axonal mitochondria and serves as a platform for mitochondrial 
protein synthesis locally. This process is defective in axons expressing CMT2B-associated Rab7a 
mutants, causing a reduction of mitochondria-related mRNAs translation and mitochondrial dysfunction.
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4.9 Discussion 
This study report a critical role of late endosome-sited translation in regulating local axonal 
proteome, supporting a model in which mRNAs and the translation machinery are associated 
with the outer membrane of late endosomes, which serve as a platform for local protein 
synthesis. This process is particularly important for localized synthesis of mitochondrial 
proteins necessary for maintaining mitochondria integrity and axon survival. Finally, this 
mechanism is shown to be perturbed in axons expressing the CMT2B neuropathy-associated 
Rab7a mutants, leading to a reduction of mitochondria-related mRNAs translation and 
subsequent mitochondrial dysfunction (Figure 4.19). 
RNA transport and control of translation are key processes by which cells regulate protein 
localization and function. In the current model, subcellular mRNA distribution relies on specific 
association with RBPs and targeted transport through direct or indirect binding with cytoskeletal 
motor proteins (Buxbaum et al., 2015). Through live tracking of endogenous RNAs and high-
resolution imaging of RGC axons, we found that about a third of RNPs are associated with the 
outer membranes of early (GFP-Rab5a positive) and late (GFP-Rab7a positive) endosomes. 
Interestingly, perturbation of Rab11 activity or mutations in the endosomal sorting complex 
required for transport II (ESCRT-II) in the Drosophila oocyte have been showed to alter the 
anchoring preference of oskar and bicoid mRNA to the posterior pole (Dollar et al., 2002; Irion 
and St Johnston, 2007), and reduction of Rab11 function was also found associated with 
attenuated oskar local translation (Dollar et al., 2002). In Xenopus, down-regulation of ESCRT-
II led to a decrease in intra-axonal protein synthesis in RGCs (Konopacki et al., 2016). This 
work combined with our finding that endosome-linked protein synthesis is frequently seen 
adjacent to mitochondria suggests that endosomes could play a role in concentrating new 
protein synthesis at exact subcellular locations where it is needed.  
In retinal axons, mRNAs and components of the translation machinery, such as ribosomal 
proteins and initiation factors, were present on both early and late endosomes. The presence of 
Rab7a in brain polysome fractions and the spatial enrichment of newly synthesized proteins 
colocalising with Rab7a positive endosomes in axons, strengthen the idea of late endosome 
membrane as a physical platform for protein translation. Supporting this idea, I showed that 
constitutive and inactive Rab7a mutant expressions led to around 20% to 30% downregulation 
of axonal translation. The generic protein synthesis inhibitor cycloheximide, however, led to a 
50% reduction in axonal protein synthesis, suggesting that although endocytic pathway-
mediated translation accounts for a significant proportion of constitutive axonal protein 
synthesis, not all intra-axonal translation occurs on late endosomes.  
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Focal points of protein synthesis, or translational hotspots, have been reported in axons and 
dendrites (Kim et al., 2013; Spillane et al., 2013; Wong et al., 2017), which occur in specific 
regions where the translational machinery and mRNAs are locally accumulated. In axons, some 
translational hotspots correlate with the presence of mitochondria (Spillane et al., 2013; Wong 
et al., 2017). In accordance with these observations, we report RNPs anchored to slow-moving 
or stationary late endosomes in close proximity of mitochondria in RGC axons, in line with the 
previous finding that the axonal cargos such as lysosomes tend to slow down or transiently 
pause when crossing mitochondria (Che et al., 2016). Strikingly, live imaging revealed that 
RNPs associated with late endosomes remain in contact with mitochondria for several minutes, 
suggesting the presence of anchoring systems facilitating this tethering. Whereas a tethering 
complex has yet to be identified, there is increasing evidence for functional coupling between 
the two organelles. Indeed, an interaction between endosomes and mitochondria has been 
reported in erythroid cells, facilitating a direct iron transfer (Das et al., 2016), and direct protein 
trans-interactions have been demonstrated to sustain ER-endosome membrane contact sites 
(Raiborg et al., 2015). The close proximity of mitochondria to late endosomes could thus be a 
prerequisite to sustain axonal endosome-sited local protein synthesis by providing the necessary 
energy. 
Interestingly, I reciprocally found that axonal late endosomes-sited local translation of 
mitochondria-related mRNAs might play a role in axonal mitochondria function and integrity. 
The vast majority of mitochondrial proteins is encoded in the nuclear genome, synthesized in 
the cytoplasm and subsequently imported into the organelle. Recent studies in yeast identified 
the presence of mitochondria-related mRNAs near the outer membrane of mitochondria for 
local translation on-site (Marc et al., 2002; Williams et al., 2014). Ever since, only few similar 
observations have been reported in other organisms (Gehrke et al., 2015; Lesnik et al., 2015; 
Matsumoto et al., 2012), but a mitochondria-related RNA regulon orchestrated by the RBP 
SFPQ has been recently identified in axons (Cosker et al., 2016), opening the possibility for 
mitochondria-linked mRNAs to be translated at precise subcellular locations in neurons. Our 
study shows that a large repertoire of mRNAs related to mitochondria is translated in RGC 
axons in vivo, supporting the physiological importance of this phenomenon in vertebrates 
(Kaplan et al., 2009). Moreover, SFPQ was found on late endosomes in axons, where the 
translation of its associated lmnb2 mRNA takes place. This mechanism appeared to be 
modulated by the activation of TORC1 activity, a pathway linked to the translation of 
mitochondria-related genes and mitochondria biogenesis (Morita et al., 2013). Our results not 
only establish a novel functional relevance of the direct coupling between late endosomes and 
mitochondria, but also suggest that late endosomes could act as platforms to provide spatial 
control of protein translation adjacent to the site of action.  
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It has been a long-standing enigma that despite Rab7 being a ubiquitous protein, only long 
axons of peripheral neurons are susceptible to the conformational and functional alternations 
caused by the CMT2B-associated mutations. Clinically, sensory perturbations were frequently 
limited to the toes or forefeet in the early disease stage and the disease progression does not 
normally lead to wheelchair confinement. Several studies have been conducted to elucidate the 
pathogenic mechanism. One plausible explanation is that Rab7 mutations disrupt the interaction 
and regulation of downstream effectors functioning specifically in peripheral nervous system 
(PNS). For instance, one of the Rab7 key effectors Rab-interacting lysosomal protein (RILP), 
responsible for recruiting dynein to late endosome through direct interaction with the p150Glued 
subunit of dynactin, was demonstrated to control EGF degradation (Cantalupo et al., 2001). The 
protein level of RILP was significantly reduced in sural nerve biopsy from a CMT2B patient 
(Houlden et al., 2004), but not altered in HeLa cells expressing CMT2B-related mutants 
compared to the wild-type control (Spinosa et al., 2008), suggesting a cell-type specific 
intervention of Rab7 effector expressions by disease mutants. Recently, an intermediate 
filament cytoskeleton component predominantly expressed in PNS, peripherin, has shown to 
directly interact with Rab7. Mutant Rab7 bound peripherin with higher affinity, compromising 
peripherin filament assembly and possibly affecting neurofilament dynamics and axonal 
transport (Cogli et al., 2013), providing an alternative example for the PNS-restricted 
phenotypes in CMT2B patients.  
In this study, we propose a novel explanation highlighting the perturbation of local protein 
synthesis in distal axons and failure to maintain normal mitochondrial functions caused by 
CMT2B-related mutants, accounting for the distal-axon-exclusive CMT2B neuropathology. 
Mitochondrial proteins LaminB2 and VDAC2 local synthesis was compromised in disease 
mutant-expressing axons, and axonal translation of LaminB2 has been proven crucial for 
mitochondria integrity and axon survival (Cosker et al., 2016; Yoon et al., 2012). Local 
translation is particularly critical for the distal portions of long axons, such as human sensory 
neurons, as they allow the precise targeting and efficient production of new proteins on demand. 
In fact, reduced axon branching and guidance errors observed in sensory axons (Ponomareva et 
al., 2016) are typical axonal phenotypes when local protein synthesis is deregulated (Leung et 
al., 2013). Intriguingly, it has been reported that endosomes with Rab7 disease mutants paused 
less in Drosophila sensory axons (Janssens et al., 2014), supporting our hypothesis that mRNA-
containing late endosomes stall at subcellular locations in need of nascent proteins synthesized 
on late endosomes. Unexpectedly, lipophilic dye labelling of CMT2B-associated mutant-
expressed retinal axon projection revealed severe defects at the early synaptogenesis stage, in 
despite of the relatively shorter distance travelled by Xenopus RGC compared to human sensory 
or motor neurons. Because the disease onset is typically at the second or third decades in 
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CMT2B patients, it would be interesting to explore if the loss of axons in the Xenopus optic 
tract is a developmental or maintenance defect. Even though mitochondria-related protein 
synthesis and mitochondrial physiology have been our focus, it will be compelling to find out if 
other axonal mRNA translation and organelle functions are equally affected, or nuclear-encoded 
mitochondrial genes are the most susceptible ones in the CMT2B context, which can be 
achieved by examining the axonal translatome modulated by disease mutants.  
Using Xenopus laevis RGC as a vertebrate system, we aimed to provide insights into the 
debatable question whether the disease mutations lead to a gain-of-function toxicity (BasuRay 
et al., 2010; Cogli et al., 2010; Janssens et al., 2014; Liu and Wu, 2017; Ponomareva et al., 2016; 
Spinosa et al., 2008) or a partial loss of wild-type Rab7 function (Cherry et al., 2013). In our 
study, overexpression of the CMT2B-associated mutants inhibited mRNA translation (Figure 
4.16), disrupted mitochondria functions (Figure 4.18) and caused axon projection defects 
(Figure 4.15), consistent with the results obtained in disease mutant-expressing zebrafish 
(Ponomareva et al., 2016). In distal RGC axons expressing CMT2B-linked mutants, discrete 
vesicles were clearly visible with a moderate diffuse expression, resembling patterns observed 
in wild-type and CA Rab7, instead of the completely diffuse expression of DN Rab7. However, 
these findings are contradictory to the lack of phenotype in Drosophila photoreceptors 
expressing pathogenic mutants (Cherry et al., 2013), which may be attributed to the short 
lengths of Drosophila photoreceptors axons, where local protein synthesis and the local energy 
supply from mitochondria become less indispensible. Nevertheless, further studies on peripheral 
neurons from Rab7 knockout or CMT2B-associated mutant knock-in mammalian models can 
provide a more relevant basis for developing therapeutic strategies. 
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5 ROLE OF ALS/FTD-
ASSOCIATED PROTEIN FUS 
IN REGULATING AXONAL 
PROTEIN SYNTHESIS 
5.1 Introduction 
A veritable explosion of interest in the role of intrinsically disordered proteins (IDPs) in a broad 
range of biological contexts has been taking place during the past two years (Feric et al., 2016; 
Jiang et al., 2015; Lin et al., 2015; Molliex et al., 2015; Patel et al., 2015; Shin et al., 2017; Su 
et al., 2016). IDPs are proteins consist of low-complexity domains (LCDs) with low sequence 
complexity and amino acid compositional bias, many of which undergo transitions to more 
ordered states or fold into stable secondary or tertiary structures upon binding to their targets, 
including DNA and RNA molecules (Dyson and Wright, 2002). Other functional advantages of 
IDPs include flexibility to interact with multiple targets, accessible sites for posttranslational 
modification to fine tune the protein functions and ability to bind targets with high or modest 
affinity to facilitate the dynamic IDP-target association and dissociation (Dyson and Wright, 
2005; Kriwacki et al., 1996; Wright and Dyson, 1999). These unique characteristics make IDPs 
versatile proteins to regulate diverse fundamental biological process ranging from regulating the 
assembly and function of ribonucleoprotein (RNP) granules in different cell types, to the 
formation of specialised assemblies such as the postsynaptic density complexes in neurons 
(Wright and Dyson, 2015). 
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Research during the past decade has revealed the close association of IDPs to numerous human 
diseases, including cancers, cardiovascular disease, Alzheimer’s disease, amyotrophic lateral 
sclerosis (ALS), frontotemporal dementia (FTD) (Uversky et al., 2008).  Paradoxically, the 
properties of IDPs responsible for the development of pathological conditions are the same 
features renders them master regulators of key cellular processes. For instance, when phase 
transition or the switch between high and low target-binding affinity of the IDP becomes 
dysregulated, its interacting partners could become irreversibly trapped within IDP-containing 
complexes, preventing them from performing normal functions. Moreover, due to its binding 
promiscuity, any aberrant IDP function may lead to catastrophic effects on many biological 
processes. Therefore, understanding the biophysical basis and the molecular and cellular factors 
that control the reversible assembly of IDPs and how it affects cellular behaviours would 
provide invaluable fundamental knowledge for IDP-related disease treatment. 
Particularly, I was intrigued by IDP-related neurodegenerative diseases, including ALS and 
FTD, where distal axon dysfunction precedes clinical phase of the diseases, indicating a “dying 
back” pathophysiology (Dadon-Nachum et al., 2011; Fischer et al., 2004). However, the 
pathogenic mechanism by which dysfunctional IDPs cause axon degeneration remains elusive. 
Early studies linked the diseases with oxidative damage, excitotoxicity, defective axonal 
transport, mitochondrial impairment and endoplasmic reticulum stress (Ferraiuolo et al., 2011). 
However, more recently, advances in sequencing technologies led to the identification of 
additional disease-causing genes that encode proteins involved in RNA biogenesis and 
processing, including TAR DNA-binding protein (TDP-43), Fused in Sarcoma (FUS) and 
C9orf72, redirecting the focus to defects in RNA metabolism, potentially affecting local protein 
synthesis in distal neuronal compartments important for axon development and maintenance 
(Bowden and Dormann, 2016; Ederle and Dormann, 2017; Svetoni et al., 2016; Yasuda and 
Mili, 2016). 
In this chapter, using an ALS- and FTD-associated IDP protein FUS as an example, I sought to 
understand how mutations and posttranslational modification of IDPs result in axonopathy by 
investigating protein phase transitions, axonal RNA trafficking, local protein synthesis and 
axonal phenotypes. In partial agreement with earlier reports (Han et al., 2012; Kato et al., 2012), 
in vitro gelling assay showed that in a process driven by its low complexity domain, FUS 
undergoes phase transitions, reversibly shifting between dispersed liquid droplets and hydrogel-
like phases. Crucially, pathogenic FUS mutants limited this ability and increased the propensity 
of FUS to condense into stable and poorly soluble assemblies both in vitro and in axons, 
resulting in attenuated axonal translation and defective axon projections. Furthermore, besides 
disease-associated mutations, intracellular FUS assembly formation could be finely modulated 
in the cellular environment by changes in the posttranslational methylation of arginine residues, 
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and by the presence of other proteins acting as molecular chaperones, such as Transportin-1 
(Dormann et al., 2012; Tradewell et al., 2012). When these processes go awry, axonal protein 
synthesis was also compromised. The results presented in this chapter provide insights into FUS 
protein aggregation is physiologically modulated and how perturbations in these mechanisms 
may promote neurodegenerative diseases.   
5.2 FUS low complexity domain mutations convert reversible into 
irreversible hydrogel 
FUS protein sequence is over 80% conserved across vertebrates and composed of an N-terminal 
low complexity domain (LCD), an RNA-recognition motif (RRM), multiple RGG (arginine, 
glycine and glycine)-repeat regions, a zinc finger motif and a nuclear localization signal (NLS) 
at its C-terminus (Figure 5.1 A). All experiments in this chapter are based on overexpression of 
wild-type (WT) or mutant human FUS in Xenopus CNS. The FUS mutations include two 
benign LCD variants: FUS(N21H) and FUS(N63S), two pathological mutants of LCD: 
FUS(S96del) and FUS(G156E), the clinical C-terminal mutants: FUS(R495X), FUS(R522G), 
FUS(R524S), FUS(P525L), and a NLS-deleted mutant FUS501, which models several 
ALS/FTD-associated C-terminal truncating mutations (Figure 5.1 A). Because the FUS LCD 
(residues 2–214) has been reported to induce the assembly of wild-type FUS into hydrogel in 
vitro (Han et al., 2012; Kato et al., 2012), truncated LCD and its 4 mutants were also included 
in specific experiments to explore to what extent FUS aggregation propensity affects cellular 
activities.  
To quantify the biophysical aggregation propensity of FUS, the Zyggregator method developed 
by my collaborators, which measures the intrinsic aggregation propensity of proteins in the 
unfolded state based on the physic-chemical properties of their amino acid sequences, including 
α-helix and β-sheet propensity, hydrophobicity, charge, local stability and other factors, 
(Tartaglia et al., 2008; Tartaglia and Vendruscolo, 2008) was applied to reveal the aggregation 
propensity profile of human FUS protein (Figure 5.1 B). The profile indicates that the LCD is 
highly prone to aggregate, but this tendency is offset by the lower aggregation propensity of the 
C-terminal domains. Therefore, it can be speculated that ALS/FTD mutations in the FUS LCD 
(e.g., S96del and G156E) might directly increase the propensity of the LC domain to induce 
FUS assembly into higher order structures, while ALS/FTD mutants in the C-terminus would 
indirectly have the same effect by reducing the anti-aggregation effect of the C terminus.  
In collaboration with Seema Qamar at Cambridge CIMR, we adapted a previously described in 
vitro method (Han et al., 2012; Kato et al., 2012) to quantitatively assess the biophysical 
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Figure 5.1 FUS constructs and predicted aggregation propensity.
(A) FUS constructs and mutations. Full-length FUS constructs include wild-type FUS(WT) and 
ALS/FTD mutations (S96del, G156E, R522G, R524S, P525L, and R495X), or FUS (FUS501),  which 
mimics several ALS/FTD truncation mutants. FUS(LC)-only constructs include wild-type FUS(LC), 
pathogenic S96del or G156E mutants, or clinically benign P21H and N63S sequences. 
(B) Aggregation propensity profile of FUS (UniProt code: P35637) calculated with the Zyggregator 
method. The horizontal bars indicate structurally disordered regions located at positions 1-214 (low 
complexity domain; green), the RNA-binding domain at position 285-371 (RRM; purple) and nuclear 
localization sequence at positions 450-526 (NLS; orange). The N-terminus shows higher aggregation 
propensity (residues 1-100) than the C-terminus (residues 450-526). The intrinsic profile is smoothed 
using a 25-residue window.
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features of purified FUS(LC) during phase transition from soluble monomer to reversible liquid 
droplet and eventually stable assemblies. In this assay, when 1mM solutions of FUS(LC) in 500 
mM NaCl were cooled to 4°C, they condensed into gels, which dissolved into a clear solution 
when rewarming to 23°C (Figure 5.2 A). The physical states of FUS(LC) solution can be 
determined by inverting the siliconised tube: liquid assemblies readily fall under gravity, while 
gelled assemblies remain at the bottom of the tube. Interesting, when the liquid-gel-liquid or 
23°C-4°C-23°C cycle was repeated multiple times, the hydrogel formed at 4°C in the last cycle 
could not be dissolved anymore even when the temperature went up to 23°C, which was defined 
as irreversible gels (Figure 5.2 A).  
Using this assay, the number of liquid-gel-liquid cycles of wild-type and mutant FUS(LC) 
solutions before reaching irreversible gels could be determined by varying the temperature 
between 23°C and 4°C. Wild-type FUS(LC) and FUS(LC) containing benign polymorphic 
variants (P21H or N63S) cycled between two states 4-5 times before becoming irreversibly 
gelled. In contrast, the ALS-associated FUS(LC) mutants (S96del or G156E) turned into 
irreversible gels within 2 cycles (Figure 5.2 B).  
To further investigate the biophysics of phase transitions, single particle tracking methods were 
used to measure viscosity of liquid, reversible and irreversible gels formed by purified wild-type 
and pathological mutants of FUS(LC). In this experiment, 20nm radius fluorescent beads were 
dispersed within 15µl FUS(LC) solution cycling through different phases. The Brownian 
motion of the beads was used to infer viscosities of the FUS(LC) solutions in each phase. The 
assay revealed little difference between wild-type and mutant FUS(LC) in liquid or irreversible 
gel states. Compared to wild-type FUS(LC), mutant FUS(LC) forming reversible assemblies 
displayed a much greater viscosity, much more similar to viscosity of irreversible gels, 
consistent with smaller liquid-gel-liquid cycle numbers of FUS(LC)-S96del and FUS(LC)-
G156E.  
Despite all these measurements were carried out in vitro, they provided valuable insights into 
the biophysical properties of wild-type and mutant FUS proteins. The reversible hydrogels 
formed by wild-type FUS(LC), which showed only a modest difference in viscosity compared 
to liquid state, might reflect partial polymerisation into a loose but reversible fibrous network 
that provides more stability for higher order assemblies in cells. However, the aggregation 
propensity of LCD-containing proteins including FUS also renders them vulnerable to further 
condensation into hyper-stable intracellular structures, as reflected by rapid formation of 
irreversible gels by disease FUS(LC) mutants.  
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Figure 5.2 The reversibility of FUS hydrogels is reduced by ALS/FTD Mutants.
(A) Purified recombinant FUS(LC) forms clear solution at 23°C (left panel) but forms reversible 
gel-like structures at 4°C (center panel). Rewarming to 23°C reverts FUS(LC) to a liquid state (left panel). 
Repeated cycling of wild-type FUS(LC) eventually results in the formation of irreversible gels (right 
panel).
(B) Around 4 to 5 assembly/disassembly cycles can be achieved by wild-type FUS(LC) and FUS(LC) 
containing benign polymorphic variants (P21H and N63S). ALS/FTD mutations dramatically reduce the 
number of cycles to less than 1 cycle before irreversibility.
(C) Analysis of liquid, reversible gel, and irreversible gel using fluorescent particle tracking revealed 
that liquid and reversible gels have low viscosities. Mutant reversible gels were more viscous than 
wild-type reversible gels. Irreversible gels, regardless of whether made from wild-type or ALS/FTD 
mutant FUS exhibit very high viscosities.
Mean±s.e.m.; n.s., not significant, **P<0.01, ***P<0.001, unpaired t-test.
 
136
      
5.3 FUS is expressed in Xenopus laevis RGC axons 
In order to investigate whether the phase transition property of FUS influences neuronal 
physiology, I used Xenopus RGC as a model system. Genomewide microarray profiling 
identified FUS mRNA in retinal axons isolated by laser capture microdissection (Zivraj et al., 
2010). Moreover, recent unpublished data from the lab studying axonal proteome using pSILAC 
technique demonstrated FUS is locally translated in Xenopus RGC axons. To validate these 
transcriptomic and proteomic findings, immunocytochemistry on 24-hour retinal cultures from 
stage 24 and stage 32 embryos revealed endogenous FUS expressed in RGC axons and growth 
cones (Figure 5.3 A). In addition, endogenous FUS was detected from stage 32 and 40 Xenopus 
brain lysates by western blotting (Figure 5.3 B).  
However, due to the difficulty in editing endogenous FUS gene in Xenopus laevis, I studied the 
effect of ALS/FTD-associated FUS mutations by expressing human FUS proteins, which has 
been successfully applied in various biological systems (Lanson et al., 2011; Murakami et al., 
2012; Philips and Rothstein, 2015). In vitro synthesised mRNAs of C-terminally GFP-tagged 
wild-type or mutant FUS (Figure 5.1 A) were introduced into Xenopus embryos by blastomere 
injection. There was no obvious morphological abnormality in FUS(WT)-GFP-expressing 
embryos, indicating overexpression of GFP-tagged wild-type human FUS did not induce major 
toxicity to embryos. When comparable amount of each GFP-tagged mutant FUS was expressed 
in Xenopus CNS (Figure 5.3 D), only slightly smaller eye size was observed for embryos 
expressing FUS501-GFP (Figure 5.3 C) or other FUS mutants, implying mutant FUS expression 
did not impede embryonic development. 
As reported in other systems, wild-type FUS mainly localises to cell nucleus (Zinszner et al., 
1997), while NLS-deleted/mutated FUS mutants mislocalised to cytoplasm (Gal et al., 2011; 
Murakami et al., 2012), Next, I examined subcellular localisation of GFP-tagged wild-type and 
mutant FUS in RGCs and how they affect retinal layering (Figure 5.4). As expected, in 
cryosections of Xenopus retina, GFP was ubiquitously expressed in all retinal cell types, while 
FUS(WT)-GFP was predominantly localised to the nucleus. FUS(LC)-GFP expressed in both 
nucleus and cytoplasm due to the absence of NLS. In contrast, mutations in LCD alone, such as 
FUS(S96del)-GFP and FUS(G156E)-GFP, did not induce apparent cytoplasmic mislocalisation 
of FUS proteins. Unexpectedly, deletion or mutation of NLS, including FUS(R495X), FUS501, 
FUS(R522G), FUS(R524S), FUS(P525L), did not significantly increase cytoplasmic proportion 
of FUS. It could be because other regions of human FUS beyond NLS and LCD are partially 
responsible for its nuclear localisation, so only an under-detection level of NLS-deleted/mutated 
FUS localised to cytoplasm. In all cryosections, the retinal structure was preserved and RGC 
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Figure 5.3 FUS is expressed in Xenopus laevis RGC axons.
(A) Immunohistochemistry with anti-FUS antibody revealing axonal localisation of endogenous FUS 
proteins in stage 24 and 32 RGCs.
(B) FUS is endogenously expressed in Xenopus central nervous system of stage 32 and 40 embryos. 
(C) Stage 41 embryos expressing FUS(WT)-GFP or FUS501-GFP show no prominent phenotype.
(D) In vitro synthesised mRNA of all C-terminal GFP-tagged FUS constructs are expressed at similar 
levels in Xenopus CNS introduced by blastomere injection.
Scale bars: 5μm in A, 1mm in C.
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Figure 5.4 FUS predominantly localise to nuclei in Xenopus retina.
In retinal cryosections, GFP and GFP-tagged FUS proteins are expressed in all cell types. Wild-type FUS 
and full-length mutants showed predominantly nuclear localisation, while truncated LC domain localises 
to both nuclei and cytoplasm.
Scale bars: 50μm in column 1-3, 20μm in column 4.
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layer could be readily identified, suggesting overexpression of wild-type and mutant FUS did 
not perturb retinal organisation. 
To further investigate the expression pattern of GFP-labelled FUS in RGC axon shafts and 
growth cones, I imaged live axons expressing FUS constructs in retinal cultures (Figure 5.5). 
Diffuse GFP control was strongly expressed in axons. Due to the presence of NLS in FUS(WT)-
GFP, only a small amount of FUS protein localised to distal axons. When NLS was deleted in 
FUS(R495X)-GFP, significantly more FUS proteins localised to distal axon shafts and growth 
cones, even though the proportion of cytoplasmic FUS was relatively low in FUS(R495X)-
GFP-expressing somata (Figure 5.4). Despite LCD mutated FUS preferentially localised to the 
nucleus and a low level of FUS was detected in distal axons, bright granules composed of 
mutant FUS were visible (white arrowheads), signifying the high aggregation propensity of 
FUS LCD mutants in vivo. Finally, consistent with the cytoplasmic mislocalization of 
FUS(LC)-GFP in retina, both wild-type and pathological mutants of truncated FUS LCD were 
highly expressed in axon shafts and growth cones, forming FUS(LC)-GFP- and FUS(LC)-
S96del-GFP-granules in majority of retinal axons.  
To understand the dynamics of the visible GFP-labelled granules, 1-minute time-lapse images 
of human FUS-expressing axons were recorded with spinning disk confocal microscopy. In 
agreement with previous observations, no visible granule was detected in FUS(WT)-GFP-
expressing axons (Figure 5.6 A). Strikingly, with higher imaging sensitivity and magnification, 
accumulation of stationary or oscillatory granules was evident in a number of growth cones 
expressing FUS(R495X)-GFP (Figure 5.6 B), suggesting in addition to mutation of FUS LCD, 
NLS mutation also promotes axonal FUS assembly formation. By tracking axonal 
FUS(S96del)-GFP granules, I identified both stationary and moving FUS granules in axons 
(Figure 5.6 C), revealing the motility of a subset of mutant-FUS-containing granules.  
To summarise, FUS is endogenously expressed in RGC axons. Exogenous human FUS protein 
and its mutants localised to the predicted subcellular compartments, largely dependent on the 
NLS integrity. FUS granules formed by FUS LCD- or NLS- mutants, but not wild-type proteins, 
could be readily detected in axon terminals using confocal microscopy, supporting the 
speculation that LCD mutations might directly enhance the aggregation tendency of FUS, while 
NLS mutations would compromise the C-terminal anti-aggregation effect, leading to the same 
result of protein deposition. Notably, the absence of visible FUS-granules in FUS(WT)-GFP 
axons could be explained by the transience or small sizes of FUS liquid droplets, as such small 
FUS assemblies were only visible under super-resolution microscopy at the single molecule 
level (Schoen et al., 2015). 
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Figure 5.5 Axonal localisation of wild-type and mutant FUS.
In cultured RGC axons, all GFP-tagged FUS proteins revealed different degrees of axonal localisation. 
Small aggregates of FUS(WT)-GFP can be visualised in growth cones and occasionally along axon shafts 
(yellow arrowheads). Larger granules are visible in axons expressing FUS (R495X)-GFP (white 
arrowheads), but less obvious for FUS (S96del)-GFP. In axons expressing FUS(LC)-GFP and pathological 
mutants, moving granules are visible along axons (pink arrowheads) together with diffuse expressions. 
Scale bars: 10μm.
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Figure 5.6 Stationary and moving granules contain mutant FUS in axons.
(A) Some small aggregates might be present in FUS(WT)-GFP-expressing growth cones. Larger 
oscillatory granules (blue arrowheads) accumulates in growth cones expressing FUS(R495X)-GFP.
(B) Both stationary (blue arrowheads) and moving (yellow arrowheads) granules are present in axons 
expressing FUS(S96del)-GFP.
Scale bars: 5μm in A, 10μm in B.
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5.4 Mutant FUS confined RNP movement in axons 
Since FUS is a RNA-binding protein, the visible GFP-tagged FUS granules in axons are likely 
to carry RNA molecules. To explore this possibility, I delivered Cy5-UTP monomers 
intracellularly by blastomere injection to label endogenous RNAs in live axons expressing GFP-
labelled FUS(WT), FUS(R495X), FUS(S96del) and FUS(LC), the same approach described in 
the previous chapter. In cultured retinal axons, 91.87±5.37% of FUS(LC)-GFP granules 
colocalised with Cy5-labelled RNAs, illustrating most of axonal FUS assemblies are RNPs 
(Figure 5.7 A). Mutant FUS-containing RNPs were also observed in FUS(R495X)-GFP- and 
FUS(S96del)-GFP-expressing axons, but it was challenging to quantify the percentage of 
FUS/RNA colocalisation due to the low signal-to-noise ratio of those GFP granules during 
time-lapse imaging.  
Next, I asked whether RNP trafficking in axons were perturbed in mutant FUS-expressing 
axons compared to the FUS(WT) control. Given the absence of readily detectable FUS granules 
in most conditions except for FUS(LC)-GFP, the global RNP movement in 50µm axon 
segments were analysed regardless of their association with FUS granules. During each 1-
minute imaging session, significantly more Cy5-RNA granules in axons expressing mutant FUS 
showed less than 1µm/min displacement (Figure 5.7 B), defined by the distance between the 
start and end location of the Cy5-RNP within the axon segment. However, Cy5-RNPs in all 
axons displayed similar average speed (Figure 5.7 C), calculated from the mean of 
instantaneous speed disregarding the direction RNPs travelled. It appears Cy5-RNPs in mutant 
FUS-expressing axons were still transported with regular speed but within more confined spaces. 
Even though the data and analysis are still preliminary, they implied that mutant FUS, possibly 
in the form of more compact, non-reversible aggregates, may restrict RNA movement in axons. 
These results coincide with the observation of smaller net anterograde displacement of RNPs 
visualised by molecular beacons in TDP-43 mutant-expressing axons of human motor neurons 
compared to the wild-type TDP-43-expressing control (Alami et al., 2014). 
5.5 Mutant FUS perturbs new protein synthesis in growth cones 
The experiments so far demonstrate that mutant FUS has an increased propensity to form 
neuronal assemblies that display atypical trafficking in axons. These movement-confined 
mutant FUS assemblies could trap and titrate out key factors important for neuronal activity and 
survival. In the nucleus, this could affect transcription and splicing. In the cytoplasm, and 
particularly in specific subcellular niches such as dendrites and axon terminals, the trapping 
could impair local RNA metabolism and translation, thereby converting FUS RNP granules into 
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Figure 5.7 FUS granules colocalise with Cy5-labelled RNPs in axons.
(A) Representative images showing the colocalisation of FUS(R495X)-GFP granules and Cy5-RNA 
granules (white arrowheads) in cultured axons.
(B) A higher percentage of Cy5-RNA granules in axons expressing mutant FUS showing a 
displacement less than 1μm/minute compared with those in FUS(WT)-GFP-expressing axons. N=2000 
Cy5-RNA granules from 12-15 axon segments per condition analysed.
(C) The mean velocities of Cy5-RNA granules are not significantly different in axons expressing 
wild-type or mutant FUS. 
Mean±s.e.m.; n.s., not significant, **P<0.01, unpaired t-test. Scale bars: 10μm.
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local translation repressors. Particularly, mutant FUS are present in stress granules, which act as 
translational repressors (Anderson and Kedersha, 2002; Bosco et al., 2010; Decker and Parker, 
2012).  
To assess this hypothesis, I investigated de novo protein synthesis in axon terminals of primary 
Xenopus retinal neuron cultures expressing equivalent quantities of human full-length FUS(WT), 
full-length mutant FUS, wild-type FUS(LC), pathogenic mutant FUS(LC), or non-pathogenic 
FUS(LC) variants under basal or heat shock conditions (Figure 5.8 A). 
Applying the same approach used in previous chapters, newly synthesised proteins in retinal 
axons from stage 32 embryos were detected by pulse labelling with puromycin, which could be 
imaged using an anti-puromycin antibody (Figure 5.8 B). Under basal conditions, axonal 
translation measured in growth cones was not significantly affected in axons expressing 
FUS(WT)-GFP or FUS(P525L)-GFP, compared to the GFP-expressing control. However, de 
novo protein synthesis was significantly reduced in axons expressing most of the GFP-tagged 
NLS mutants, such as FUS501, FUS(R495X), FUS(R522G), FUS(R524S). Likewise, mutations 
in FUS LCD, including FUS(S96del) and FUS(G156E), also perturbed axonal protein synthesis, 
even more severely than the NLS mutants. 
For neurons expressing truncated FUS(LC)-GFP, local translation in axons was significantly 
attenuated compared to axons expressing full-length FUS. ALS/FTD-associated mutations 
within FUS(LC), such as S96del or G156E, further decreased local translation, in contrast to 
clinically benign variants P21H and N63S, which reversed the negative effect on protein 
synthesis caused by wild-type aggregation-prone FUS(LC). 
As environmental stress could induce cytoplasmic stress granules formation, a subset of which 
may comprise of FUS proteins. Therefore, retinal cultures were challenged by heat shock 
treatment by rapidly raising the temperature to 37°C for 30 minutes before puromycin 
administration. Following heat shock, new protein synthesis was reduced in all axons 
expressing GFP control or FUS-GFP constructs, compared to their respective basal conditions. 
In particular, local translation in all NLS-mutant-expressing axons were now significantly 
reduced compared to the control or FUS(WT) axons, including FUS(P525L)-GFP that showed 
little effect under basal condition. 
Finally, as a negative control, when cultures are pre-treated with 50uM cycloheximide for 15 
minutes before puromycin administration, puromycin incorporation was reduced by 
approximately 60%. 
To summarise, mutant FUS expression impaired axonal protein synthesis under both basal and 
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Figure 5.8 Mutant FUS perturbs new protein synthesis in RGC growth cones.
(A) Under basal conditions, de novo protein synthesis is equivalent in non-injected neurons, and in 
neurons expressing GFP-tagged FUS(WT). However, protein synthesis measured in growth cones was 
significantly reduced in neurons expressing ALS/FTD mutants including: FUS501, FUS(R495X), 
FUS(R522G), FUS(R524S), FUS(S96del), FUS(G156E), and in gelling-prone truncated FUS LC 
domains: FUS(LC), FUS(LC)-S96del, FUS(LC)-G156E, but not significantly different in benign 
polymorphic variants FUS(LC)-P21H and FUS(LC)-N63S. Upon 20-minute heat shock at 37°C, axonal 
translation are significantly decreased mutant FUS, but minimal impact on non-transfected and 
FUS(WT)-expressing neurons. 
(B) New protein synthesis was detected by puromycylation in growth cones of cultured Xenopus 
retinal axons expressing equivalent quantities of full-length FUS(WT) or various mutant and truncated 
human FUS proteins.
Mean±s.e.m.; n.s., not significant, *P<0.05, **P<0.01, ***P<0.001, unpaired t-test. Scale bars: 10μm.
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heat shock conditions, which could be attributed to the perturbation of axonal RNP granule 
function by mutant FUS assemblies trapping key components of the RNA metabolism and 
translation machinery. However, an alternate possibility is that the inhibition of new protein 
synthesis arises from cellular stress due to accumulation of misfolded mutant FUS proteins.  
5.6 Unfolded protein response does not account for translation 
attenuation 
The next obvious question to address is whether misfolded FUS proteins activated cellular 
stress pathways and down-regulated new protein synthesis in axons. While there are several 
non-specific forms of stress that might differentially occur in neurons expressing mutant FUS, 
the type of stress most clearly associated with the accumulation of misfolded proteins and with 
inhibition of new protein synthesis is the unfolded protein response (UPR), also known as the 
endoplasmic reticulum (ER) stress response. Traditionally, the UPR has only been associated 
with accumulation of misfolded proteins in the ER. However, in some models of 
neurodegenerative diseases, intracellular misfolded non-ER resident proteins have also been 
noted to activate the UPR and attenuate protein synthesis (Moreno et al., 2013; Nishitoh et al., 
2002; Xiang et al., 2017). 
Translation repression in the UPR is mediated by PERK (protein kinase RNA-like endoplasmic 
reticulum kinase) pathway (Figure 5.9 A). Essentially, when cells are under unfolded protein 
stress, PERK proteins, which are the transmembrane protein kinases of the pancreatic eIF-2α 
kinase (PEK) family, are oligomerised and autophosphorylated. PERK also phosphorylates eIF-
2α, decreasing global protein synthesis, which helps to reduce ER protein folding load and 
restores the cellular homeostasis (Walter and Ron, 2011). GSK2606414 inhibits PERK 
autophosphorylation and thus deactivates UPR (Axten et al., 2012). In contrast, sarcoplasmic or 
endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor thapsigargin activates UPR by 
depleting ER calcium storage and impairing calcium-dependent ER chaperone activity (Lytton 
et al., 1991; Zwaal et al., 2001).  
To understand whether UPR plays a role in mutant FUS-induced protein synthesis inhibition, 
GSK2606414 was applied to mutant FUS-expressing neurons to block potential UPR. To 
determine the optimal concentration of GSK260641, different concentration of the compound 
from 100nM to 1µM was administered to wild-type retinal cultures for 30 minutes (Figure 5.9 
B). A modest translation inhibition was caused by high concentration of GSK260641. In 
addition, a significant proportion of growth cones collapsed at 500nM or 1µM concentration. 
Therefore, 250nM was used to inhibit UPR. As a positive control, thapsigargin was applied to 
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Figure 5.9 Translation inhibition in axons expressing mutant FUS is not induced by unfolded 
protein stress.
(A) Schematic of PERK-dependent unfolded protein response (UPR) on endoplasmic reticulum (ER) 
membrane. Upon ER stress, PERK monomers dimerise and trans-autophosphorylated, leading to 
phosphorylation of PERK substrate, eIF2α, which attenuates protein synthesis. Thapsigargin induces ER 
stress by increasing intra-ER calcium concentration. GSK2606414 inhibits PERK activation.
(B) Titration of PERK inhibitor GSK2606414: at concentration up to 100nM, GSK2606414 does not 
significantly decrease protein synthesis in growth cones. However, a significant proportion of growth 
cones collapse at 500nM and 1000nM. Therefore, 250nM is chosen as the working concentration for 
GSK2606414.
(C) Titration of thapsigargin: at 500nM and 1000nM concentration, thapsigargin significantly 
decreases protein synthesis in growth cones. But a significant proportion of growth cones collapse at 
1000nM. Therefore, 500nM is chosen as the working concentration for thapsigargin.
(D) Thapsigargin treatment induced unfolded protein response (UPR) and reduced new protein 
synthesis in RGC growth cones expressing FUS(WT). PERK1 inhibitors rescued reduced protein 
synthesis in thapsigargin-treated neurons expressing FUS(WT), but not mutant FUS-expressing neurons.
Mean±s.e.m.; n.s., not significant, **P<0.01, ***P<0.001, unpaired t-test. 
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FUS(WT)-GFP-expressing cultures to activate UPR. 20-minute incubation of thapsigargin at 
different concentration revealed a decrease of puromycin incorporation as the concentration of 
thapsigargin increased, indicating thapsigargin-induced UPR inhibited new protein synthesis in 
growth cones (Figure 5.9 C). Because growth cones treated with 1uM thapsigargin collapsed, 
500nM was selected as the working concentration.  
First, I validated the effect of GSK260641 in UPR inhibition. When FUS(WT)-expressing 
neurons were treated with GSK260641 for 30 minutes, no apparent difference in puromycin 
incorporation was detected. On the other hand, 20-minute thapsigargin incubation resulted in 12% 
decrease in new protein synthesis, which could be fully reversed by pre-treating the cultures 
with GSK2606414. However, none of the attenuated translation caused by mutant FUS could be 
restored when UPR was inhibited by the equivalent dose of GSK260641, illustrating the 
reduction in local translation of mutant FUS-expressing axons did not arise from unfolded 
protein stress.  
5.7 Mutant FUS leads to defective phenotypes in the optic tract 
Finally, I assessed the effect of mutant FUS on RGC axon development and maintenance in vivo. 
Conventionally, motor neurons and cortical neurons are the mostly used disease models for 
ALS/FTD studies (Fallini et al., 2012; Groen et al., 2013; Valetdinova et al., 2015). In this study, 
Xenopus RGCs expressing mutant FUS were used to model ALS/FTD-affected axons as they 
can be easily imaged in vivo to examine axon development, morphology and integrity at 
different developmental stages.  
In particular, this system can be manipulated to distinguish the RGC-autonomous or substrate-
associated axon behaviours (Roque et al., 2016). GFP-tagged wild-type or mutant FUS RNAs 
were injected into only one of the two dorsal blastomeres at 4-cell stage, resulting in embryos 
with half of the CNS overexpressing the exogenous FUS while the other half remaining wild-
type (Figure 5.10 A). To trace RGC axons expressing human FUS proteins, a lipophilic 
fluorescent dye (DiI) was injected into the eye cavity on the “ipsilateral” half of the embryos to 
label retinal axons of stage 45 embryos, when a majority of axons have reached their targeted 
tectal area and arborized. Because all RGC axons cross the midline at the optic chiasm and 
project contralaterally (Figure 5.10 B), all DiI labelled axons navigate within the wild-type 
brain hemisphere, excluding any contribution from exogenous FUS-affected brain substrates.  
Among all embryos unilaterally injected with GFP-tagged wild-type or mutant FUS, mutations 
in LCD (S96del and G156E) and NLS deletion (R495X) led to a significantly larger percentage 
of embryos with defective RGC projections compared to the GFP control (Figure 5.10 C, D). 
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Figure 5.10 Phenotypes of RGC projections in vivo of embryos expressing wild-type and mutant 
FUS.
(A) Schematic of DiI labelling of stage 45 RGC axons in unilaterally injected embryos. Only one of 
the two CNS-fated cells at 4-cell stage is injected with GFP or GFP-tagged FUS mRNA. The “ipsilateral” 
eye on the injected hemisphere (indicated by green) is labelled with the fluorescent dye. After crossing 
chiasm, RGC axons from the injected eye enter the “contralateral” wild-type hemisphere.
(B) A side-view of RGC projection in the contralateral brain hemisphere. A: anterior, P: posterior, D: 
dorsal, V: ventral.
(C) Representative images of RGC axon projections in stage 45 embryos expressing GFP-tagged 
wild-type or mutant FUS.
(D) Percentage of embryos with defective RGC projections in embryos unilaterally injected with 
GFP-tagged wild-type or mutant FUS.
Mean±s.e.m.; n.s., not significant, ***P<0.001, unpaired t-test. Scale bars: 100μm.
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The most prominent defect was loss of axons, which could be explained by impaired axon 
outgrowth. Therefore, defective projections are referred to those with fewer than 30 visible 
axons post optic chiasm. Alternatively, axons might degenerate after target arrival. Therefore, in 
future studies, it will be interesting to investigate the mechanism underlying axon loss in mutant 
FUS-expressing embryos, which suggest mutant FUS might dysregulate key cellular processes 
critical for axon development or maintenance. 
5.8 Hypomethylated FUS assemblies impair new protein 
synthesis in axons 
ALS and FTD have been considered as two extremes of a continuum of the same underlying 
disorder based on their shared genetics and overlapping movement and cognitive impairments 
(Devenney et al., 2015; Lillo et al., 2012; van Es et al., 2017). However, mutations of FUS have 
rarely been reported in FTD cases, even though FUS-positive cytoplasmic inclusions have been 
identified in 10% of FTD patients (Halliday et al., 2012; Neumann et al., 2009; Snowden et al., 
2011). In fact, the largest genome-wide association study of FTD to date involved 3526 FTD 
patients and 9402 healthy controls confirmed the weak correlation between FTD and FUS locus 
variants (Ferrari et al., 2014). This suggests a potential alternative mechanism driving 
cytoplasmic FUS aggregation independent of FUS mutations in FTD cases.  
Recently, FUS proteins with monomethylated arginine (UMA) and unmethylated arginine 
(MMA) have been found in FTD-FUS inclusions (Suarez-Calvet et al., 2016). Arginine is a 
positively charged amino acid known to mediate hydrogen bonding and amino-aromatic 
interactions. The nitrogens of arginine within polypeptides can be posttranslationally modified 
to contain methyl groups by protein arginine methyltransferases (PRMT) (Bedford and Richard, 
2005). Arginine methylation does not alter the charge of the protein, but it can affect hydrogen 
bonding and local hydrophobicity, critical for intramolecular or intermolecular interactions (Lee 
and Stallcup, 2009). Arginine methylation of FUS regulates nuclear-cytoplasmic localization by 
modulating the binding affinity of FUS to nuclear protein Transportin-1 (TNPO1), which 
imports FUS from cytoplasm into nucleus (Dormann et al., 2012; Tradewell et al., 2012). 
Outside of the nucleus, TNPO1 is known to be expressed in some cytoplasmic RNA granules, 
where it coexists with FUS; with purine-rich element binding protein A (Pur-α, which 
modulates toxicity of ALS-associated FUS mutants); and with Staufen-1 (a marker of neuronal 
transport granules) (Jain et al., 2016). In this non-nuclear role, TNPO1 facilitates the import of 
protein components into RNA granules in a Ras-related Nuclear protein-GTP-independent 
fashion (Chang and Tarn, 2009; Twyffels et al., 2014). Therefore, the change of arginine 
methylation states may be an explanation for non-mutant FUS deposits in FTD models. 
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In vertebrates, wild-type FUS proteins undergo extensive asymmetric dimethylation at arginine 
residues by PRMT1 and PRMT8, which are known components of intracellular FUS inclusion 
bodies (Scaramuzzino et al., 2013). Thus, inhibition of PRMT activities can effectively reduce 
asymmetric dimethylarginine (ADMA) on FUS and increase MMA and UMA forms. 
Adenosine-2,3-dialdehyde (AdOx) is a widely-used inhibitor of PRMT activities (Dormann et 
al., 2012; Fujii et al., 2016; Suarez-Calvet et al., 2016). Transfected human FUS-GFP 
immuneprecipitated from Sf9 cells treated with 25µM AdOx showed a significant reduction of 
the ADMA form of FUS compared with FUS-GFP purified from mock treated cell lysates, 
probed with antibodies to asymmetrically dimethylated arginines (Figure 5.11 A), 
demonstrating AdOx treatment effectively inhibited asymmetric dimethylation on arginine 
residues of FUS proteins.  
Next, to examine how changes in FUS methylation might affect its aggregation propensity in 
axons, I investigated the impact of AdOx on FUS granules in retinal cultures. 
Immunocytochemistry revealed a higher endogenous FUS protein level in RGC axons with 1-
hour AdOx treatment compared to axons with DMSO mock treatment (Figure 5.11 B), 
consistent with the reported cytoplasmic mislocalization of hypomethylated FUS (Dormann et 
al., 2012). Notably, FUS appeared to form larger aggregates in AdOx-treated growth cones 
(Figure 5.11 B, yellow arrowheads), yet it was challenging to define FUS inclusions in fixed 
cells labelled with anti-FUS antibodies. In order to quantify the number of FUS assemblies in 
axons, I injected FUS(WT)-GFP mRNA into Xenopus embryos and imaged live RGC axons 
expressing GFP-tagged exogenous FUS. In a good agreement with the immunocytochemistry 
results, there were significant more FUS(WT)-GFP-containing granules in axons incubated with 
AdOx than mock treatment. Collectively, these results confirm the effect of AdOx in phase 
transition of FUS in axonal assemblies. 
To investigate whether compromised arginine methylation affects axonal protein synthesis, low 
concentration of puromycin was added to the culture during the last 10 minutes of AdOx or 
buffer incubation. Puromycin incorporation was significantly diminished in 30-minute or 1-hour 
AdOx-treated growth cones expressing endogenous FUS compared to control growth cones 
mock-treated with DMSO only (Figure 5.12 A). The magnitude of this effect (~0.80 of control) 
approximates that induced by ALS-associated FUS mutations (0.60-0.80 of control) (Figure 5.8).  
As discussed previously, Transportin-1 (TNPO1) has been detected in cytoplasmic FTD-FUS 
inclusions (Brelstaff et al., 2011). But little is known about its role in modulating the function of 
FUS granules in axons. Introducing mCherry-TNPO1 mRNA by blastomere injection resulted 
in motile granules composed of TNPO1 in axon (Figure 5.12 C), confirming the axonal 
localisation and potential RNP-related function of TNPO1. I therefore investigated whether 
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Figure 5.11 AdOx-induced hypomethylation of FUS promotes the formation of bright FUS granules 
in RGC axons.
(A) Representative western blot and quantification of FUS-GFP purified protein from Sf9 total cell
lysate after 4 days of 25μM AdOx or control treatment reveal the reduction in methylation level of
transfected FUS upon AdOx treatment.
(B) Representative images and quantification of endogenous FUS detected by anti-FUS antibody in
30min mock- or AdOx-treated growth cones (n=26 and 16 growth cones respectively).
(C) Representative images and quantification of GFP-FUS in live distal axon segments following
30min mock or AdOx treatment (n=7 and 9 axons respectively)
Mean±s.e.m.; * p<0.05, ** p<0.01, unpaired t-test. Scale bars: 5μm.
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Figure 5.12 AdOx-induced hypomethylated endogenous FUS reduces translation in RGC growth 
cones.
(A) 20μM AdOx treatment of somaless RGC growth cones for 30min or 1h significantly reduces de 
novo protein synthesis, indicated by the relative levels of puromycin incorporation. N:120 growth cones 
are analysed in each condition.
(B) Puromycin labelling of new protein synthesis was equivalent in axon terminals expressing 
endogenous FUS plus mCherry, endogenous FUS plus mCherry-tagged TNPO1, but was significantly 
reduced in axon terminals express endogenous FUS plus mCherry after 30min AdOx treatment. The 
AdOX-induced attenuation in new protein synthesis in axon terminals expressing endogenous FUS was 
rescued by overexpression of mCherry-TNPO1. N:161 growth cones are analysed in each condition.
(C) Moving granules containing mCherry-TNPO1 are visible in RGC axons (white arrowheads).
Mean±s.e.m.; n.s., not significant, ***P<0.001, unpaired t-test. Scale bars: 5μm.
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overexpression of TNPO1 might positively or negatively influence axonal translation. 
Quantifying puromycin incorporation in growth cones revealed no difference between mCherry- 
and mCherry-TNPO1-expressing axons. Strikingly, overexpression of mCherry-TNPO1 in 
AdOx-treated neurons fully rescued the reduction in protein synthesis (Figure 5.12 B). When 
interpreted in the context of previous results on the effects of ALS-associated mutations, the 
puromycylation assay demonstrated that one consequence of hypomethylation of FUS was the 
formation of stiff intracellular hydrogels that retain RNP granule cargo and impair new protein 
synthesis in axons. By acting as a molecular chaperone to prevent or reverse formation of stiff 
hydrogels, TNPO1 can counteract this effect.   
5.9 Discussion 
A detailed explanation of how ALS/FTD-associated mutations or post-translational 
modifications in RBPs might impact neuron biology would increase our understanding both of 
the molecular origins of these neurodegenerative disorders and of the biology of nuclear and 
cytoplasmic RNP granules. This chapter provides several important insights into these issues. 
First, in vitro and in vivo experiments described in this chapter support a physiological model in 
which reversible phase transition of LC-containing proteins including FUS can involve in 
controlling the assembly and function of membrane-free structures such as axonal RNP granules. 
Immunohistochemistry revealed endogenous FUS proteins forming small clusters in growth 
cones (Figure 5.11 B left panel). The absence of visible axonal granules in FUS(WT)-GFP-
expressing axons (Figure 5.5 and 5.6 A) could be due to the small sizes of these assemblies, 
which are likely to be only visible under super-resolution microscopes (Schoen et al., 2015). 
Another possibility is the low fluorescent signal-to-noise ratio of these granules, as they might 
be mainly composed of endogenous untagged FUS proteins. The biophysics of conversion from 
liquid droplet to reversible hydrogel remained elusive, but they differ only slightly in viscosity. 
Thus, reversible hydrogels might reflect the partial polymerization into a loose but reversible 
fibrous network that provides more stability for longer-lived granules.  
However, the biophysical propensity of LC-containing proteins to undergo phase transitions to 
liquid droplets and hydrogels also renders them vulnerable to further condensation into hyper-
stable structures. According to the biophysical aggregation propensity calculated by 
Zyggregator method, FUS assembly is largely driven by its LC domain, while other parts of the 
protein, especially the C terminus, likely buffer this tendency and render the overall protein less 
prone to form higher order assemblies. In vitro gelling assay indicated mutations in FUS LCD 
might directly increased its propensity to undergo phase transition into stable “irreversible” 
hydrogel-like states, while mutations in the C terminal NLS are likely to indirectly increase the 
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risk of phase transition by reducing the anti-assembly property of the C terminus. Still other 
mutations may affect this process by altering binding of RNA or other proteins, which are 
known to nucleate FUS assembly (Schwartz et al., 2013). In good agreement with gelling assay 
results, stationary and moving FUS granules were only visible in retinal axons expressing LCD- 
or NLS-mutated instead of wild-type FUS.  
Intriguingly, even wild-type FUS could eventually be induced to phase shift into fibrillar 
hydrogel form, an observation that provides a mechanism for the occurrence of aberrant FUS 
assemblies in cases of sporadic ALS/FTD with FUS pathology, but without mutations in FUS 
(Figure 5.2). This phenomenon strongly indicates the protein has an intrinsic aggregation 
property. Therefore, there are likely to be active processes to maintain FUS in a dispersed state, 
and to reverse gelled forms. Some of these processes are likely related to autophagy and 
proteasome pathways, as is the case for TDP-43 (Gotzl et al., 2016; Scotter et al., 2014; 
Urushitani et al., 2010), but as demonstrated in this chapter and unpublished work by my 
collaborators, post-translational modifications on FUS and external factors in the intracellular 
microenvironment, such as salt concentration and molecular chaperons, are likely to modulate 
the dynamic FUS granule assembly and disassembly.  
One example shown in this study is that the changes in the posttranslational state of FUS can 
also have a powerful effect on FUS phase transition. Arginine residues in FUS are typically 
heavily asymmetrically dimethylated. In some forms of frontotemporal lobar degeneration 
(FTLD), demethylated FUS aggregates accumulate in the nucleus and cytoplasm of frontal and 
temporal neurons (Bowden and Dormann, 2016; Brelstaff et al., 2011). The experiments in this 
chapter provide direct evidence that in axons, hypomethylation of FUS increases its propensity 
to undergo phase separation, leading to intra-axonal FUS granules formation and diminishing 
new protein synthesis in growth cones. These findings closely resemble the effect of FUS 
assemblies composed of disease-associated mutant FUS, which suggests a common molecular 
mechanism between FUS mutation- and hypomethylation-induced axonopathy and 
neurodegeneration. 
To identify potential molecular chaperons of axonal FUS granules, the function of a FUS-
binding protein Transportin-1 (TNPO1) was investigated in the context of FUS 
hypomethylation. TNPO1 is well known to act as a nuclear import receptor for FUS and has 
been reported to bind with higher affinity to more aggregation-prone hypomethylated forms of 
FUS (Suarez-Calvet et al., 2016). TNPO1 is a component of β-karyopherin within nuclear pore 
complex involved in active nucleo-cytoplasmic transport of proteins. A large proportion of 
TNPO1 cargo proteins, including FUS, EWS, hnRNP A1 and HuR, most of which are RNA-
binding proteins, interact with TNPO1 via PY-NLS motif for nuclear import (Twyffels et al., 
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2014). However, less is known whether TNPO1 is also present in axonal RNP granules, which 
is now confirmed in retinal axons (Figure 5.12 C). As shown by puromycylation assay, one of 
the axonal function of TNPO1 is to act as a molecular chaperon of FUS and ameliorate the 
translation attenuation effect induced by FUS hypomethylation, possibly by binding to 
aggregation-prone hypomethylated FUS and preventing pathogenic FUS granule formation.  
As discussed in the introduction, several mechanisms could account for considerable 
neurotoxicity induced by FUS mutants or hypomethylated FUS. Results in this chapter strongly 
suggest that one, but not necessarily the only, neurotoxic effect of phase transition into higher 
order assemblies is to perturb the function of axonal RNP granules and reducing new protein 
synthesis in growth cones, resulting in axon development or maintenance defects. Previously, it 
has been proposed that pathological FUS- and other RBP-containing aggregates are related to 
translationally stalled stress granules, based on the presence of stress granules markers in these 
RNPs (Li et al., 2013). In addition, eukaryotic translation initiation factor eIF-2α 
phosphorylation, which is known to promote stress granule formation and attenuate global 
translation under stress conditions (Anderson and Kedersha, 2002), is upregulated in patients 
with neurodegenerative diseases, including TDP-43 mutant-induced ALS, while inhibition of 
eIF-2α phosphorylation rescues TDP-43 toxicity in Drosophila and mammalian ALS models 
(Kim et al., 2014; Moreno et al., 2012). In this study, however, inhibition of PERK activation, 
which phosphorylates eIF-2α during unfolded protein response, did not restore protein synthesis 
blocked by mutant FUS in retinal axons (Figure 5.9 D), suggesting unfolded protein stress and 
activation of PERK pathway may not be causative for mutant FUS-induced translation 
inhibition. Thus, despite the resemblance to stress granules, FUS granules may have their 
distinct properties. For instance, mutant FUS assemblies in cytoplasm of fibroblasts appeared to 
be translationally active sites detected by FUNCAT and puromycin labelling (Yasuda et al., 
2013), in contrast to most of the reported impaired protein synthesis in mutant FUS-expressing 
models.  
Besides the potential stress granule origin of pathologically mutant FUS assemblies, the 
reduction in local new protein synthesis could arise through other molecular mechanisms that 
are not mutually exclusive, including altering intracellular transport of FUS granules (Figure 
5.7), (Alami et al., 2014; Liu-Yesucevitz et al., 2014), and sequestration of cargo proteins 
involved in regulating local RNA metabolism and local translation.  
Finally, while the mechanism of mutant/hypomethylated FUS-induced translation suppression 
remains to be elucidated, it will be also important to catalogue the differential RNA and protein 
components of normal and pathological FUS assemblies in ALS and FTD and to discover the 
signaling events that govern their assembly and disassembly. Understanding the basis for these 
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processes may provide an explanation for the different ALS/FTD clinical phenotypes induced 
by FUS assemblies. More importantly, as shown in this chapter, manipulation of molecular 
components of pathological RNP granules to destabilize pathological assemblies and 
manipulation of the signaling pathways that govern assembly and disassembly of physiological 
and pathological RNP granules might be tractable therapeutic targets for these diseases. 
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6 CONCLUDING REMARKS 
Local mRNA translation in growing axons enables precise control of axonal proteomes in 
response to intracellular and environmental signalling, a process crucial to axon maintenance 
and survival. In this thesis, several imaging approaches were first adapted to measure cue-
stimulated dynamics of protein synthesis in distal axons and growth cones. Single molecule 
translation imaging (SMTI) allows ultimate spatiotemporal resolution to detect specific protein 
synthesis in growth cones in real time. In the rest of the study, the optimised imaging methods 
were applied to explore the relationship between axonal translation and two neurodegenerative 
diseases, CMT2B and ALS/FTD. In CMT2B cases, mutations in late endosome-associated 
small GTPase Rab7a attenuated late endosome-site mRNA translation in axons. Specifically, 
synthesis of nuclear-encoded mitochondrial proteins on late endosomes docking adjacent to 
axonal mitochondria was inhibited by disease mutants, resulting in multiple mitochondrial 
defects. Axons expressing ALS/FTD-related mutants with altered sequences in low complexity 
domain or nuclear localisation sequence, some of which formed visible axonal RNP granules, 
showed altered axonal RNA transport, attenuated local translation and defective axonal 
phenotypes. Furthermore, hypomethylated forms of FUS identified in some FTD cases also 
caused a reduction in axonal protein synthesis, which can be mitigated by overexpression of 
molecular chaperon, transportin-1. Overall, this study highlights that dysregulation of local 
protein synthesis may be a unifying theme in numerous neuropathies. 
In this study, the retinal ganglion cell axon of Xenopus laevis embryos is the primary neuronal 
model for investigating disease pathology. The observed retinal projection phenotypes in vivo 
caused by CMT2B or ALS-linked mutations may partially reflect the disease-linked axonopathy 
in humans, which demonstrates Xenopus RGCs as a promising disease model. In addition to the 
well-studied mature neuronal models, it is exciting to observe cellular and molecular changes in 
developing axons expressing disease-related proteins, raising the possibility that disease-
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associated variations of cellular physiology may occur and accumulate until the initial 
manifestations become evident. Therefore, it would be of interest to validate some of the 
findings in other animal models and eventually in humans.  
  
Even though CMT2B and ALS/FTD appear to be two independent disorders, they share several 
common aspects over their courses of development. Both diseases are progressive late-onset 
neuropathies, affecting primarily neurons with long axons, such as sensory and motor neurons, 
resulting in impaired motor ability in patients. Disease-associated proteins FUS and Rab7 
interact with an intermediate filament protein peripherin, important for axon outgrowth and 
regeneration. Pathological mutations in FUS and Rab7 lead to abnormal neurofilament 
assembly in disease-affected axons (Cogli et al., 2013; Corbo and Hays, 1992). Proteins 
associated with both diseases are involved in interconnected pathways. For instance, ALS/FTD-
related protein TDP43 loss of function perturbed dendritic transport of recycling endosomes but 
slight increase Rab7-positive endosomes (Schwenk et al., 2016). Defects in endosomal 
trafficking have been reported in ALS/FTD cases (Schreij et al., 2016), implying different 
neurological diseases may utilise some common pathogenic strategies. 
 
The question how mutations in ubiquitously expressed proteins cause defects exclusively in the 
nervous system has been discussed throughout this thesis and in many published studies (Cogli 
et al., 2009; Monani, 2005). Results from CMT2B and ALS/FTD disease models in this study 
support an RNA-based hypothesis – the long distance between the distal axon, where specific 
proteins are needed, and the soma, where mRNAs are transcribed, renders neurons with long 
axons vulnerable to subtle perturbation of mRNA localisation and local protein synthesis caused 
by disease mutants. In axons expressing CMT2B-associated Rab7 mutants, local production of 
mitochondrial proteins was compromised, resulting in mitochondria dysfunction and 
axonopathy. In mutant FUS-expressing axons, altered RNA trafficking likely accounts for 
translation attenuation in growth cones and defective axon projection in vivo. The findings in 
this thesis proposing a local translation-based mechanism may be extended to other 
neuropathies, hopefully providing some mechanistic insights for future therapeutic development 
to combat neurological disorders.  
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